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ABSTRACT

ACID SUSPENDS THE CIRCADIAN CLOCK IN HYPOXIA THROUGH INHIBITION OF MTOR
Zandra E. Walton
Chi Van Dang

Recent reports indicate hypoxia influences the circadian clock through the transcriptional
activities of hypoxia inducible factors (HIFs) at clock genes. Unexpectedly, we uncover a
profound disruption of the circadian clock and diurnal transcriptome when hypoxic cells
are permitted to acidify, recapitulating the tumor microenvironment. Buffering against
acidification or inhibiting lactic acid production fully rescues circadian oscillation.
Acidification of several human and murine cell lines, as well as primary murine T cells,
suppresses mechanistic target of rapamycin complex 1 (mTORC1) signaling, a key
regulator of translation in response to metabolic status. We find acid drives peripheral
redistribution of normally perinuclear lysosomes away from perinuclear RHEB, inhibiting
activity of lysosome-bound mTOR. Restoring mTORC1 signaling and the translation it
governs rescues clock oscillation, revealing a model in which acid produced during the
cellular metabolic response to hypoxia suppresses the circadian clock through
diminished translation of clock constituents.
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CHAPTER 1 - Introduction
Some prokaryotes and nearly every eukaryote possess a form of a circadian
clock (Dibner and Schibler, 2015). This convergent evolution, as well as the frequent
ubiquity of such clocks within the various tissues of an organism, reflects the
evolutionary fitness endowed by the ability to temporally align biological processes with
the day-night cycle (Rosbash, 2009). In mammals, although clocks are hierarchically
orchestrated, with a central hypothalamic clock sending synchronizing stimuli to
peripheral clocks throughout the body, each peripheral clock, found in virtually every cell,
is autonomous and capable of self-sustaining oscillation (Box 1) (Dibner et al., 2010).
The molecular basis for these clocks is a series of interlocking negative feedback loops
that take 24 hours to play out (Box 2) (Partch et al., 2014). In the core loop, the clock
circadian regulator (CLOCK) and brain and muscle ARNT-Like 1 (BMAL1) heterodimer
drives the expression of many E-box containing genes throughout the genome, including
transcripts encoding its own inhibitors, the period (PER) and cryptochrome (CRY)
proteins. This, together with reinforcing secondary loops, generates oscillating clock
transcription factor activities and ultimately circadian rhythmicity of thousands of
transcripts in a given tissue, particularly those with metabolic roles (Bass, 2012; Koike et
al., 2012; Pizarro et al., 2013; Takahashi, 2017; Zhang et al., 2014). Subsequent
oscillations in protein levels, enzymatic activities, metabolites, and cellular processes
follow (Box 3) (Janich et al., 2015; Krishnaiah et al., 2017; Panda, 2016).
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Box 1 – Hierarchically organized circadian clocks anticipatorily time physiology
Circadian clocks allow organisms to anticipate cyclical (daily) events and coordinate
physiologic processes with optimal timing (Bass and Takahashi, 2010). In mammals,
clocks in the suprachiasmatic nucleus of the hypothalamus constitute a central
pacemaker tuned to the appropriate phase by retina-sensed light relayed via the
retinohypothalamic tract. Through neuronal and hormonal (e.g. glucocorticoid)
outputs, rhythmic control of behaviors such as eating, and other signaling pathways,
the central clock synchronizes the oscillation of autonomous peripheral clocks found in
nearly every cell (Dibner and Schibler, 2015; Dibner et al., 2010).

These cellular peripheral clocks can sustain oscillation outside the body, observance
of which is aided by synchronizing a population of cultured cells with dexamethasone
and serum in vitro (Balsalobre et al., 2000).

2

Box 2 – Molecular mechanism of the mammalian circadian clock
The mechanistic basis for both central and peripheral clocks is an interlocking network
of feedback loops centered on the heterodimer CLOCK-BMAL1 (Partch et al., 2014).
CLOCK-BMAL1 drives the expression of many genes containing E-box consensus
sequences in their regulatory regions. Among these target genes are those encoding
period (PER) and cryptochrome (CRY) proteins, which feedback to inhibit CLOCKBMAL1 posttranslationally, forming the core negative feedback loop. A second
negative feedback loop arises from CLOCK-BMAL1–mediated transcription of genes
encoding REV-ERB proteins, which bind the RORE motif in the promoter for BMAL1
and negatively regulate its transcription. Together these feedback loops cause
circadian oscillation of CLOCK-BMAL1 activity and, consequently, directly or indirectly,
the circadian expression of thousands of downstream clock-controlled genes (CCGs)
in a given tissue type.

Adapted with permission from Walton, Z. et al. (2018). Circadian Clock’s Cancer
Connections. Annual Review of Cancer Biology 2,133-153.
3

Box 3 – Clocks optimally time metabolism
In the mouse liver, the core circadian clock (orange circle) oscillates in synchrony with
the day-night cycle (innermost circle) and drives rhythmic expression of many genes
involved in metabolic pathways (green circle) to appropriately time their transcription
(black font) and subsequent translation (blue font). As a result, metabolites oscillate
around the clock (blue circle), supporting (and also a consequence of) rhythmic
cellular processes (outer area) optimally timed to anticipate demand. In addition to
providing evolutionary fitness by timing metabolic activities to coincide with daily
patterns in substrate (food) availability and product need, clocks also permit temporal
segregation of otherwise incompatible processes (Eckel-Mahan and Sassone-Corsi,
2013; Feng and Lazar, 2012; Huang et al., 2011). Whether peripheral clocks continue
to cycle normally and exert temporal constraint under metabolic or oncogenic stress,
however, is largely unknown.
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Abbreviations: AMP, adenosine monophosphate, BNIP3, BCL2 interacting protein 3;
CPT1A, carnitine palmitoyltransferase 1A; ERK, extracellular signal-regulated kinase
(a.k.a. MAPK); GSH, glutathione; GSSG, oxidized glutathione (glutathione disulfide);
MnSOD, manganese-dependent superoxide dismutase (a.k.a. superoxide dismutase
2); NAD+, oxidized nicotinamide adenine dinucleotide; mTORC1, mechanistic target of
rapamycin complex 1; PDH, pyruvate dehydrogenase; p-eIF2α, phosphorylated
eukaryotic translation initiation factor 2A; PERK, PRKR-like endoplasmic reticulum
kinase; SLC7A2, solute carrier family 7 member 2 (a.k.a. cationic amino acid
transporter 2); TCA cycle, tricarboxylic acid cycle; UPR, unfolded protein response;
VO2, rate of oxygen consumption. Gene names: Acly, ATP citrate lyase; Fasn, fattyacid synthase; Gck, glucokinase; Glut2, glucose transporter type 2 (a.k.a. Slc2a2);
Mdh2, malate dehydrogenase 2; Nr1d1, Nr1d2, genes encoding REV-ERBα and REVERBβ proteins; Pdhb, pyruvate dehydrogenase beta (a component of the PDH
complex); Per1, Per2, Per3, period genes; Tfrc, transferrin receptor encoding TFR1
(a.k.a. TFRC).
Adapted with permission from Walton, Z. et al. (2018). Circadian Clock’s Cancer
Connections. Annual Review of Cancer Biology 2,133-153. (figure credit: CV Dang)
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Despite their physiological benefit, such extensive daily transcriptionaltranslational mobilizations, as well as the temporal constraints imposed by a clock, might
pose a liability for cells during stress (Woelfle et al., 2004; Xu et al., 2013). Intriguingly,
links have been uncovered between circadian disruption and cancer, with circadian
disruption (e.g. night shift work) associated with increased incidence of certain cancers
and deregulation of clock network components noted in some human malignancies and
observed to accelerate tumorigenesis in mice (Kettner et al., 2016; Papagiannakopoulos
et al., 2016; Shostak, 2017; Walton et al., 2018a). Recently, we identified that the
oncogene MYC blunts oscillation of the molecular clock (Altman et al., 2015). Given that
regulation of metabolism is a key clock function, we wondered if metabolic stress
inherent to cancer might trigger circadian perturbations in cancer.
Exquisitely low oxygen tensions are common in solid tumors owing to
outstripping of perfusion offered by abnormal tumor vasculature (Carmeliet and Jain,
2011; Gallagher et al., 2008; Gillies et al., 2002) (Box 4). As oxygen is required for
energy-producing oxidative phosphorylation among other enzymatic activities, this poses
a substantial challenge for tumor cells (Nakazawa et al., 2016). Hypoxia stabilizes
hypoxia inducible factor alpha subunits (HIFs), allowing them to carry out a
transcriptional program that profoundly alters metabolism to cope with the low oxygen
tensions (Box 5) (Semenza, 2013). Resulting upregulation of glycolytic enzymes and
simultaneous deflection of carbon away from the tricarboxylic acid (TCA) cycle cause a
substantially

elevated

flux

of

glucose

to

lactic

microenvironment (Box 6) (Divakaruni et al., 2014).
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acid,

acidifying

the

tumor

Box 4 – Tumor hypoxia
Solid tumors often exhibit hypoxic regions due to high metabolic activity of cancer cells
and insufficient or abnormal angiogenesis in tumors (Carmeliet and Jain, 2011). The
metabolic changes that ensue in response to low oxygen tensions cause this hypoxic
stress to frequently be coupled to pH stress (Box 5, Box 6) (Gallagher et al., 2008;
Gillies et al., 2002; Sattler et al., 2007; Song C.W., 2006). Necrotic tumor regions
seemingly evince the severe end of a spectrum of such metabolic stress (Manzoor et
al., 2008).
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Box 5 – Hypoxia inducible factors mediate the transcriptional response to low
oxygen
Hypoxia inducible factor (HIF) transcription factors are silenced in normoxia (oxygenreplete conditions) as a consequence of oxygen (O2)-dependent hydroxylation events
(Keith et al., 2011; Schofield and Ratcliffe, 2004). HIF alpha subunit (HIF1 HIF2
hydroxylation by prolyl-hydroxylases (PHD1, PHD2, or PHD3) leads to recognition by
the E3 ubiquitin ligase complex component von Hippel-Lindau (VHL) and rapid
proteasomal degradation. Factor inhibiting HIF (FIH) cooperates to block HIF signaling
through transactivation-inhibiting hydroxylation of a C-terminal asparagine.

Hypoxia diminishes PHD and FIH activity largely through substrate (O2) limitation.
Once thus stabilized, HIF alpha subunits translocate to the nucleus and dimerize with
constitutively expressed ARNT (HIF1β) to transcriptionally activate hypoxia-response
element (HRE)-containing genes that aid survival in low oxygen (Majmundar et al.,
2010; Semenza, 2007). In addition to these well-described profound metabolic

8

rewirings by HIF (Xie and Simon, 2017), we wondered if hypoxic signaling might also
alter the circadian clock to direct cooperative confrontation of the hypoxic stress given
the clock’s central role in homeostatic metabolism.

PHDs = prolyl hydroxylases; bHLH = basic helix-loop-helix; PAS = PER-ARNT-SIM;
P= proline; N = asparagine; OH = hydroxyl group; others as in text.
Elements of figures adapted from Keith, B. et al. (2011). HIF1α and HIF2α: sibling
rivalry in hypoxic tumour growth and progression. Nature Reviews Cancer 12, 9-22.,
and Adams, J. (2004). The proteasome: a suitable antineoplastic target. Nature
Reviews Cancer 4, 349-60.
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Box 6 – HIF-mediated metabolic rewiring increases acid production through
elevated glycolytic flux
Mitochondrial

metabolism

(oxidative

phosphorylation)

slows

in

hypoxia.

To

compensate, HIF1 spurs anaerobic glycolysis, greatly elevating flux of glucose to
lactate through upregulation of genes encoding a glucose transporter (GLUT1),
glycolytic enzymes, lactate dehydrogenase A (LDHA), and an inhibitor of pyruvate
tricarboxylic acid (TCA) cycle entry, pyruvate dehydrogenase kinase 1 (PDK1) (all in
orange font below) (Kim et al., 2006). Conversion of pyruvate to lactate by LDH
enzymes cycles NADH back to NAD+, allowing high glycolytic flux to continue. Proton
(acid) production increases in hypoxia because of this shift to acid-generating
glycolysis to meet ATP demands in place of more proton-neutral full oxidation of
glucose to CO2 (see detailed H+ accounting in reference (Divakaruni et al., 2014)).
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HK1 = hexokinase 1; HK2 = hexokinase 2; PFK = phosphofructokinase; ALDA =
fructose bisphosphate aldolase (“Aldolase A”); PGK1 = phosphoglycerate kinase 1;
NAD+ and NADH = nicotinamide adenine dinucleotide, oxidized and reduced,
respectively; ADP = adenosine diphosphate; ATP = adenosine triphosphate; Pi =
inorganic phosphate (HPO42-); H+ = proton (hydrogen ion); others as in text above.
Figure based on description in Divakaruni, A. S. et al. (2014). Analysis and
Interpretation of Microplate-Based Oxygen Consumption and pH Data. Methods in
Enzymology 547, 309-354.
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We wondered if hypoxia might additionally rewire clock-controlled metabolism to
meet the hypoxic challenge. Indeed, recent papers have shown HIFs to be capable of
influencing various clock transcripts in a cell-type-dependent manner (Adamovich et al.,
2017; Peek et al., 2017; Wu et al., 2017). Here, we report a more profound suspension
of the circadian clock and the diurnal transcriptome when hypoxic cells are permitted to
acidify their environment in a manner recapitulating the tumor microenvironment
(Chapter 2 Figure 1A). Pursuing the underlying clock-suppressive mechanism reveals a
previously undescribed means by which low pH potently inhibits the key regulator of
cellular metabolism mechanistic target of rapamycin complex 1 (mTORC1) (Box 7) and
gives functional significance to a long-recognized phenomenon of lysosome spatial
scattering in low pH previously of unknown consequence (Heuser, 1989). We find this
mechanism of acid-mediated suppression of mTORC1 to be shared by T cells in addition
to the multiple tumor cell lines tested, suggesting tumor acidity is posed to facilitate
tumorigenesis through immunomodulation as well as stress-adaptation-driven circadian
suppression.
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Box 7 – mTOR senses stress signals to appropriately time anabolic processes
mTOR complex 1 (mTORC1), a multi-protein assembly composed in part by the
kinase mTOR, regulates cell growth, matching anabolic processes to periods of
substrate sufficiency and growth-affirmative humoral signals (Saxton and Sabatini,
2017). Such coordination emerges from multiple parameters indicative of suitability for
growth converging on two populations of GTP-binding proteins immediately upstream
of mTORC1, Ras-related GTP-binding (RAG) and Ras homolog enriched in brain
(RHEB) proteins. Sensors for arginine, leucine, and methionine signal amino acid
sufficiency to lysosome-localized RAG heterodimers through a series of protein
interactions that ultimately control RAG nucleotide binding states (Gu et al., 2017;
Saxton et al., 2016; Wang et al., 2015; Wolfson et al., 2016; Wolfson and Sabatini,
2017). Correct GTP/GDP loading of RAG proteins recruits mTORC1 to the lysosomal
surface where it is believed a population of RHEB resides allowing activation of mTOR
kinase by RHEB (Sancak et al., 2010). RHEB is GTP-bound and thus capable of
activating amino-acid-recruited mTOR so long as the tuberous sclerosis complex
(TSC), which contains TSC2, the GTPase-activating protein (GAP) for RHEB, is
spatially disengaged from RHEB in response to growth factors (e.g. signals relayed
through phosphatidylinositol 3-kinase (PI3K) and mitogen-activated protein kinase
(MAPK) signaling) (Menon et al., 2014) and kept inactive through absence of TSC2activating

stress

signals

(e.g.

energy

insufficiency

sensed

by

adenosine

monophosphate (AMP)-sensitive AMP kinase (AMPK)) (Dibble and Manning, 2013).
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Active mTORC1 positively regulates translation through mTOR phosphorylation of
downstream substrates (Nandagopal and Roux, 2015; Thoreen et al., 2012).
Phosphorylation of ribosomal S6 kinase (S6K) stimulates S6K phosphorylation of
ribosomal protein S6, a component of the 40S ribosomal subunit, driving cell growth
through debated mechanisms (Meyuhas, 2015). mTOR also phosphorylates inhibitory
binding partners of the eukaryotic initiation factor 4E (eIF4E), the 4EBP proteins,
preventing their engagement with eIF4E and thereby releasing suppression of capdependent translation. mTORC1 thus senses stress and reserves energy-costly
translation and downstream biosynthetic processes for periods in which reserves of
energy and building blocks can support these demands.
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CHAPTER 2 - Results
Hypoxia suspends the clock through acid
To explore the effect of hypoxia on the clock, we utilized the U2OS Arntl::dLUC
circadian reporter cell line, a human osteosarcoma line in which luciferase expression is
driven by the promoter for Arntl, the gene encoding BMAL1 (Zhang et al., 2009). We
avoided assessing bioluminescence, an O2-dependent reaction, in low oxygen tensions
by periodically harvesting lysate from cells grown in hypoxia or normoxia over a
timecourse for assay of luciferase activity in normoxia. We found that hypoxia
significantly suppressed the circadian oscillation of this reporter (1B, S1A). This
disruption was readily reversible upon reoxygenation (S1A), consistent with a possible
role for HIFs. Indeed, stabilization of HIF with dimethyloxalylglycine (DMOG) (1C, 1D) or
desferrioxamine (DFX) (S1B), inhibitors of the prolyl hydroxylases that mediate HIF
degradation, was sufficient to reversibly disrupt oscillation of the Arntl reporter and a
Per2 promoter-reporter in normoxic cells monitored continuously by a luminometer.
Knockdown of HIF1A and EPAS1 (HIF-2α) restored oscillation of the Arntl reporter in
DMOG, confirming that HIFs mediate disruption of circadian oscillation in hypoxia (1E).
Intriguingly, the ability of DMOG to disrupt the clock depended highly on the
buffering capacity of the media. Hypoxia or DMOG, via HIF, greatly increases flux of
glucose to lactic acid. Buffering against acidification fully preserved clock reporter
oscillation in DMOG-treated live cells (1F, 1G). pH did not affect the luciferase reaction,
as identical results were seen in lysates collected and assayed in neutral pH (S1C,
S1D). Analogous results were seen in low oxygen tensions, with the clock suppressed
reversibly in low buffer media but temporarily protected from disruption in more highly
buffered media until later time points when acid overwhelmed the buffering capacity
15

(S1E). Acidification of low buffer media upon HIF stabilization (1F, S1E) was anticipated
given that HIF drives acid-generating glycolytic flux through induction of glycolysis
enzymes and lactate dehydrogenase A (LDHA) (Chapter 1, Box 6). Surprising, however,
was that pH commensurate with that found in solid tumors (Gallagher et al., 2008) was
sufficient to reversibly disrupt the circadian clock (1I, S1F). Correspondingly, knockdown
of HIFs rescued clock oscillation (1E) in association with normalization of HIFαresponsive glycolytic mRNAs (S1K, S1L) and pH (1H). Further, titration with a highly
specific chemical inhibitor of LDHA (Boudreau et al., 2016) rescued clock oscillation (1J)
in proportion to normalization of pH (1K). Application of the inhibitor in the presence of
acidic media failed to rescue clock oscillation (1J, K), consistent with rescue through ontarget reduction in acid production.
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Figure 1 – Hypoxic metabolism suspends the circadian clock through
generation of acid
A. Summary of findings in this report. B. Lysate luciferase activity (relative light units
(RLU)) of U2OS cells stably expressing the Arntl::dLUC circadian clock reporter grown
in normoxia or hypoxia (1% O2) for 57 hours. RE of 2, 1-3 BR each. C. Continuous
luminescence monitoring of U2OS Arntl::dLUC cells treated with 750 uM DMOG or
vehicle. DMOG washout at 4 days. RE of ˃5. D. Cells stably expressing the
Per2::dLUC reporter treated with 1 mM DMOG as in C. Washout of vehicle/DMOG at
1.7 days. RE of 2, 1-3 BR. E. Luminescence monitoring of U2OS Arntl::dLUC cells
treated with non-targeting control (siCtl) siRNA or siRNA against both HIF alpha
subunits (HIF1A, EPAS1) prior to exposure to vehicle or 750 uM DMOG. Mean of 3
BR. RE of 3. F./G. Luminescence monitoring of U2OS Arntl::dLUC cells treated with 1
mM DMOG or vehicle in low (F) or high (G) buffer media. Mean of 2 BR. RE of ˃5.
Indicated mean media pH after 1.5 days for 2 BR treated in parallel (standard error of
the mean (SEM) <0.05). H. Media pH after 4 days of DMOG treatment in low buffer
media following siRNA treatment as in E. Mean pH of 2 BR ± SEM. T-test (unpaired,
two-tailed, unequal variances) *p≤0.05. I. Luminescence monitoring of U2OS
Arntl::dLUC cells grown in triplicate in media of pH 6.3. After 1.5 days, media of two
plates was exchanged for media of pH 7.5 (washout) or 6.3 (mock washout). RE of ˃3.
J./K. Luminescence monitoring (J) and media pH after 2 days (K) of U2OS
Arntl::dLUC cells treated with vehicle or 750 uM DMOG (left) or pH 7.4 or pH 6.3
media (right) and the indicated concentration of GNE-140 (color-coded as in K). Mean
of 2 BR (+/- SEM in K). Ordinary one-way ANOVA with Dunnett’s multiple comparison
test comparing all means to respective control (DMOG or pH 6.3 condition with 0 uM
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GNE-140) **p≤0.01, ****p≤0.0001, ns = p>0.05. RE of 3. All cells B-K synchronized
(see Methods) at time 0. RE = representative experiment. BR = biological replicates.
See also Figure S1.
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Figure S1. Acid produced by HIF-mediated metabolism disrupts oscillation of
the molecular circadian clock. Related to Figure 1.
A. Luciferase activity of lysate collected periodically from U2OS Arntl::dLUC cells
synchronized (with dexamethasone and media change) and grown in normoxia or
hypoxia (1% O2, media pre-deoxygenated) for up to 57 hours. After 33 hours some
cells were removed from hypoxia and their media exchanged for normoxic media.
Luminescence plotted as relative light units (RLU). Representative experiment of 2. B.
Real-time luminescence monitoring of U2OS Arntl::dLUC cells synchronized and
treated with 18.75 uM desferrioxamine (DFX). After 4.7 days, DFX-containing media
was exchanged for fresh media. Representative experiment of ˃5. C./D. Luciferase
activity of lysate and luminescence of live cells immediately prior to lysate harvest of
U2OS Arntl::dLUC cells synchronized and treated with 1mM DMOG or vehicle for up
to 3.5 days in low (C) or high (D) buffer media. Data presented as mean of cells plated
in triplicate ± standard error of the mean (SEM). Representative experiments of two
each with biological triplicates. E. Upper panel: Luciferase activity of lysate collected
periodically from U2OS Arntl::dLUC cells synchronized and grown in normoxic high
buffer or hypoxic (1% O2, media pre-deoxygenated) low or high buffer conditions for
up to 51 hours. After 29 hours some cells were removed from hypoxia and their media
exchanged for normoxic high buffer media. Data presented as mean of technical
duplicates ± standard deviation (SD) (but error bars generally too small to see).
Representative experiment of 2. Lower panel: pH of media across timecourse. F.
Real-time luminescence monitoring of U2OS Arntl::dLUC cells synchronized and
grown in media of initial pH of 7.5, 7.0, 6.5, and 6.3. Representative experiment of 2
each with 1-2 biological replicates. Note the data shown for pH 6.3 appear also in
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Figure 1H as the data were divided between these figures for clarity. G. Real-time
luminescence monitoring of U2OS cells stably expressing a hypoxia response element
(HRE) reporter derived from the HRE of PGK1 (PGK1-HRE::dLUC) synchronized and
treated with media pH 7.4 or 6.3 or 300 uM DMOG or vehicle in low buffer conditions.
Data presented as the mean of cells plated in triplicate ± SEM error bars. H.
Expression

of

the

hypoxia

inducible

factor

(HIF)-responsive

genes

lactate

dehydrogenase A (LDHA), phosphoglycerate kinase 1 (PGK1), solute carrier family 2
member 1 (SLC2A1, GLUT1), and vascular endothelial growth factor A (VEGFA) in
U2OS Arntl::dLUC cells in acidic (pH 6.3) and neutral (pH 7.4) media over a 52-hour
timecourse as determined by RNA-sequencing (RNA-seq) of RNA collected every 4
hours. Reported as fragments per kilobase of transcript per million mapped reads
(FPKM). I. Immunoblot for HIF1α using lysate collected periodically from U2OS
Arntl::dLUC cells treated with 1 mM DMOG in low or high buffer media or media of pH
7.4 or 6.3 (in parallel to Fig 2B-D). J. Real-time luminescence monitoring of U2OS
cells stably expressing PGK1-HRE::dLUC or a reporter derived from the HRE of
VEGF (VEGF-HRE::dLUC) synchronized and treated with 1mM DMOG or vehicle in
low or high buffer media. Data presented as mean of ≥2 plates ± SEM error bars.
Representative experiment of ≥2 per reporter. K. Relative expression of HIFα subunits
(upper) and HIF-responsive genes (lower) in U2OS Arntl::dLUC cells following
treatment with non-targeting control (siCtl) siRNA or siRNA against both HIF1α
subunits (HIF1A, EPAS1) prior to synchronization and DMOG (787.5 uM) treatment as
in 1E and IH. 10 nM siRNA each condition (5 nM each when two siRNA). qPCR of
RNA collected 14 hours after DMOG or vehicle treatment, with expression normalized
to respective target expression in the siCtl vehicle condition. Data presented as mean
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of technical triplicates ± SEM. T-tests of individual genes (unpaired, two-tailed,
unequal variance), **p<0.01 each. L. Expression of genes encoding HIFα subunits in
U2OS Arntl::dLUC cells after 4 hours in media of pH 7.4 as determined by RNA-seq.
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Importantly, acid failed to stabilize HIF1α (S1I), activate a reporter of HIF
transcription (S1G), or induce HIF-responsive genes (S1H). Although highly buffered
media does shorten the duration of high HIF-stability (S1I), destabilization of HIF does
not account for the ability of highly buffered media to rescue the clock, as HIF is
transcriptionally active in highly buffered media (S1J). Moreover, for the first 32 hours,
induction of pyruvate dehydrogenase kinase 1 (PDK1) in response to DMOG or hypoxia
is comparable in both low and highly buffered media (S2A)—indicating robust HIF
activity across this interval in all buffer conditions—however vastly different effects are
seen on the clock (S2B, S2C). This discordance between HIF transcriptional activity and
clock oscillation stands in contrast to the high concordance between media pH (S2D)
and clock oscillation (S2B, S2C). Hence, clock disruption by hypoxia is an indirect
consequence of HIF transcriptional abilities mediated by acid.
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Disruption of the clock network by acid is extensive
Single-cell luminescence imaging (Welsh et al., 2005; Welsh et al., 2004)
revealed acid severely dampened amplitude without significant alteration of period or
phase, indicating low pH caused disruption not through loss of coherence of the cell
population but through suppression of the molecular oscillator (2A, S2E). To fully
characterize this acid-mediated clock perturbation in hypoxia, we stabilized HIF with
DMOG in media of high or low buffering capacity and assessed transcript levels of
components of the core clock every 4 hours over a 52-hour timecourse (2B-C). Cells
grown in neutral (pH 7.4) or acidic (pH 6.3) media were similarly probed (2D). The
expression of endogenous ARNTL revealed by these timecourses faithfully matched the
luminescence detected from the Arntl::dLUC reporter (S2B, S2C). These timecourses
evinced that HIF-induced acidification disrupted the normal circadian oscillation of all
members of the core clock assessed, causing loss of both the 24-hour periodicity of
these genes and the antiphasic relationship between ARNTL and its targets (PER, CRY,
NR1D1, and NR1D2) (2B). Highly buffered media rescued these distortions (2C, S2D).
Acidic media was sufficient to disrupt the clock network (2D) with kinetics that outpaced
that in response to gradual HIF-mediated acidification (2B, S2D). Like DMOG, hypoxia
severely disrupted the clock in low buffer, halting oscillation of all assessed core clock
components (S2F). In agreement with luciferase-reporter results (S1E), buffered media
preserved hypoxic clock oscillation for 24-28 hours, after which oscillation diminished as
the media acidified (S2F). Intriguingly, some components of accessory loops of the clock
(BHLHE40 (DEC1), RORA) remained induced by HIF in buffered media (S2G),
indicating that their induction was insufficient for clock perturbation.
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Figure 2 – Acidification is both necessary and sufficient to disrupt the clock
network.
A. Rhythmicity, amplitude, period, and phase as a function of media pH as determined
by single-cell luminescence imaging of U2OS Arntl::dLUC cells. Mean ± SEM of ≥ 25
analyzed cells (13-25 rhythmic) each pH. ANOVA with post-hoc Dunnett’s comparing
to control pH 7.4. *p<0.05, ***p<0.001, ns=p>0.05 B./C. Expression of endogenous
core clock components assessed by qPCR over a 52-hour timecourse in synchronized
U2OS Arntl::dLUC cells treated with 1 mM DMOG or vehicle in low (A) or high (B)
buffer media. D. Expression similarly probed in parallel in cells treated with neutral (pH
7.4) or acidic (pH 6.3) media. See also Figure S2.
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Figure S2. Low pH mediates suppression of the endogenous clock network in
hypoxia. Related to Figure 2
A. Expression of the HIF-responsive gene pyruvate dehydrogenase kinase (PDK1)
during the timecourses shown in Fig 2B-D as well as in a similar timecourse obtained
in hypoxia (S2F, described below) as determined by qPCR and normalized to the
respective control (e.g. vehicle, pH 7.4, normoxia) 4 h time point. B. Real-time
luminescence monitoring of U2OS Arntl::dLUC cells treated in parallel to the
endogenous RNA timecourses in Fig. 2B-D. Mean of cells plated in triplicate or
duplicate ± SEM error bars. Data from the hypoxic timecourse shown in S1E are also
shown again here for completeness of comparisons. C. Endogenous ARNTL
expression (previously depicted in Fig. 2B-D or appearing in S2F) is shown to highlight
that the luciferase reporter shown in B closely mirrors these endogenous transcript
levels. D. Media pH over the same timecourses as C (and Fig. 2B-D). E. Scatterplot of
normalized fast Fourier transform (FFT) peak (descriptive parameter of variance of
periodic data indicative of strength of rhythmicity) vs. period for individual cells
analyzed by single-cell luminescence imaging (n= 30, 29, 25 for pH 7.4, 6.8, 6.3,
respectively). Cells above the annotated FFT=0.07 threshold were scored rhythmic as
cells with a period (τ) clearly outside the circadian range (τ <15 h, τ > 35 h) tended to
have a FFT peak value < 0.07. Cells with FFT peak < 0.07 were scored arrhythmic.
Percent rhythmic cells reported in Figure 2A is the percent of cells analyzed with FFT
peak ≥ 0.07. See Methods. F. Expression of constituents of the endogenous core
clock over a 52-hour timecourse in U2OS Arntl::dLUC cells synchronized and grown in
normoxic high buffer or hypoxic (1% O2, media pre-deoxygenated) low or high buffer
conditions for 52 hours. Total RNA was collected every 4 hours and expression was
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assessed by qPCR and normalized to that at 4 h in normoxia. Media pH during this
timecourse (shown also in D) shown here to highlight the correlation between
acidification and suppression of circadian oscillation of transcripts. G. Expression of
DEC1 (BHLHE40) and RORA during 1 mM DMOG treatment or upon exposure to
acidic (pH 6.3) media relative to control (vehicle or pH 7.4) conditions at 4 or 8 hours
after synchronization and exposure. Representative experiment of at least two
independent experiments.
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Given the extensive clock disruption in acid, we suspected the circadian
transcriptome might be impacted. RNA-sequencing (RNA-seq) over the 52-hour
timecourses revealed virtually identical expression profiles of the core clock as
measured by qPCR, confirming the reliability of RNA-seq to address this question (S3A).
Using ARSER, a statistical test of circadian rhythmicity (Yang and Su, 2010), we
interrogated protein-coding transcripts and identified 1206 robustly circadian transcripts
in neutral pH (p<0.05, false discovery rate (FDR) <0.2) (3A, 3B). As expected, among
significantly circadian transcripts were those encoding the core clock, secondary
feedback loops (e.g. NR1D1, NR1D2), clock output regulators (DBP, TEF), and clock
paralogs (e.g. NPAS2) (3C, S3C). These 1206 genes illustrate the robust cell
autonomous circadian transcriptome (3A). Not surprisingly, the cell cycle and circadian
clock topped the enriched pathways (3D), with many additional functional categories
represented including aspects of metabolism, DNA repair, gene expression, and protein
modification.
By contrast, less than 8% as many transcripts in cells exposed to acidic media met
statistical significance for circadian oscillation (3B, S3B). Nearly all the 1206 robustly
circadian genes lost oscillation in acidic media (3A), including members of the core clock
(3C, S3C). Additionally, of the 86 transcripts deemed circadian in acid, many appeared
only weakly so (S3B) and all but 12 were not circadian at pH 7.4, illustrating that few
strongly oscillating transcripts retained their circadian profile in acid (S3B). Thus, acid
profoundly suppresses both the core clock and circadian transcriptome. Further, acid
induced (log2 > 1, n = 571) and suppressed (log2 < -1, n=859) many transcripts (3E-G),
particularly those involved in the unfolded protein response or the cell cycle, respectively
(S3D). Together these findings reveal a multifaceted cellular response to acid, which
suppresses the circadian clock and activates stress responses.
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Figure 3 – The normally circadian transcriptome ceases oscillation in acid.
A. Expression in pH 7.4 and 6.3 of the 1206 protein-coding genes with statistically
significant circadian oscillation in neutral conditions (pH 7.4) (p<0.05, false discovery
rate (FDR) <0.2) ordered by pH 7.4 phase. Fragments per kilobase of transcript per
million (FPKM) mapped reads determined from RNA-seq of RNA collected every 4
hours for 52 hours from U2OS Arntl::dLUC cells treated with media of each pH as in
2D. Normalized expression (see Methods) color-coded as indicated. Green lines
highlight the circadian periodicity in expression in pH 7.4. B. Histogram and Venn
diagram indicating the number of protein-coding genes with statistically significant
circadian oscillation in pH 7.4 or 6.3 or both. C. FDR statistic of test for circadian
rhythmicity of expression (as in A) for core and secondary feedback loop clock genes
and representative clock paralogs (NPAS2) and output regulators (DBP, TEF) in pH
7.4 or 6.3. D. Pathway ontologies significantly enriched (B&Y q <0.05) amongst
circadian transcripts indicated in B. P=PantherDB, R=Reactome, K=KEGG. Terms
related to cell cycle and clock colored as shown. p<0.05 above dashed line. E. Acidinduced and acid-suppressed transcripts defined as log2 of the ratio of the average
expression over all 13 time points (4h-52h) in pH 6.3 to pH 7.4 >1 or < -1. F./G.
Expression in pH 7.4 and 6.3 of the 571 acid-induced (F) and 859 acid-suppressed
transcripts (G) defined in E. Color scale as in A. Ranked from top by most highly
induced or suppressed. See Figure S3.
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Figure S3. Transcriptomic analyses reveal loss of oscillation of the core clock
and its outputs during acid stress. Related to Figure 3
A. Expression of representative core clock genes over the 52-hour timecourse in pH
7.4 and 6.3 as determined by RNA-sequencing (RNA-seq) (left) versus real-time
polymerase chain reaction (qPCR) (right, data also appear in 2D) of RNA collected as
described in 3A. RNA-seq reported as fragments per kilobase of transcript per million
mapped reads (FPKM). B. Expression in pH 7.4 and 6.3 of the 86 protein-coding
genes with statistically significant circadian oscillation in pH 6.3 (3B) (p<0.05, false
discovery rate (FDR) <0.2) ordered by phase. Color scale as in 3A. C. p-value statistic
of test for circadian rhythmicity of expression (as in 3A) for core and secondary
feedback loop clock genes and representative clock paralogs (NPAS2) and output
regulators (DBP, TEF) in pH 7.4 or 6.3. D. Most highly significant biological process
ontologies represented in the 571 acid-induced and 859 acid-suppressed transcripts
(defined in 3E) with terms related to unfolded protein response, vesicle trafficking,
DNA repair, and cell cycle colored as shown. p<0.05 above the dashed line. For pH
6.3, all ontologies with B&H q-value<0.05 shown; for pH 7.4, the top 10 ontologies are
shown (q<1x10-5).
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Low pH inhibits translation and thereby the clock
To delineate the mechanism by which hypoxia-generated acid suppresses the clock,
we first determined how extracellular pH (pHe) and DMOG affect intracellular pH (pHi).
We generated a U2OS cell line stably expressing a cytoplasmic pH probe consisting of
pH-insensitive mCherry fused to pH-sensitive GFP (SuperEcliptic (SE) pHluorin)
(Koivusalo et al., 2010). Using a pHi standard curve generated with ionophores (S4A,
S4B), we concluded that pHi fell in cells exposed to acidic media or DMOG (4A, S4C), in
accord with findings of others (McBrian et al., 2013; Pouyssegur et al., 1985). Consistent
with pHi acidification driving clock collapse, two inhibitors of hydrogen ion efflux
pathways, amiloride (which inhibits sodium-hydrogen antiporter 1 (NHE1) among other
exchangers) and α-cyano-4-hydroxycinnamate (a monocarboxylate transporter 1
inhibitor) lowered intracellular pH (S4E) (Koivusalo et al., 2010; McBrian et al., 2013)
and reversibly suppressed circadian oscillation of Arntl::dLUC (S4D).
Because acid profoundly disrupted transcript levels of clock network components, we
assessed their protein levels. Indeed, hypoxia decreased PER2 and BMAL1 amplitudes
in a manner rescuable by highly buffered media (4B). However, this rapid and durable
protein-level suppression was unexpected given its divergence from RNA-level
distortions previously noted in hypoxia, where ARNTL transcript was suppressed but
PER2 transcript was induced (S2F). To clarify these surprising results, we examined
BMAL1 and PER2 protein levels over 48 hours at four-hour resolution and confirmed
suppressed protein levels and oscillation in hypoxia when the media was of low buffering
capacity (4C, 4G). Exposure to acidic media was sufficient to recapitulate this rapid and
durable suppression (4D, 4G). Similar suppression of CLOCK protein level was also
noted in both hypoxic low buffer media and acidic media (S4F). Consistent with
acidification downstream of HIF suppressing clock network protein levels and thereby
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molecular clock oscillation, during low dose DMOG treatment, which initiates gradual
acidification (S4I), amplitude of oscillation of both endogenous clock proteins (S4G) and
the Arntl::dLUC reporter (S4H) remained intact through about 24 hours, after which
dampening began in concert with the accumulating acid load.
The rapid and profound protein-level suppression of the clock suggested regulation
of protein production or stability might underlie clock collapse. Although acid is reported
to activate a kinase of the eukaryotic elongation factor 2 (eEF2K), thereby inhibiting
translational elongation in acid (Xie et al., 2015), eEF2K activity was neither detected in
nor required for acid-mediated clock collapse (S4J, S4K). In contrast, mTORC1
signaling, a key regulator of translation in response to the cell’s nutrient status and
growth factor signals (Dibble and Manning, 2013; Saxton and Sabatini, 2017), was
profoundly inhibited in acidic conditions arising from HIF stabilization by hypoxia or
DMOG, as indicated by the reduction in phosphorylation of downstream components:
ribosomal protein S6 and its kinase (S6K) and eukaryotic translation initiation factor 4Ebinding protein 1 (4EBP1) (4E, S4G). Application of acidic media was sufficient to inhibit
mTORC1 signaling (4F), while highly buffered media rescued mTORC1 signaling from
suppression by hypoxia or DMOG treatment in association with rescue of levels of
representative clock proteins (PER2, CRY2) (4H). This ability of acid to suppress
mTORC1 signaling, previously seen by others (Balgi et al., 2011; Chambard and
Pouyssegur, 1986), was observed in all other cell lines studied: 293T, MDA-MB-231,
MEFs, HCT116, MCF7 (S4L, S5F, S7J, S7K).
Consistent with mTORC1 inhibition causing clock suppression, we found that
inhibitors of mTORC1 dampened Arntl::dLUC oscillation in proportion to their efficacy.
For example, the active-site inhibitors Torin1 and Torin2 or n-butanol, which depletes
phosphatidic acid required for mTORC1 activity (Toschi et al., 2009), durably
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suppressed mTORC1 signaling (4K, S4M, S4P) and the amplitude of the circadian
reporter (4I, 4J, S4N, S4O, S4Q). Rapamycin, an allosteric mTOR inhibitor, only partially
reduced clock amplitude, consistent with its inability to significantly suppress
phosphorylation of 4EBP1 (a well-recognized limitation of this agent (Saxton and
Sabatini, 2017)) and the rapid partial rebound of phosphorylation of S6 (S4R).
To determine whether alleviating the sequestration of translation initiation factor
eIF4E by 4EBPs could restore the clock in acid or DMOG, we knocked down (4L) or out
(4M, 4N, S4S) individual 4EBPs. As anticipated given the multiplicity of 4EBP proteins
and unresolved S6K inhibition, these approaches yielded partial rescue of clock protein
levels (S4S) and clock oscillation (4L, 4M, 4N) in both acidic media and DMOG
exposure. Interestingly, while 4EBP1 deletion initially rescued high amplitude oscillation
in DMOG, these cells quickly began to die, perhaps consistent with the notion that high
amplitude clock oscillation is untenable for a cell confronted with acid stress while
sustaining itself on a limited (hypoxic) metabolic program (4M).
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Figure 4 – Acid suspends the circadian clock through inhibition of mTORC1.
A. Intracellular pH (pHi) of U2OS cells as measured by ratiometric pH probe mCherrySEpHluorin after incubation in media of the indicated pH or treated with vehicle or 500
uM DMOG in low buffer conditions for 24 hours. Extracellular pH (pHe) recorded from
the same cells after 33 hours treatment also shown. pHi ± standard deviation (SD)
derived from three or more 10x fields per condition (S4C) using a standard curve (as
in S4A) generated in parallel. T-tests (unpaired, two-tailed, unequal variances) of pHi
****p≤0.0001, ***p≤0.001, **p≤0.01. RE of 2-3 per condition. B. Immunoblots of core
clock proteins using lysate from U2OS cells grown in normoxic high buffer or hypoxic
(1% O2, media pre-deoxygenated) low or high buffer conditions. C/D. Immunoblots for
HIF1α and the indicated clock proteins from U2OS cells as in B (C) or in media of pH
7.4 or 6.5 (D). E/F. Immunoblots of lysate collected in C (E) and D (F) using antibodies
specific to phosphorylated sites (Ser2448 (mTOR), Thr389 (S6K), Ser235/236(S6),
Thr37/46(4EBP1)) or total levels of mTORC1 substrates and downstream signaling
components. Tubulin shared by E, C. G. Media pH over the 48-hours shown in C-F. H.
Immunoblots for core clock proteins and mTORC1-signaling components using lysate
from U2OS cells in normoxia or hypoxia (1% O2, media pre-deoxygenated) or treated
with vehicle or 300 uM DMOG in low or high buffer conditions or exposed to media of
pH 7.4 or 6.3 for 8 hours. I. Luminescence of U2OS Arntl::dLUC cells treated with
vehicle or 100 nM Torin1. Mean±SEM of 3 BR. RE of 2. J. Normalized ratio of the
intensities of p4EBP1 to total 4EBP1 at 27 hours (quantified from K) and the
mean±SEM amplitude over 4 days (calculated from the mean of 3 BR as in I) both as
a function of Torin1 dose. Y-axis scaled as log([Torin]+1). K. Immunoblot for mTORC1
signaling using U2OS cell lysate collected after 1 and 27 hours of treatment with
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vehicle or 1-1000 nM Torin1. Unrelated intervening lanes cropped. L. Luminescence
of U2OS Arntl::dLUC cells treated with 10 nM non-targeting control (siCtl) siRNA or
siRNA against EIF4EBP1 (4EBP1) or EIF4EBP2 (4EBP2) prior to treatment with 300
uM DMOG in low buffer media. Mean of 2 BR. RE of 2. M/N. Luminescence of U2OS
Arntl::dLUC EIF4EBP1 CRISPR knockout (4EBP1 -/-) and editing control (no sgRNA)
clonal lines treated with vehicle or 500 uM DMOG in low buffer conditions (M) or
media of pH 7.4 or 6.3 (N). Mean of 2-3 BR. RE of ≥3. Black rectangles enclose
immunoblots from same gel. Yellow lines for readability only. All cells synchronized at
time 0 except A, K. RE = representative experiment. BR = biological replicates. See
also Figure S4.
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Figure S4. mTORC1 inhibition mediates suppression of the circadian clock by
acid. Related to Figure 4
A. Representative standard curve and linear best-fit equation relating the ratiometric
signal of the cytoplasmic pH probe mCherry-SEpHluorin to intracellular pH (pHi)
generated by incubating U2OS cells stably expressing the construct in media of pH
6.0-8.0 containing ionophores that cause pHi to equilibrate with extracellular pH (pHe).
Data presented as mean ± standard deviation (SD) of the ratios of the intensities of
the SEpHluorin and mCherry signals across an entire 10x field for three or more fields
per pH standard. Representative experiment of ˃6. B. Representative 10x fields upon
which A was generated. C. Representative 10x fields upon which 4A was generated.
D. Real-time luminescence monitoring of U2OS Arntl::dLUC cells synchronized and
treated with vehicle or 200 uM amiloride (left) or 250 uM α-cyano-4-hydroxycinnamate
(right). At the indicated times, treatment was washed out by media change.
Representative experiments of ≥3. E. Timecourse of pHi of U2OS cells over three
days of treatment with vehicle, 500 uM DMOG, 200 uM amiloride or 250 uM αCHC.
Day 1 pHe also indicated for reference (orange line). pHi ± SD derived from three or
more 10x fields as in A. Student’s T-tests (unpaired, two-tailed, equal variances)
comparing treatment to vehicle at same time point. *p≤0.05, **p≤0.01, ***p≤0.001,
****p≤0.0001, ns = p>0.05. Representative experiment of 3. F. Immunoblots for
CLOCK using lysate collected in 4C and 4D. Tubulin loading controls shared with 4C
and 4F. G. Immunoblots for HIF1α and the indicated mTORC1-signaling components
using lysate collected from U2OS cells every 4 hours for 48 hours after
synchronization and treatment with vehicle or 300 uM DMOG in low buffer media.
Ser209 (EIF4E). H. Real-time luminescence monitoring of U2OS Arntl::dLUC cells
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treated in parallel to the timecourse in G. Representative of 2. I. Media pH during G. J.
Immunoblot for phosphorylation of Thr56 of eEF2 using U2OS cell lysate collected 8
hours after synchronization and placement in normoxia or hypoxia (1% O2, media predeoxygenated), or treatment with vehicle or 300 uM DMOG in low or high buffer
media, or exposure to media of pH 7.4 or 6.3. Tubulin control shared with blots in 4H.
K. Real-time luminescence monitoring of U2OS Arntl::dLUC cells synchronized and
treated with vehicle or 300 uM DMOG and 0-100 uM A-484954 (eEF2K inhibitor) in
low buffer media. Mean of triplicates. Similar results seen with A-484954 treatment of
cells in media of pH 7.4 and 6.3 (not shown). L. Immunoblots for the indicated
mTORC1 signaling or clock components using lysate collected periodically from 293T
(left) or synchronized MDA-MB-231 cells (right) treated with 500 (293T) or 500 and
1000 (MDA-MB-231) uM DMOG in low buffer conditions or exposed to acidic media.
Representative experiment of ≥3 each condition. Vehicle control in high (293T) or low
(MDA-MB-231) buffer media. Bottom panel indicates media pH at the time of lysate
collection in 293T cells. M. Immunoblot for mTORC1 signaling using lysate collected
from U2OS cells after 1 and 27 hours of treatment with vehicle or 1-1000 nM Torin2.
All lanes from same gel with intervening lanes cropped for space. N. Real-time
luminescence monitoring of U2OS Arntl::dLUC cells synchronized and treated with
vehicle or 100 nM Torin2. Mean ± SEM of cells plated in triplicate. Representative
experiment of 2. O. Normalized ratio of the background-corrected intensities of
p4EBP1 to total 4EBP1 at 27 hours (quantified from M) and the average amplitude (±
SEM) over 4 days (beginning 1 day after synchronization and based upon the mean
profile of biological triplicates as in N) both as a function of Torin2 dose. Y-axis scaled
as log([Torin]+1). P. Immunoblots for mTORC1 signaling using lysate collected
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periodically over 2 days from U2OS cells synchronized and either left untreated or
treated with 0.4% of the primary alcohol n-butanol to deplete phosphatidic acid or
control treated with the non-phosphatidyl-reactive tertiary alcohol tert-butanol (see
Methods). Q. Real-time luminescence monitoring of U2OS Arntl::dLUC cells treated in
parallel to P. Representative experiment of 4 each with 1-3 biological replicates and
with additional arms not shown revealing dose-dependent effects of 0.2-0.6% nbutanol treatment. R. Immunoblots (left) for mTORC1 signaling using lysate collected
from synchronized U2OS cells after treatment with vehicle or 5-30 nM rapamycin for 1,
6, 27, or 46 hours in two independent experiments. Right: Real-time luminescence
monitoring of U2OS Arntl::dLUC cells synchronized and treated with vehicle or 5-30
nM rapamycin. Mean of cells plated in triplicate. S. Immunoblots for HIF1α and
indicated clock network proteins (left) or 4EBP1 (right) using lysate collected from
unsynchronized (no dexamethasone) Arntl::dLUC EIF4EBP1 (4EBP1) CRISPR
knockout or parental Arntl::dLUC U2OS cells after 1 or 16 hours of exposure to media
of pH 7.4 or 6.3 or treatment with vehicle or 500 uM DMOG in low buffer media. Black
rectangles enclose immunoblots from same gel. Yellow lines for readability only.
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Acid inhibits mTORC1 signaling independently of both amino acid sensing and
TSC2
mTORC1 activity requires sensing of both growth factors and amino acids
(predominantly, leucine and arginine) through pathways converging on Ras homolog
enriched in brain (RHEB) and Ras-related (RAG) GTP binding proteins, respectively,
with neither pathway alone sufficient for activation (Saxton and Sabatini, 2017). Acidic
media blunted activation of mTORC1 in response to stimulation with either serum
(growth factors) (5A) or leucine and arginine (5B), consistent with acid inhibiting signals
through either of these requisite pathways. The binding of leucine by sestrins upstream
of RAG GTP-binding proteins relies on a histidine residue in a lid-latch mechanism
(Saxton et al., 2016). Given the near-neutral pKa of histidine, we wondered if protonation
of this residue might disable leucine sensing and render mTORC1 inactive. Knockdown
of leucine-sensing mTORC1-inhibiting sestrin-1 and sestrin-2, but not the leucineinsensitive sestrin-3 (Wolfson et al., 2016), weakly rescued both mTORC1 signaling and
clock reporter oscillation in HIF-generated acidic conditions (S5A, S5B). However,
leucine-triggered dissociation of sestrin2 from GATOR2 component WDR24 (S5C) was
pH insensitive (S5D), suggesting acid did not block leucine sensing. Moreover, cells in
which all three sestrin proteins are deleted (Saxton et al., 2016) remained sensitive to
the mTORC1-suppressive effects of acid (S5E). Further, U2OS cells stably expressing
constitutively GTP-bound RAGB were generated, rendering mTORC1 signaling
independent of amino acids as anticipated (5C) (Sancak et al., 2008), but these cells
likewise remained sensitive to the inhibitory effects of HIF-generated acid on mTORC1
signaling (5D) and clock oscillation (5E), refuting the hypothesis that acid hinders amino
acid sensing.
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We therefore suspected that acid instead suppressed signaling to RHEB through
activation of tuberous sclerosis 2 (TSC2), the GTPase-activating protein (GAP) for
RHEB. Consistent with this hypothesis, both in TSC2 null MEFs (S5F) (Zhang et al.,
2003) and U2OS cells with TSC2 knockdown (S5G) or CRISPR deletion of TSC2 (5F),
significant rescue of mTORC1 signaling was seen both in directly acidified media or
media acidified downstream of stabilization of HIF. However, this rescue of mTORC1
activation was incomplete (best appreciated with quantification shown in 5G) and did not
fully maintain clock amplitude in acidic media (S5H). Furthermore, when we queried
upstream regulators of TSC2 (Dibble and Manning, 2013; Saxton and Sabatini, 2017)
over 48-hour timecourses, we found no evidence for TSC2 activation by AMPK or
GSK3B activation or ERK inhibition (S5I, S5J, S5K, S5L). Similarly, although regulated
in development and DNA damage responses (REDD1/DDIT4), a HIF target, can
stimulate TSC2 (Dibble and Manning, 2013), REDD1 did not appear to activate TSC2 in
acid, as REDD1 induction by acid was modest (S5M, S5N, S5O) and much weaker than
that in response to HIF stabilization in highly buffered media (S5O), a condition where
mTORC1 signaling was preserved.
Absence of evidence indicative of TSC2 activation by acid and only partial rescue by
TSC2 knockout suggested that acid inhibited mTORC1 through TSC2-independent
means. We further tested this hypothesis in a distinct cellular context. T cells encounter
low pH in the tumor microenvironment and require mTORC1 signaling for differentiation
and activation of effector cells (Delgoffe et al., 2011; Pollizzi et al., 2015). Remarkably,
acidic media blunted mTORC1 activation in both CD4+ and CD8+ primary T cells in
response to stimulation in vitro (5H). Intriguingly, T cells, like cancer cells, demonstrated
a TSC2-independence in the ability of acid to suppress mTORC1.
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Figure 5 – Acid inhibits mTORC1 and the clock in a RAG-independent manner
not fully rescuable by TSC2 loss.
A./B. Immunoblots for mTORC1 signaling using lysate from U2OS cells unstarved or
starved of serum for 50 minutes in pH 7.4 or 6.3 and then rescued or not for 10
minutes with 10% undialyzed serum (A), or unstarved or starved of leucine, arginine,
or lysine for 50 minutes in pH 7.4 or 6.3 and then either rescued or not for 10 minutes
with the indicated concentrations of the missing amino acid (approximately twice the
reported sensor Kd (Wolfson and Sabatini, 2017) and full DMEM level) in the same
pH. 10% dialyzed serum throughout (B). C. Immunoblots for mTORC1 signaling in
U2OS Arntl::dLUC cells stably expressing RAP2A or RAGBQ99L after 1 hour of nearcomplete amino acid (AA) or leucine (L) starvation or incubation in media with AA or L
added back. All media pH 7.4 with 5% undialyzed serum. D. Immunoblots of lysate
from cell lines in C 23 hours after synchronization and treatment with vehicle or 500
uM DMOG in low buffer (replete AA) media. E. Luminescence of the Arntl::dLUC
reporter in parallel to D. 3 BR. F. Immunoblots for HIF1α, mTORC1 signaling, and
BMAL1 using lysate from Arntl::dLUC TSC2 CRISPR knockout (TSC2--) or parental
Arntl::dLUC U2OS cells (++) following treatment with vehicle or 500 uM DMOG in low
buffer media or exposure to media of pH 7.4 or 6.3 for 17 and 24 hours. RE of 2. G.
Quantification of F. Ratio of the intensity of pS6K or pS6 to total S6K or S6,
respectively. Each control-treatment pair normalized to respective control (vehicle, pH
7.4). H. Mean fluorescence intensity (MFI) of pS6 staining of wildtype (+/+) and TSC2
knockout (-/-) CD4+ and CD8+ T cells assessed by flow cytometry after TCR
stimulation for 1 hour in media of the indicated pH. RE of 5 each with 1-4 BR.
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RE=representative experiment, BR=biological replicates. See also Figure S5.
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Figure S5. Disruption of the clock by acid is independent of amino acid sensing
and TSC2 activation. Related to Figure 5
A. Immunoblot for mTORC1 signaling using lysate collected from U2OS cells treated
with 5 nM non-targeting control (siCtl) siRNA or siRNA against transcripts encoding
leucine-sensing Sestrins (SESN1, SESN2) or the non-leucine sensing SESN3 prior to
synchronization and treatment with vehicle or 500 uM DMOG in low buffer media for
20 hours. 2.5 nM siRNA each when two oligos used. B. Real-time luminescence
monitoring of Arntl::dLUC U2OS cells treated with 2 nM non-targeting control (siCtl)
siRNA or siRNA against SESN1 or SESN3 prior to synchronization and treatment with
500 uM DMOG in low buffer media. Representative experiment of ≥4 with 1-3
biological

replicates

per

condition.

C.

Immunoblot

for

Sestrin-2

following

immunoprecipitation of FLAG-tagged proteins from lysate collected from 293T cells
stably expressing Flag-tagged Rap2A (control protein) or WDR24 (a component of the
GATOR2 complex) and near-starved of all amino acids (AA) or leucine (L) for 50
minutes (pH 7.4) prior to rescue with AA/L or continued starvation for 10 minutes.
Lysate was additionally immunoblotted for components of mTORC1 signaling.
(Starvation media base contained no AA/L but was supplemented with 5% undialyzed
serum.) Note Ig heavy chain runs just below Sestrin-2. D. Immunoblots of
immunoprecipitated proteins and lysate as in C using lysate collected from FlagWDR24 293T cells near-starved of leucine for 50 min in pH 7.4 or 6.3 prior to 10
minutes of leucine rescue or continued starvation (in same pH). An additional
independent experiment generated similar results after 14 hours of acid exposure. E.
Immunoblot for mTORC1 signaling using lysate collected from wild-type or SESN
triple knockout (SESN TKO, where all three SESN genes have been silenced by
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CRISPR editing) 293T cells after exposure to media of pH 7.4 or 6.6 for 50 minutes or
treatment with vehicle or 1mM DMOG in low buffer media for 6 hours. F. Immunoblot
for mTORC1 signaling using lysate collected from wild-type (+/+) or TSC2 null (-/-)
mouse embryonic fibroblasts (MEFS) (both p53 null) after 8 hours of exposure to
normoxic or hypoxic (1% O2, pre-deoxygenated media) low or high buffer media or
media of pH 7.4 or 6.3. Unrelated intervening lanes cropped. G. Immunoblot for
mTORC1 signaling using lysate collected from U2OS cells treated with 10 nM nontargeting, EIF4EBP, or TSC2 siRNA prior to treatment with vehicle or 300 uM DMOG
treatment in low buffer media for 14 hours. H. Real-time luminescence monitoring of
the Arntl::dLUC reporter monitored continuously in parallel to 5F. Mean of biological
duplicates. Representative experiment of 3 each with 2-3 biological replicates. I./J.
Immunoblots for phosphorylated (Thr172) and total AMPK using lysate collected every
4 hours for 48 hours from synchronized U2OS cells in normoxic high buffer or hypoxic
low buffer media (I) or in media of pH 7.4 or 6.5 (J). AMP-activated protein kinase
(AMPK) was inactivated (dephosphorylated) in acidic conditions. Two additional
independent experiments encompassing 8, 19, 37, 49, and 66-hour time points
confirmed reduced pAMPK in pH 6.5 or DMOG low buffer conditions. K/L.
Immunoblots for phosphorylated cRaf (Ser338), ERK (Thr202/Tyr204), and GSK3β
(Ser9) using lysate collected every 4 hours for 48 hours from synchronized U2OS cells
treated with vehicle or 300 uM DMOG in low buffer media (K) or in media of pH 7.4 or
6.5 (L). Although phosphorylation of c-Raf was suppressed in DMOG treatment, the
downstream extracellular signal-regulated kinase (ERK/MAPK) was not suppressed in
either DMOG or acidic media. Dephosphorylation indicative of activation of glycogen
synthase kinase 3 beta (GSK3B), a TSC2-activating kinase, was unapparent in acidic
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conditions (L). M. Expression of DDIT4 (REDD1) in media of pH 6.3 and 7.4 over a
52-hour timecourse as determined by RNA-seq of RNA collected every 4 hours.
Reported as FPKM as in S1H. Note REDD2 (DDIT4L) was not expressed
(undetectable by RNA-seq). N/O. Immunoblots for REDD1 using lysate collected
every 4 hours for 48 hours from synchronized U2OS cells treated with vehicle or 300
uM DMOG in low buffer media or in media of pH 7.4 or 6.5 (N). Additional
immunoblots from an independent experiment using lysate collected at three time
points following treatment with vehicle or 500 uM DMOG in low or high buffer media or
exposure to media of pH 7.4 or 6.5 (O). Unrelated intervening lanes cropped. Tubulin
loading controls in I-L and N shared with corresponding membranes in 4C-D, 4F, S4G,
and S7O.
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Centrifugal redistribution of lysosomes inhibits mTORC1 signaling
Because TSC2 deletion could not fully rescue mTORC1 signaling and clock
oscillation in low pH, we hypothesized that acid might prevent mTOR localization to the
lysosomal surface in response to RAG signaling, precluding mTOR activation by
lysosome-tethered RHEB. In U2OS cells, as in other cell types (Jongsma et al., 2016),
lysosomes predominantly reside in a perinuclear aggregate seen by staining of
endogenous lysosomal associated membrane protein 2 (LAMP2) in fixed cells (6A, S6A)
or by addition of the fluorescent probe LysoTracker to live cells (6B). mTOR is recruited
to this perinuclear lysosomal aggregate in an amino acid-dependent manner (6C, S6B),
as reported (Sancak et al., 2008). Startlingly, acidic conditions profoundly disrupted this
perinuclear clustering and rapidly and reversibly dispersed lysosomes (LAMP2)
throughout the cell (6D, 6E), which imaging of live cells expressing tagged versions of
LAMP1 confirmed (6F, S6C). Despite this phenomenon being noted in the literature
(Heuser, 1989), its significance remains obscure. As such, we wondered if this scattering
of lysosomes in low pH might contribute to mTORC1 silencing and clock suppression by
acid.
Lysosomes traffic on microtubules through the action of motor proteins.
Correspondingly, the perinuclear lysosome aggregate intimately associated with
microtubules, rather than the actin cytoskeleton (S6D), coinciding with a microtubule
organizing center (MTOC) (6G, S6E). In acid, the actin and microtubule cytoskeletons
remained intact while lysosomes dispersed throughout the cell (6G, S6D, S6E),
suggesting lysosomes move peripherally toward the plus ends of microtubules in acid
(6H). Indeed, quantification of the radial distribution of nuclear, tubulin, and LAMP2
staining revealed a peak in both LAMP2 and tubulin intensity adjacent to the nuclear
envelope in neutral pH. In acidic media, the density of LAMP2 dispersed to distances
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farther from the nucleus despite near identical architecture of tubulin (6I). However,
mTOR and LAMP2 continued to show high staining coincidence, whether in sustained or
more rapid reversals of pH and lysosome spatial distribution (6J, 6K, S6F, S6G, S6H).
Indeed, quantification readily revealed the expected amino acid-dependence of mTOR
enrichment in the lysosomal compartment but revealed no such pH-dependence (6L).
mTORC1’s persistent localization to lysosomes in acid yet diminished activity
suggests that centrifugal redistribution of lysosome-bound mTORC1 might be sufficient
to disable signaling. To test this hypothesis, we inhibited dynein, which moves cargo
toward the nucleus, with Ciliobrevin D (CbD) (Li et al., 2016). Incubation of cells with
CbD revealed dispersion of LysoTracker peripherally away from the MTOC (6M). The
dimming of the acidophilic LysoTracker dye (6M) yet persistent intensity of GFP-tagged
LAMP1 (6N, S6I) is consistent with published reports indicating peripherally localized
lysosomes are less acidic (Johnson et al., 2016). Treatment of cells with CbD over a
timecourse caused a gradual decrease in mTORC1 signaling (6O) and dampening of
clock amplitude (6P) in association with the gradual redistribution of lysosomes (GFPLAMP1) to the periphery (6N, S6I). Depolymerization of microtubules with nocodazole
likewise disrupted the polarized perinuclear aggregate of lysosomes (S6J, S6L) and
inhibited mTORC1 signaling (S6K). Reaggregation of lysosomes at later time points was
accompanied by reactivation of mTORC1 (S6M, S6N).
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Figure 6 – Acid causes peripheral redistribution of lysosomes and silencing of
lysosome-localized mTORC1.
A. U2OS cells immunostained for lysosomal protein LAMP2. Nuclei and extent of
cytoplasm annotated in lower panel. B. Live imaging of U2OS cells with lysosomes
labeled with LysoTracker. Lower panel merged with phase-contrast image. C. U2OS
cells immunostained for LAMP2 and mTOR. Cells were starved of amino acids for 115
min and then rescued (+AA) or not (-AA) for 25 min before processing. D./E. U2OS
cells immunostained for LAMP2 following exposure to media of pH 7.4 or 6.3 for 2.25
hours (D) or following incubation in media of pH 6.3 for 105 min followed by exchange
of media for media of pH 7.4 (rescue, left) or 6.3 (mock rescue, right two fields) for 25
min (E). F. Live imaging of U2OS cells expressing lysosomal protein LAMP1 fused to
mRFP after incubation in media of pH 7.4 or 6.3 for 4 hours. Lower panels: merged
mRFP and phase-contrast images. G. U2OS cells immunostained for LAMP2 and αtubulin following exposure to media of pH 7.4 or 6.3 for 2.25 hours. H. Schematic
interpreting 6D-G. The typical perinuclear aggregate of lysosomes disperses upon
cellular acidification with lysosomes displaced toward the cell periphery (microtubule
plus (+) ends). I. Mean intensity of DAPI (nuclear stain), α-tubulin, and LAMP2 as a
function of distance from nucleus center (i.e. radial coordinate) after 2.75 hours in
media of pH 7.4 and 6.3. n=15 cells each pH. Mean±SEM normalized to each
channel’s

maximum.

Student’s

T-test

(unpaired,

two-tailed,

equal

variance)

unadjusted p<0.05 (*) at 0/228, 2/228, and 117/228 radial data points, respectively.
Representative images in S6E. J./K. U2OS cells immunostained for LAMP2 and
mTOR following amino acid starvation for 130 minutes in media of pH 7.4 or 6.3 and
subsequent restimulation with amino acids for 10 minutes in the same pH (J), or
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following incubation in media of pH 6.3 for 2 hours with media change (same pH) 15
minutes prior to processing (K). L. Quantification of mTOR lysosomal enrichment in
U2OS cells immunostained for LAMP2 and mTOR following starvation of amino acids
for 155 min prior to continued starvation or rescue with amino acids for 10 minutes or
following exposure to media of pH 7.4 or 6.3 for 165 min. n =11 fields per condition,
encompassing 86, 98, 101, and 93 cells, respectively. Mean±SEM superimposed with
raw data. T-tests (unpaired, 2-tailed) ****p<0.0001, ns = p>0.05. Representative of
quantifications of two RE from >3 RE. M. Live imaging of U2OS cells treated with
vehicle or 40 uM ciliobrevin D (dynein inhibitor) for 10.5 hours. Lysosomes and
polymerized tubulin labeled with LysoTracker and TubulinTracker. N. Live imaging of
U2OS cells expressing LAMP1 fused to GFP (pseudocolored red) after treatment with
vehicle or 60 uM ciliobrevin D for 55 min (cropped inset) and 9 hours (different fields).
Right: merged GFP and phase-contrast images. O. Immunoblot for mTORC1 signaling
using U2OS cell lysate collected over an 8-hour timecourse of vehicle (veh.) or 40 uM
ciliobrevin D treatment. RE of 3. P. Luminescence of U2OS Arntl::dLUC cells
synchronized and treated with 50 uM ciliobrevin D or vehicle. Mean of 2 BR. RE of 2,
2-3 BR each. Representative fields of ≥3 BR for all microscopy. RE = representative
experiment. BR = biological replicates. See also Figure S6.
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Figure S6. Spatial dispersion of lysosomes suppresses mTORC1 signaling.
Related to Figure 6
A. U2OS cells immunostained for lysosomal protein LAMP2 imaged at lower
magnification. Independent replicate experiment of that shown in 6A. B. U2OS cells
coimmunostained with LAMP2 and mTOR. Cells were starved of amino acids for 140
min followed by rescue (+AA) or not (-AA) with amino acids for 10 min before
processing and imaging. Independent experiment from that shown in 6C. C. Live
imaging of U2OS cells transiently expressing lysosomal protein LAMP1 fused to green
fluorescent protein after incubation in media of pH 7.4 or 6.3 for 2.5 hours. Lower
panels: merged GFP (pseudocolored red for better visibility) and phase-contrast
images. (Heterogeneity in LAMP1 expression owing to variable transfection
efficiency). Independent replicate experiment of that shown in 6F using different
LAMP1-fusion construct. D. U2OS cells coimmunostained for LAMP2 and filamentous
(F-) (polymerized) actin following exposure to media of pH 7.4 or 6.3 for 2.25 hours. E.
U2OS cells coimmunostained for LAMP2, alpha-tubulin, and DAPI (nuclear stain)
following exposure to media of pH 7.4 or 6.3 for 2.75 hours. Quantified in 6I.
Independent replicate experiment from that shown in 6G. F. U2OS cells
coimmunostained for LAMP2 and mTOR following incubation in media of pH 7.4 or 6.3
for 2.25 hours. Independent experiment from that shown in 6J. G. U2OS cells
coimmunostained for LAMP2 and mTOR following incubation in media of pH 6.3 for
120 min. Enlarged to highlight colocalization of LAMP2 and mTOR. Independent
replicate experiment of that shown in F. H. U2OS cells coimmunostained for LAMP2
and mTOR following incubation in media of the first indicated pH for 105 min followed
by 30 min in media of the second indicated pH. I. Live imaging of U2OS cells
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expressing LAMP1 fused to GFP after treatment with vehicle or 60 uM ciliobrevin D for
55 min, 90 min, and 9 hours. Images on right at each time point show merged GFP
and phase-contrast images. Additional fields and time point of 6M. J. Live imaging of
U2OS cells treated with vehicle or 2 uM nocodazole (tubulin depolymerizing agent) for
6.5 hours. Lysosomes and polymerized tubulin labeled with the acidophilic dye
LysoTracker (L) and TubulinTracker (T), respectively, prior to imaging. K. Immunoblot
for mTORC1 signaling using lysate collected from unsynchronized U2OS cells over an
8-hour timecourse during treatment with vehicle or 2 uM nocodazole. Representative
experiment of 3. L. Live imaging of U2OS cells expressing LAMP1 fused to GFP after
treatment with vehicle or 2 uM nocodazole for 25 min, 75 min, and 6 hours. M. Live
imaging of U2OS cells expressing LAMP1 fused to GFP after treatment with vehicle or
2 uM nocodazole for 7 hours showing initiation of lysosome reclustering. Lysosomes
labeled with LysoTracker prior to imaging to highlight colocalization of signal from both
lysosome-labeling techniques for the subset of cells expressing LAMP1-GFP.
(Heterogeneity in LAMP1 expression owing to variable transfection efficiency.) N.
Immunoblot for mTORC1 signaling using lysate collected from unsynchronized U2OS
cells after 4 and 30 hours of treatment with vehicle (veh.), 60 uM ciliobrevin D (CbD),
or 2 uM nocodazole (Noc.). Representative fields of multiple fields acquired from each
of ≥3 biological replicates. Images visualizing endogenous proteins/lysosomes
contrasted uniformly (see Methods).
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The influence of lysosome spatial location on mTORC1 signaling is reminiscent of
the mechanism by which human cytomegalovirus (HCMV) maintains persistent
mTORC1 signaling. HCMV encodes a viral protein, UL38, which inhibits host TSC2
(Moorman et al., 2008). Unlike uninfected cells (6C, S6B), HCMV also bypasses
mTORC1’s requirement for amino acids by maintaining perinuclear localization of
mTORC1 through a dynein-dependent mechanism (Clippinger and Alwine, 2012;
Clippinger et al., 2011). As such, we infected cells with HCMV and saw impressive
rescue of mTORC1 signaling in both acidic media and in HIF-generated acid (7A). As
kinesins oppose dynein and traffic cargo toward the plus (peripheral) end of
microtubules, we reasoned inhibition of kinesin motor proteins might also thwart acidinduced peripheral redistribution of lysosomes and rescue signaling. However,
antagonism of plus-directed lysosomal trafficking is challenging as there are over 35
kinesins expressed in U2OS cells (S7A, S7B). Nonetheless, we decided to knockdown
the most abundantly expressed kinesin, kinesin family member 5B (KIF5B), a
component of kinesin-1 which has been shown to contribute to lysosome trafficking in
other cell types (Li et al., 2016). As anticipated given kinesin redundancies, partial
knockdown of kinesin-1 resulted in partial resistance of mTORC1 signaling to
suppression by acid with all three siRNAs tested (7B), consistent with acid inhibiting
mTORC1 through centrifugal dispersion of lysosomes.

Restoration of spatial coincidence of RHEB and lysosome-bound mTORC1
rescues mTORC1 signaling and the clock from acid suppression
Interestingly, in primary CD8+ T cells, we noted that the acid-mediated suppression
of mTORC1-signaling, previously found to be TSC2-independent (5H), was not
associated with loss of mTOR from the lysosomal surface (S7C, S7D). Thus, data from
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both U2OS cells (5F, 5G) and primary T cells (5H) indicated that TSC2 deletion was
insufficient to fully rescue mTORC1 signaling despite intact amino acid sensing (5D) and
persistent localization of mTOR to lysosomes in acid (6L, S7D). We therefore wondered
if the unified explanation might be that peripheral redistribution of lysosomes in acid
limits the ability of RHEB to activate lysosome-bound mTOR (7C), explaining why TSC2
deletion could enhance but not fully rescue mTORC1 activity. Consistent with this model,
dynein inhibition reduced mTORC1 signaling in TSC2 knockout cells despite the
expected higher basal level of mTORC1 signaling in these cells (7D). More precisely, we
wondered whether contact between RHEB and mTOR might be affected by spatial
redistributions driven by acid. After validating an anti-RHEB antibody (S7E-G), we
coimmunostained for mTOR, LAMP1, RHEB, and nuclei and observed, consistent with
others (Menon et al., 2014), that RHEB is enriched in a perinuclear location similar to
that of lysosomes (7E-F) irrespective of amino acid status (S7H). In response to amino
acids, mTOR is recruited to lysosomes (S7H), allowing RHEB and mTOR to interact.
Remarkably, in acid, RHEB retained its perinuclear niche while lysosomes with bound
mTOR redistributed to the periphery (7E-F). Indeed, quantification of the radial
distribution of nuclear, RHEB, LAMP1, and mTOR staining indicated strong perinuclear
affinity of all three proteins in neutral conditions but clear reduction in spatial
concordance between RHEB and LAMP1-mTOR in low pH as a result of RHEB’s
resistance to the centrifugal forces acting on LAMP1 and mTOR (7G).
These data suggested a model in which peripheral redistribution of lysosomes in acid
inhibited the circadian clock by limiting RHEB’s ability to spatially contact lysosomebound mTOR to activate it. We reasoned, then, that a sufficient increase in the amount
of RHEB in the periphery should rescue the circadian clock by restoring activity of
peripherally redistributed mTOR. Indeed, abundant overexpression of constitutively
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active RHEBN153T (Urano et al., 2005) caused mislocalization of RHEB throughout the
cell and thereby increased peripheral RHEB density to quantified levels at or above the
typical neutral perinuclear level without altering LAMP1 or mTOR localization (7F, 7G).
As hypothesized, this restoration of RHEB-mTOR coincidence was accompanied by a
full rescue of clock oscillation in acidic media (7H) and a corresponding more thorough
resistance of mTORC1 signaling to acid compared with knockout of TSC2 (7I). That
acidification facilely spatially separates RHEB and mTOR but not LAMPs and mTOR
suggests that in these cells the majority of RHEB may normally be localized on nonlysosomal endomembranes at the MTOC—a distribution supported by high resolution
images showing tight spatial congruity in LAMP and mTOR distribution and close
apposition but discordance between either of these two and RHEB (S7I)—a surprising
notion given current favored models of mTORC1 signaling (Sancak et al., 2010), but not
unprecedented (Hanker et al., 2010; Manifava et al., 2016), that would indicate transendomembrane RHEB-mTOR interaction mechanistically underlying mTOR activation
(7J).
Having delineated a mechanistic model to explain how acid produced by hypoxic
metabolic rewiring suppresses mTORC1 signaling, we then wished to test whether such
mechanisms could be observed in tumors in vivo on account of the hypoxic and acidic
nature of significant portions of tumors (Gallagher et al., 2008; Gillies et al., 2002). To do
so we made use of tumor specimens available from several previously undertaken
studies (Estrella et al., 2013; Ibrahim-Hashim et al., 2017) in which tumor xenografts
were hosted by mice drinking either tap water or water supplemented with sodium
bicarbonate, the latter a method shown in these studies and by others (Gallagher et al.,
2008) to raise intratumoral pH, including, notably, intracellular pH (Raghunand et al.,
1999). We assessed these tumors by immunohistochemistry for phosphorylated S6
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(pS6) as a measure of mTORC1 signaling. This analysis revealed that, in two tumor
models (colon cancer HCT116, breast cancer MCF7) exhibiting low pS6 staining in
tumors hosted by control mice, sodium bicarbonate therapy significantly elevated
mTORC1 signaling (7K, S7L), consistent with in vitro corollary work with these cell lines
showing acid sufficient to inhibit mTORC1 signaling and additional bicarbonate (highly
buffered media) able to blunt HIF-mediated mTORC1 suppression (S7J-K). Importantly,
this elevation in mTORC1 signaling in treated tumors is not a secondary effect of
bicarbonate stimulating proliferation, as growth rates of bicarbonate-treated tumors in
these studies were either slower (HCT116) or unaffected (MCF7) (Estrella et al., 2013;
Ibrahim-Hashim et al., 2017). In a third model (breast cancer MDA-MB-231), tumor
mTORC1 activity was already high in control mice and no further augmentation was
seen with bicarbonate therapy (S7M). This suggests tumor acidity suppresses mTORC1
signaling in significant regions of tumors in vivo but that some tumors have unknown
mechanisms of escape.
Interestingly, unlike the full rescue of circadian oscillation observed with RHEBN153T
overexpression in acidic media (7H), overexpression of RHEBN153T failed to rescue
circadian oscillation from DMOG treatment despite high mTORC1-signaling (7I) and
cells began to die after about 2.5 days (S7N). Consistent with the unfolded protein
response RNA signature seen in acid (S3D), modest phosphorylation of the translation
initiation factor eIF2α was seen in exposure to acidic media and in more acidic late time
points during DMOG exposure (S7O). We speculated that persistent mTORC1-signaling
forced by RHEB overexpression might compound the unfolded protein response of
acidified hypoxic cells and evoke a strong stress response that inhibits translation
orthogonally to mTORC1 and thwarts our efforts to rescue the clock (S7P). Indeed, in
support of this model, only cells overexpressing RHEBN153T during DMOG exposure
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displayed hyperphosphorylation of endoplasmic reticulum (ER) transmembrane protein
PRKR-like ER kinase (PERK) and induction of downstream ER-stress-responsive
targets activating transcription factor 4 (ATF4) and C/EBP homology protein
(CHOP/DDIT3) (S7Q) (Wouters et al., 2005). Thus, forced high mTORC1-induced
translation in acidified hypoxic cells exacerbates ER stress, inhibiting cap-dependent
translation through eIF2α phosphorylation which in turn drives translation of the DDIT3
transcription factor ATF4 (S7Q). Consequently, continued suppression of the clock in
RHEB-overexpressing HIF-stabilized acidic cells highlights the same fundamental
principle learned from acid-mediated mTOR suppression: inhibition of translation during
hypoxic stress suspends the molecular circadian clock.
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Figure 7 – Acid inhibits mTORC1 signaling and the clock by spatially separating
RHEB and lysosome-bound mTORC1.
A. Immunoblot for mTORC1 signaling, HIF1α, and the human cytomegalovirus
(HCMV) proteins IE72 and IE86 using lysates from HCMV-infected or uninfected
(mock) U2OS cell. Cells were treated with vehicle or 500 uM DMOG in low buffer
conditions for 8 and 12 hours prior to harvest at 27 and 59 hours post infection (hpi),
respectively. Exposure to pH 7.4 and 6.4 began 1 hour prior to harvest. B. Immunoblot
for mTORC1 signaling and kinesin-1 heavy chain (HC) using U2OS cell lysate
collected at 52, 76, and 99 hours post delivery of 10 nM control (Ctl) siRNA or three
different siRNA against KIF5B (kinesin-1 HC). Cells exposed to media of pH 7.4 and
6.5 one hour prior to harvest. RE of 2. C. Model. Acid produced during hypoxic
metabolic rewiring suppresses circadian clock oscillation through inhibition of
mTORC1-governed translation as a consequence of centrifugal redistribution of
lysosome-bound mTORC1 limiting mTOR activation by RHEB. D. Immunoblot of
mTORC1 signaling using lysate collected over a 32-hour timecourse from clonal TSC2
CRISPR knockout (-/-) or parental U2OS cells (+/+) treated with vehicle or 50 uM
ciliobrevin D. Left: time points up to 15 hours. Right: 23 and 32-hour time points. E/F.
U2OS parental and constitutively active RHEBN153T-expressing cells immunostained
for LAMP1, mTOR, RHEB and nuclei (DAPI) after 160 minutes in media of pH 7.4 or
6.3. White boxes in F correspond to the fields enlarged in E to highlight representative
perinuclear and peripheral regions of parental cells. RE of 3. G. Mean intensity of
DAPI, mTOR, RHEB, and LAMP1 as a function of distance from the nucleus
quantified from F. n=10-13 cells each pH for each cell line. Mean±SEM normalized to
each channel’s maximum for parental pH 7.4 H. Luminescence monitoring of the
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Arntl::dLUC reporter in TSC2 CRISPR knockout (-/-), RHEBN153T-expressing, and
respective control U2OS synchronized and exposed to pH 7.4 or 6.5 media. Mean of 3
BR. RE of 3-4, 1-3 BR each. I. Immunoblot for mTORC1 signaling using lysate
collected from cells treated in parallel to H or treated with vehicle or 500 uM DMOG in
low buffer conditions for 20 (TSC2) or 16 (RHEBN163T) hours. RE of 2. J. Model of
trans-endomembrane contact between lysosome-localized mTORC1 and nonlysosomal RHEB disrupted upon acid-driven peripheral redistribution of lysosomebound mTOR. MTOC = microtubule organizing center K. Immunohistochemical pS6
staining of HCT116 xenograft tumors carried by host mice drinking normal tap water or
200 mM sodium bicarbonate ad libitum throughout tumor hosting (up to 3 weeks).
Representative high-power fields with inset low-power images of entire tumor cross
section. Positivity mask in lower panels. Percent pS6 positive pixels quantified over
entire viable area of tumor cross section. Mean±SD n=4 mice each arm. 2-tailed
Student’s t-test. RE= representative experiment. Biological replicates = BR. See also
Figure S7.
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Figure S7. Dampened translation subsequent to either silencing of lysosomebound mTORC1 by acid or ER stress disrupts the clock. Related to Figure 7
A. Expression of kinesin family members (n=46) in U2OS cells as determined by RNAseq reported as the log2 of the mean fragments per kilobase of transcript per million
mapped reads (FPKM) determined every 4 hours for 52 hours (13 time points) after
exposure to media of pH 7.4 or 6.3. Ranked by mean expression in pH 6.3. B.
Expression of the 6 most abundant kinesins as determined in A. C. Previously
activated OVA-specific CD8+ T cells (OT-1, see Methods) coimmunostained for
LAMP2, mTOR, and DAPI following starvation of amino acids and growth factors for 1
hour (neutral pH) prior to continued starvation for 30 minutes or rescue with replete
media (full amino acids and serum) of pH 7.6, 7.2, 6.5, or 6.2 for 60 minutes. Images
of staining of endogenous proteins contrasted uniformly (see Methods). D.
Quantification of mTOR lysosomal enrichment in C. n = 5-7 fields each condition,
encompassing 437, 293, 303, 243, and 393 total cells, respectively. Mean ± SEM
superimposed by raw data. Ordinary 1-way ANOVA followed by Tukey method
comparing all means. Rescue from starvation increases mTOR lysosomal enrichment.
Increasing acidity of rescue media does not reduce mTOR lysosomal association.
*p≤0.05. E. U2OS cells coimmunostained for LAMP1 and RHEB after 2 days of
treatment with non-targeting siRNA or siRNA targeting RHEB, RHEBL1, or both RHEB
and RHEBL1 (10 nM each target, normalized to 20 nM with non-targeting siRNA
where needed) to validate immunofluorescence specificity of the anti-RHEB antibody.
RE of >3. F/G. qPCR (F) and immunoblot (G) of RNA and protein collected in parallel
to E to assess knockdown efficiency and accordance with an independent anti-RHEB
antibody (Cell Signaling) (G). Mean±SEM of technical replicates in F. RE of 3 each. H.
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U2OS cells immunostained for LAMP1, mTOR, RHEB and nuclei (DAPI) after amino
acid starvation for 155 minutes followed by 10 minutes of amino acid or mock rescue.
RE of 3. I. Representative U2OS cell in media pH 7.4 immunostained for LAMP1,
mTOR, RHEB, and nuclei (DAPI). Channel combinations as shown to highlight high
coincidence of mTOR and LAMP1 staining consistent with localization of mTOR to
lysosomes. Distinct patterning of RHEB suggests possible occupancy of a separate
but spatially adjacent compartment. J. Immunoblots for mTORC1 signaling using
lysate collected from HCT116 cells exposed to media of the indicated pH or treated
with vehicle or 1 mM DMOG in low or high buffer media for the durations indicated. RE
of 2 each with 2 BR. K. Immunoblots of lysate from MCF7 cells as in J. L/M.
Immunohistochemical pS6 staining of cross sections of MCF7 (L) and MDA-MB-231
(M) xenograft tumors carried by host mice drinking normal tap water or 400 mM
sodium bicarbonate ad libitum from 3 days post tumor cell inoculation through tumor
harvest (five weeks later). Representative high-power fields with inset low-power
images of tumor cross section. Positivity mask in lower panels. Percent pS6 positive
pixels quantified over entire viable area of tumor cross section. Mean±SD, n=5 mice
(L) or 4 mice (M) for each arm. 2-tailed Student’s t-tests *p<0.05, ns=not significant N.
Luminescence of RHEBN153T-overexpressing and control Arntl::dLUC U2OS cells
treated with vehicle or 500 uM DMOG in low buffer conditions. Mean of 3 BR. RE of 4,
1-3 BR each. O. Immunoblot for phosphorylated and total eIF2α (Ser51) using lysate
collected from U2OS cells every 4 hours for 48 hours after synchronization and
treatment with vehicle or 300 uM DMOG in low buffer media (upper) or exposure to
media of pH 7.4 or 6.5 (lower). Tubulin loading controls shared with S4G and 4F. P.
Model. Acid produced during hypoxic metabolic rewiring suppresses circadian clock
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oscillation through inhibition of mTORC1-governed translation as a consequence of
centrifugal redistribution of lysosome-bound mTORC1. Orthogonal stress signaling
pathways, such as that resulting in inhibitory phosphorylation of eIF2α, can likewise
inhibit circadian clock oscillation by converging on a common mechanism of
dampened cap-dependent translation. Q. Immunoblot for signaling downstream of
PERK over a 3-day timecourse using lysate collected from RHEBN153T-overexpressing
or control U2OS cells synchronized and treated with vehicle or 500 uM DMOG in low
or high buffer conditions or exposed to media of pH 7.4 or 6.5. *non-specific artifact.
Representative experiments of 4 with varying sampling intervals. RE= representative
experiment. Biological replicates = BR.
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CHAPTER 3 – Conclusions and Future Directions
Conclusions
Hypoxia, because of the significant metabolic challenge it poses, has long been
speculated to alter many aspects of normal physiology. Those conducting early rodent
and human studies observed that low oxygen reversibly dampened the amplitude of
normally circadian parameters such as body temperature (Bosco et al., 2003; Mortola
and Seifert, 2000). Others noted the structural similarities between hypoxia inducible
factors and clock network proteins (Bersten et al., 2013) and their capacity to
heterodimerize in vitro (Hogenesch et al., 1998; Hogenesch et al., 2000; Takahata et al.,
1998). Still others noted the sequence similarity between E-box (CLOCK-BMAL1) and
HRE (HIF-ARNT) consensus binding sites and reported transcriptional crosstalk
(Chauvet et al., 2004; Miki et al., 2004; Miyazaki et al., 2002; Pelster and Egg, 2015).
While our studies were in progress, three reports revived this notion of hypoxia-clock
interplay and concluded that HIF1α might disrupt the clock through binding to promoters
of specific clock network genes (Adamovich et al., 2017; Peek et al., 2017; Wu et al.,
2017). While both Wu and Peek presented evidence of endogenous (Peek) or
overexpressed (Wu) HIF1α binding to the PER2 promoter, and Adamovich proposed
HIF1α binding to RORα and CRY2 promoters, functional testing via rescue experiments
(i.e. knockdown of proposed HIF-driven clock genes) either failed (Adamovich) or was
not performed (Wu and Peek).
In contrast to these foundational studies, we show that acid—not HIF
transactivation of clock genes—mediates suspension of the circadian molecular clock
and diurnal transcriptome in hypoxia or upon pharmacologic stabilization of HIF. Acid, a
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consequence of HIF-directed hypoxic metabolism, is sufficient to drive lysosomes, the
platform upon which mTORC1 is normally activated, to the cell periphery. We find this
redistribution suppresses the clock by spatially separating mTORC1 from its upstream
regulator RHEB and thereby potently inhibiting mTORC1 signaling and the translation of
clock network proteins governed by it. Knocking down HIF1A or inhibiting its glycolytic
flux-enabling target LDHA, buffering against acidification, or restoring mTORC1 activity
each rescues clock oscillation, illustrating that acid produced due to HIF1α-mediated
metabolic rewiring halts the clock by inhibiting mTORC1, a complex well known to
coordinate cellular activities to match current metabolic resources and afflicting stresses.
Indeed, by identifying pH as the critical variable and allowing it to align to that
seen in the hypoxic solid tumor microenvironment, we uncover a more profound (Peek et
al., 2017) and consistent (Wu et al., 2017) clock disruption by HIF than that recently
described. Notably, these studies proposing direct transcriptional mechanisms for how
HIF perturbs the clock presented no or limited evidence that described HIF-driven clock
transcript-level changes propagated to the protein level. Additionally, Wu and colleagues
relied exclusively on chemical or genetic stabilization of HIF1 (rather than true
hypoxia), and they, like Peek and colleagues, performed no confirmatory timecourses at
the endogenous transcript or protein level to corroborate reporter-based conclusions of
effects on rhythmicity (Peek et al., 2017; Wu et al., 2017). With our experiments
employing both chemical- and low oxygen-mediated HIF stabilization (as well as pH
conditions) and our gathering of two-day 4-hour resolution timecourses at the clock
reporter, endogenous transcript, endogenous protein, and, in the case of pH conditions,
protein-coding transcriptome levels, we significantly extend the vantage into how
hypoxia effects the circadian biology of cells.
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To our knowledge, few others have explored the effect of low pH on the clock.
However, those that have observed, without explanatory mechanism, similarly profound
suppression of clock-driven oscillations in rat fibroblasts and mollusks, with the latter
also shown to be reversible and phenocopied by chemicals that block H+ efflux and
acidify pHi (Khalsa et al., 1991; Kon et al., 2008). Interestingly, in the one seemingly
contradictory brief report, the limited data presented appeared to indicate acidic (pH 6.7)
culture of primary human skin fibroblasts modestly enhanced amplitude of oscillation
relative to neutral culture, perhaps indicating that physiologically acidic tissues such as
skin (pHe 4.5-6.9 (Ohman and Vahlquist, 1994)) upregulate proton extrusion pathways to
maintain neutral pHi in these more acidic milieus or harbor mTOR signaling or other
factors supportive of the clock tuned for peak activity at pH values appropriate for their
physiologic niche (Lee et al., 2011).
Our conclusion that mTORC1 is rapidly, potently, and durably inhibited by acid is
corroborated by other work. Remarkably, prior to the discovery of mTOR, it was
observed that intracellular acidification (through acidic media exposure or genetic or
pharmacologic inhibition of H+ export) could potently suppress phosphorylation of
ribosomal protein S6 and translation (Chambard and Pouyssegur, 1986; Pouyssegur et
al., 1982). More recently, a group has rediscovered acid’s effect. However, the
mechanism seems to have alluded them, with their first report concluding TSC2
dependence (Balgi et al., 2011) and a subsequent report TSC2 independence (Fonseca
et al., 2012). We resolve this paradox by identifying that acid-driven peripheral
relocalization of mTOR limits its activation by RHEB; correspondingly, TSC2 knockout
partially rescues mTORC1 signaling by eliminating GAP activity toward RHEB but does
not circumvent this downstream block.
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We observed striking peripheral redistribution of lysosomes in acidic conditions, a
phenomenon first described decades ago (Heuser, 1989) and documented since in a
number of systems. To our knowledge, no one has previously queried if an acidic
environment might impact mTORC1 signaling through this spatial disturbance. Our work
thus gives mechanistic significance to a long unexplained low pH phenomenon and
intriguingly furthers in new ways a theme of governance of mTOR activity through spatial
positioning of key players (Menon et al., 2014; Sancak et al., 2010).
In summary, our studies reveal that hypoxia reversibly suspends the homeostatic
circadian timekeeper of cancer cells as a consequence of a byproduct of the metabolism
it dictates driving a subcellular inhibitory spatial alteration of mTORC1.

Future Directions
Acid as a synchronizing stimulus
Recognizing the incompleteness of their model, the recent Adamovich
publication proposed that the ability of oscillating tissue oxygen tensions and the HIF1α
axis to reset clocks in mammalian tissues and cell lines could be mediated by “other
factors yet to be identified.” Whether oscillating transient acidification fulfills this role
awaits formal demonstration; but, clock-driven circadian oscillations in pH in mammalian
tissues (Dmitriev and Mangel, 2001; Peek et al., 2017) allow for the intriguing possibility
of conserved reinforcing bidirectional acid-clock crosstalk.

mTORC1 as a mediator of peripheral clock entrainment by feeding rhythms
Our finding that mTOR governs peripheral clocks echoes prior findings in the
central clock of model organisms such as flies (Zheng and Sehgal, 2010). Notably, in the
central clock of mice, the mTOR/4EBP1/eIF4E axis is activated by light, and
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pharmacologic or genetic inhibition reduces light-induced translation of clock proteins
and entrainment (Cao et al., 2015; Cao et al., 2010; Cao et al., 2013). Recent
observations in peripheral mammalian clocks also point to a clock-mTOR connection, as
PTEN loss in human head and neck squamous cell carcinoma cell lines and mouse
epidermis increases BMAL1 protein levels in an mTORC1-dependent manner
(Matsumoto et al., 2016). Additionally, rhythmic mTOR signaling has been shown to
support circadian rhythmicity in mammalian translation rates (Jouffe et al., 2013; Lipton
et al., 2015), emphasizing the multiple levels at which mTOR acts to promote optimal
timing. Moreover, as feeding cycles are now understood to be the dominant entraining
force (zeitgeber) for peripheral clocks (Introduction Box 1) (Damiola et al., 2000), it is
especially alluring to consider that mTOR, given its role in sensing nutrient, growth
factor, and energy levels and coordinating cellular response, is poised to perhaps be a
central player in this currently only incipiently understood synchronization pathway
(Dibner and Schibler, 2015).

pH as an environmental parameter sensed by mTOR
mTORC1 integrates several environmental signals including those indicative of
levels of amino acids and energy to limit biosynthetic activities—particularly translation—
to times sufficiently supported by requisite resources (Saxton and Sabatini, 2017). It is
intriguing to think that pH might similarly be monitored by mTORC1 through mechanisms
described here to restrict protein synthesis to periods when pH is conducive to
appropriate protein folding. Additionally, mTORC1 might sense glycolytic flux through the
two protons produced for every glucose molecule metabolized to pyruvate or lactate
(Chapter 1 – Introduction, Box 6; (Divakaruni et al., 2014)). As mTORC1 positively
regulates glycolysis (Brugarolas et al., 2003; Duvel et al., 2010), an ability of mTORC1 to
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sense an accumulating metabolic acid load—which threatens to slow the kinetics of
enzymatic reactions, inappropriately protonate peptides, and otherwise harm the health
of cells—and ease its drive of this acid source would seem advantageous. In this
manner, a H+-mediated feedback loop might exist regulating glycolysis through known
mTORC1-senstive glycolysis-stimulating factors, such as HIF1α, permitting mTOR to
tune glycolytic flux to optimal rates.

Resolution of conflicting reports about active mTOR in the cell periphery
Our finding that centrifugal lysosome redistribution is both necessary and
sufficient for acid’s suppression of mTOR is consistent with prior work indicating dynein
(Clippinger and Alwine, 2012) and perinuclear clustering of lysosomes (Clippinger et al.,
2011; Rainero et al., 2015) support mTORC1 signaling. However, it is notable that
Korolchuk and colleagues reported a seemingly inverted spatial dynamic from our
findings with starvation (and therefore inhibited mTOR) associated with perinuclear
clustering of lysosomes and refeeding (and therefore active mTOR) associated with
peripheral redistribution (Korolchuk et al., 2011). As starvation-induced mTOR inhibition
induces autophagy (Kim and Guan, 2015), this perinuclear clustering of lysosomes may
reflect the movement of lysosomes and autophagosomes to the microtubule organizing
center (MTOC) to facilitate fusion. Indeed, pharmacologic inhibition of mTORC1 has
been shown to be sufficient to induce perinuclear lysosome aggregation (Li et al., 2016).
As centrifugal lysosome redistribution is a cause rather than consequence of mTORC1
inhibition in our model, acid-induced silencing of mTORC1 through peripheral
redistribution of lysosomes is not incompatible with autophagy-induced retrograde
trafficking of lysosomes.
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However, further data presented by Korolchuk and colleagues are more difficult
to reconcile with our findings. These authors reported that peripheral margination of
lysosomes in Hela cells through overexpression of several kinesins and associated
adaptors caused augmented mTOR signaling with the reverse true upon knockdown
(Korolchuk et al., 2011). However, a more recent report in Hela cells did not observe
hindered mTORC1 signaling when lysosomes clustered at the MTOC in response to
knockout of a different kinesin-associated factor (Pu et al., 2015). The reasons for these
contradictory results in the same cell line remains unclear. Nonetheless, we cannot
exclude the existence of cell-type specific differences as Hela cells appear distinctly
wired in several ways, perhaps in some way stemming from their origin in cervical tissue,
a particularly acidic environment. For instance, Korolchuk and colleagues noted that
starvation (including serum starvation) alkalinized Hela cell pHi, which they suspected
mediated lysosome perinuclear aggregation. Given that it is classically noted that growth
factor stimulation causes alkalinization of pHi, owing to the growth-factor responsiveness
of H+ exchangers such as NHE1 (Moolenaar, 1986; Pouyssegur et al., 1985), it is not
surprising that work in other cell types, or even the same cell type (Martins et al., 2011),
has noted opposite directionality with lysosomes peripherally redistributed upon
starvation (Wang et al., 2017; Zaganjor et al., 2014).
As most cells display predominantly perinuclear lysosomes (Jongsma et al.,
2016) (and mTOR (Clippinger and Alwine, 2012; Clippinger et al., 2011; Sancak et al.,
2008)) in culture (i.e. while growing and therefore dependent on mTORC1), we suspect
future investigations will clarify that perinuclear lysosome-bound mTORC1 is an active
pool and that this location is critical for spatial contact with RHEB. Indeed, in other
studies exploring the spatial localization of mTOR in Hela cells—as well as in MEFs,
A549, and PANC-1 cells—the majority of mTORC1 localized perinuclearly in serum81

stimulated (mTORC1-activated) cells with a much smaller portion localized to plasma
membranes (Saci et al., 2011). Correspondingly, a recent study across a panel of cell
types, including Hela, characterized two populations of lysosomes: a principal
perinuclear “cloud” and much tinier highly dynamic pool sparsely and transiently
populating the periphery (Jongsma et al., 2016). That HCMV has evolved a mechanism
to actively bring mTOR to the perinuclear region and that doing so allows the virus to
maintain mTORC1 activity in the face of inhibitory signals underscore, we believe, the
importance of this spatial location to mTORC1 activation (Clippinger and Alwine, 2012;
Clippinger et al., 2011). However, in our studies at neutral pH the periphery of the cell
was not devoid of lysosome-bound mTOR (Jongsma et al., 2016) and our model need
not imply that subpopulations of mTORC1 do not translocate to various niches in the cell
to regionally tailor biosynthetic activities.

Mechanism of lysosome redistribution in acid
The mechanism by which acid drives lysosomes to the periphery remains
unsettled but is generally speculated to be an upsetting of the normal balance between
centripetal (e.g. dynein) and centrifugal (e.g. kinesin) forces. It has been reported that
acidification releases inhibitory effects of kinesin light chain on heavy chain binding to
microtubules (Verhey et al., 1998), suggesting activation of a kinesin might be causative.
Alternatively, axonemal dynein is appreciated to be inhibited by intracellular acidification,
which is believed to keep spermatozoa flagella inactive during storage in the epididymis
(Nishigaki et al., 2014), and pH-dependence of cytoplasmic dynein has been likewise
proposed (Mohan et al., 2006).

82

As mentioned above, recent descriptions have characterized two pools of
lysosomes in cells, a more abundant spatially restricted perinuclear pool, and a smaller
more mobile peripheral pool (Jongsma et al., 2016). Delineation of the specific cargo
trafficked by the many kinesin and dynein subunits and adaptors would permit better
understanding of the entities redistributed by specific genetic and pharmacologic
manipulations and may clarify discrepant reported impacts of genetic manipulations
discussed above. Acid silences mTORC1 by driving mTORC1 away from its activator
RHEB. Perhaps tactics that move mTORC1 and all its supporting positive regulators and
substrates to the periphery in concert enhance activation of mTORC1 by increasing
mTOR’s proximity to upstream growth factor signaling molecules as proposed
(Korolchuk et al., 2011; Saci et al., 2011).

Role of lysosomal V-ATPase
Lumens of lysosomes are acidified by the ATP-dependent vacuolar H+ pump, VATPase (Mindell, 2012). Recently, it has been described that moving lysosomes to the
periphery alkalinizes their lumen at least in part because of reduced activity of the
lysosomal V-ATPase (Johnson et al., 2016). While knockdown and pharmacologic
inhibition have confirmed the requirement for V-ATPase activity for amino aciddependent recruitment of mTORC1 to lysosomes through RAGs (Zoncu et al., 2011),
our verification that mTOR continues to reside on lysosomes in acid makes reduced VATPase activity an unlikely contributor to reduced mTOR activity in low pH. Nonetheless,
the mechanism behind the requirement for V-ATPase activity—but peculiarly not
lysosomal lumen acidity—for mTORC1 signaling remains unknown (Wolfson and
Sabatini, 2017; Zoncu et al., 2011).
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mTOR dependence of clock network translation
Our data strongly support a model of suppression of the circadian clock in
hypoxia through mTORC1 inhibition by acid. Indeed, low pH, which we observed to be
sufficient to inhibit mTORC1 signaling, likewise displayed sufficiency for suppression of
both clock network protein levels and amplitude of clock oscillation. Correspondingly,
mTOR inhibitors (Torins, rapamycin, n-butanol) recapitulated clock suppression in
proportion to their ability to durably and thoroughly inhibit mTORC1. Knocking down or
out 4EBP proteins gave partial rescue of the clock (as hypothesized given redundancies
in 4EBP proteins and continued suppression of S6K and S6 phosphorylation), while
highly buffered media achieved commensurate full rescues of culture pH, mTORC1
signaling, clock network protein levels, and clock amplitude. Additionally, we
documented an acid-driven spatial subcellular disturbance of the platform upon which
mTORC1 signaling occurs and found this disturbance to be sufficient to inhibit mTORC1
and clock reporter oscillation. Moreover, overcoming this inhibitory spatial change with
overexpression of constitutively active RHEB rescued mTORC1 signaling in acid with
corresponding rescue of the clock, fully consistent with a model in which acid
suppresses the clock through suppression of translation governed by mTOR.
Further study confirmed representative clock network proteins including BMAL1,
PER2, and CLOCK are suppressed in low pH below the level of these proteins seen in a
population of desynchronized cells (Figure 8, see legend), and in opposition to
directionality of transcript dynamics (Chapter 2 – Results, Figure 2D), indicating proteinlevel suppression in acid rather than desynchrony of cells, in accord with single-cell
assessment presented previously (Chapter 2 – Results, Figures 2A and S2E).
Additionally, inhibition of translation with the translocation inhibitor cycloheximide not
unexpectedly similarly diminished expression of these three representative clock
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network proteins as well as clock reporter amplitude and cycling, recapitulating the effect
of acid (Figure 9).
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Figure 8 - Clock network protein levels are suppressed in acidic cells to a level
below that in desynchronized cells, indicating protein-level suppression rather
than phase/period discordance.
U2OS Arntl::dLUC cells were treated with neutral (pH 7.4) or acidic (pH 6.3) media
containing dexamethasone and compared to two populations of desynchronized cells
in media of neutral pH (pH 7.4): cells with no dexamethasone synchronization (“no
dex”) or cells with no dexamethasone synchronization and allowed to incubate without
media change for 5 days prior to experiment start to circumvent the synchronizing
stimulus of media change (“no dex, no media change”). Clock reporter luminescence
(A, B) and media pH (C) monitored in parallel to a 48-hour timecourse in which lysates
were immunoblotted for representative clock network proteins (PER2, BMAL1,
CLOCK) and mTORC1 substrate (4EBP1) phosphorylation (D). RLU = relative
luciferase units.
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Figure 9 - Inhibition of protein synthesis recapitulates pH-mediated clock
collapse.
A. Immunoblots for representative clock network proteins (PER2, CLOCK, and
BMAL1) over a 48-hour timecourse using lysate collected from synchronized U2OS
Arntl::dLUC cells treated with vehicle or 50 ug/mL cycloheximide. B/C. Luminescence
(B) and media pH (C) monitored in parallel to the timecourse in A.

88

There are several classes of transcripts that have been shown to be exquisitely
sensitive to mTORC1 inhibition (most notably, 5’-terminal oligopyrimidine tract (TOP)
transcripts) (Nandagopal and Roux, 2015; Sonenberg and Hinnebusch, 2009). Although
we have not bioinformatically scoured clock transcripts for nucleotide sequences
characteristic of membership in these groups, we are aware of no report indicating clock
genes are amongst these transcripts. However, as David Sabatini’s and colleagues’
ribosome profiling after Torin (mTOR inhibitor) treatment has revealed, while there
indeed are TOP mRNAs that are hypersensitive to mTOR inhibition, “mTOR inhibition
suppresses the translation of nearly all (99.8%) mRNAs to some degree, with a mean
reduction in translation of 61%” (Thoreen et al., 2012). (Unfortunately, clock genes, other
than REV-ERBs, did not make the detection cutoff for this analysis so were not reported
on specifically in this study.) Thus, it is reasonable to expect that translation of clock
genes is suppressed by mTORC1 inhibition.
As mTORC1 is a central regulator of numerous cellular processes, we anticipate
inhibition of the circadian clock is part of an overarching cellular response to hypoxia
mediated by acid. Indeed, both Torin treatment (Thoreen et al., 2012) and hypoxia
(Koritzinsky et al., 2006) have been reported to cause a global decrease in the portion of
ribosomes in polysomes (complexes of multiple ribosomes bound to the same mRNA,
indicative of efficient translation of these transcripts). Similarly, when we performed
polysome profiling of U2OS cells grown in neutral or acidic (pH 6.3) media for 37 hours,
we observed reduction in the global polysome fraction and an increase in the number of
monosomes and free ribosomal subunits (Figure 10, A-E) resembling the effect of Torin
(Thoreen et al., 2012). Moreover, interrogation of the distribution of two representative
clock network transcripts revealed both BMAL1 and PER2 mRNA to be
disproportionately lost from polysomes (shifting to higher percentage found in
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monosomal and free RNA) (Figure 10, F-G), consistent with a translational block. In
contrast, TXNIP mRNA, known to be robustly transcriptionally induced by low pH (Chen
et al., 2010), had substantial polysomal loading corresponding to the significant induction
of its protein level (Figure 10, H-I).
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Figure 10 – Low pH depletes clock network transcripts from polysomes while
globally shifting ribosomes out of polysomes.
A/B. Polysome profiling of U2OS Arntl::dLUC cells after 37 hours of exposure to pH
7.4 (A) or pH 6.3 media (B) as assessed by optical density of sucrose gradients at 254
nm with annotation of the 13 fractions subsequently made. C/D. “Gel-like images” of
tape station analyses of extracted RNA to assess RNA composition. Bands
corresponding to 28S and 18S (large and small ribosomal subunit component rRNAs,
respectively) annotated along with ratio of 28S to 18S yield. Fractions ≥ 9 considered
polysomes (See Methods). E. Nanodrop yield of purified RNA. Note profile
correspondence to A-B suggesting good extraction yield across fractions. F-G.
Relative abundance of clock protein-encoding mRNAs ARNTL (F) and PER2 (G) in
fractions as assessed by qPCR normalized to spike-in control (See Methods). H.
Relative mRNA abundance of acid-induced transcript TXNIP similarly determined. I.
Immunoblot for TXNIP in cells treated with 10 nM non-targeting or TXNIP-directed
siRNA and exposed to media of pH 7.4 or 6.3 for 3 days (66 hours).
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Overall, our observations suggest that low pH has a global effect on translation
resembling Torin, reflecting the commonality of mTORC1 inhibition. Moreover, we
directly document that this suppression of translation in acid encompasses clock network
transcripts, supporting a model in which mTOR inhibition by low pH and consequential
slowing of translation of clock network transcripts leads to clock collapse. Future
polysome profiling at shorter timepoints of acid exposure might reveal specific clock
network proteins to be disproportionately sensitive to mTOR inhibition. As light-induced
translation of PER proteins in the central clock is reported to be particularly sensitive to
mTORC1 inhibition (Cao et al., 2010), PER proteins might display analogous strong
sensitivity to acid-mediated TOR inhibition in peripheral clocks.

RHEB localization and mechanism of mTOR contact
The ability of acid to drive rapid spatial redistribution of lysosome-bound mTOR
without significant alteration of RHEB localization, as well as the incongruency in neutral
conditions between RHEB and both mTOR and LAMP immunostaining patterning,
suggested to us that RHEB perhaps is not localized to lysosomes. Indeed, our data led
us to propose a model of mTORC1 signaling whereby amino acids recruit mTOR to
lysosomes residing at the microtubule organizing center (MTOC) allowing mTOR to
contact RHEB localized to distinct endomembranes likewise trafficked to or enriched in
this subcellular domain. Such a model differs from the prevailing model of mTORC1
signaling (Chapter 1 – Introduction, Box 7; (Sancak et al., 2010)) in which RHEB is
asserted to be constitutively anchored to lysosomal membranes. Resolving this
opposition requires additional evidence to corroborate or reject our model or to clarify the
cell-type or other parameters dictating when each discrepant mechanism prevails.
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As described in the Results section (Chapter 2) and substantiated here with
additional fields, replicates, or further experiments (see corresponding figure legends),
we arrived at our model after careful verification of the specificity (Figure 11A) of a
previously validated RHEB antibody (Menon et al., 2014) and interrogation of the
distribution of RHEB (Figure 11B). Notably, in contrast to earlier reports suggesting that
permeabilization destroys RHEB immunofluorescence signal (Buerger et al., 2006; Saito
et al., 2005; Sancak et al., 2008), we, with incidentally mild permeabilization conditions,
retained specific RHEB signal; however, that the Manning group’s imaging excelled with
somewhat harsher conditions than even some of these earlier studies (Buerger et al.,
2006; Menon et al., 2014) suggests antibody quality not permeabilization technique
limited early experiments. We then confirmed endogenous RHEB to reside in a
perinuclear location similar to the distribution of lysosomes and independent of amino
acid status (Figure 11 C), consistent with prior reports (Menon et al., 2014). As RHEB is
described to be anchored to lysosomes through its farnesylated tail (Menon et al., 2014;
Sancak et al., 2010; Sancak et al., 2008), we anticipated RHEB would be peripherally
displaced in acid, mirroring lysosome redistribution. To our surprise, however, RHEB
retained its perinuclear location in acid, thus becoming spatially separated from
mTORC1 (Figure 11 D).
This unanticipated discrepancy between RHEB and mTOR-LAMP distribution
and dynamics in acid suggested RHEB and mTOR might reside in distinct compartments
in the perinuclear region. We decided to quantitatively characterize the spatial
distribution of mTOR, RHEB, and LAMP1 in 4-color immunofluorescence microscopy
images of U2OS cells at neutral pH to explore this possibility further. This approach
compellingly supported our model, revealing LAMP1 and mTOR to be highly coincident
in spatial distribution and RHEB to be closely apposed but discordant (Figure 11 E).
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These observations are consistent with mTORC1 localization to lysosomes and RHEB
occupancy of spatially adjacent but separate compartment. These data thus suggest the
mechanistic importance of lysosome-localized mTOR activation by RHEB localized to
non-lysosomal perinuclear endomembranes. Moreover, these data indicate a previously
unsuspected mechanism of mTORC1 inhibition under low pH and provide a function for
the rapid dispersion of lysosomes driven by acid—a phenomenon that was observed for
several decades without understanding of its function.
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Figure 11 – Immunofluorescence microscopy of endogenous RHEB suggests
RHEB residence on non-lysosomal endomembranes at the microtubule
organizing center.
Extension of data presented in Chapter 2 Figure 7 and Supporting Figure 7. A. Low
power fields of immunofluorescence imaging presented in Chapter 2 Figure S7E.
U2OS cells coimmunostained for LAMP1 and RHEB after 2 days of treatment with
non-targeting siRNA or siRNA targeting RHEB, RHEBL1, or both RHEB and RHEBL1
(10 nM each target, normalized to 20 nM with non-targeting siRNA where needed) to
validate immunofluorescence specificity of the anti-RHEB antibody. RE of >3. B.
Independent replicate experiment of data presented in Chapter 2 Figure S7H. U2OS
cells immunostained for RHEB and nuclei (DAPI) after amino acid starvation for 105
minutes followed by 10 minutes of amino acid or mock rescue. C. Additional fields of
immunofluorescence imaging presented in Chapter 2 Figure S7H. U2OS cells
immunostained for LAMP1, mTOR, RHEB and nuclei (DAPI) after amino acid
starvation for 155 minutes followed by 10 minutes of amino acid or mock rescue. RE
of 3. D. U2OS cells immunostained for LAMP1, RHEB, and nuclei (DAPI) after 105
minutes in media of pH 7.4 or 6.3. RE of 3. Images in upper panel shown in singlechannel grayscale in lower panel. Independent experiment from that presented in
Chapter 2 Figure 7 E-F. E. Images reproduced here from Chapter 2 Figure S7I to
show relationship with quantification presented here in lower panel. Representative
U2OS cell in media pH 7.4 immunostained for LAMP1, mTOR, RHEB, and nuclei
(DAPI). Intensity profile of LAMP1, mTOR, RHEB, and DAPI along a reference line
(depicted) extending from within the nucleus outward through the cytoplasm (23 μm
line, longest cell radius 54 μm). Distinct patterning of RHEB suggests occupancy of a
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separate but spatially adjacent compartment. RE= representative experiment.
Biological replicates = BR.
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Our data suggest mTORC1 is inhibited in low pH because RHEB fails to move in
concert with lysosomes to the periphery. Robustly overexpressing RHEB causes RHEB
to mislocalize throughout the cell and rescues mTORC1 signaling from acid
suppression, consistent with rescue through restoration of colocalization of RHEB with
peripherally displaced lysosome-localized mTORC1. This model suggests that targeting
RHEB to the lysosome or mTORC1 to the RHEB-containing compartment should rescue
mTORC1 signaling in acid and would thus be an important future test of our model.
Additionally, these unexpected data raise two central questions: on which membranes
does RHEB reside? Why the contradiction to the prevailing model of mTORC1
activation?
RHEB’s farnesylated tail and the ability of farnesylation inhibitors that dislodge
RHEB from membranes to inhibit mTOR signaling (Buerger et al., 2006; Hanker et al.,
2010) clearly suggest active RHEB resides on endomembranes. The perinuclear
location of RHEB suggests several membranal compartments anchored by the
microtubule organizing center are candidate endomembranes, including Golgi,
endoplasmic reticulum (ER), and mitochondrial membranes.
Despite the dominant narrative (Sancak et al., 2010), several groups have
reported non-lysosomal perinuclear RHEB localization in agreement with our inferences.
Using GFP-tagged RHEB and RHEB2 (RHEBL1) constructs, Hanker and colleagues
concluded RHEB proteins colocalized with Golgi and ER markers (Hanker et al., 2010).
Especially notably, these authors explicitly stated a failure to observe colocalization of
either RHEB protein with markers of late endosomes or lysosomes, including LAMP2
and LysoTracker. An earlier report by Buerger and colleagues likewise concluded RHEB
associated with the ER and Golgi using a similar approach (Buerger et al., 2006). More
precisely, abolition of mTORC1 signaling after treatment with brefeldin A, an ER to Golgi
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trafficking inhibitor disruptive of Golgi integrity, supported the proposition that RHEB
needed to reach Golgi membranes to activate mTORC1. Indeed, substitution of RHEB’s
endogenous membrane anchoring tail with an amino acid sequence intended to force
RHEB to the Golgi, but not one targeting RHEB to the ER, was sufficient to fully activate
mTORC1. Additionally, live cell imaging of trafficking of GFP-labeled wild-type RHEB
over a timecourse with parallel immunoblotting for mTORC1 signaling showed mTORC1
activity to peak as RHEB reached the Golgi. Although these authors neglected to
visually confirm the intended localization of RHEB following their forced-targeting
technique and peculiarly harvested lysate from a different cell line than that imaged for
their timecourse experiment, Manifava and colleagues have more recently independently
corroborated this work and documented both ER and Golgi localization of fluorescently
tagged RHEB and Brefeldin A sensitivity of mTORC1 signaling (Manifava et al., 2016).
Thus, although we may be the sole voice suggesting lysosome-localized mTORC1 and
RHEB localized to distinct endomembranes make contact by bridging these separate
endomembrane compartments via the coordinating help of the microtubule organizing
center, we are not the first to propose non-lysosomal RHEB localization. Moreover,
Manifava and colleagues’ inability to observe anticipated strong colocalization of
mTORC1 and RHEB strongly parallels our experience and observations (Figure 11E).
Interestingly, early characterization of RHEB reported that RHEB nucleotide
binding state appeared to dictate on which endomembrane compartment RHEB resided
(Saito et al., 2005). Overexpressed wild-type RHEB localized to membranes overlapping
with markers of late endocytic vesicles (late endosomes and lysosomes) but
overexpressed constitutively GDP-bound mutant RHEB or overexpressed RHEB in cells
treated with a PI3K inhibitor localized to non-lysosomal endomembranes abutting
lysosomes (Saito et al., 2005). Peculiarly, the compartment where inactive (GDP-bound)
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RHEB was thus reported to be found is more reminiscent of the domain where we
observe RHEB under conditions when mTOR signaling is active and RHEB is therefore
predicted to be GTP bound. The reasons for these discrepancies are unknown. In
addition to possible cell-specific differences, the use of overexpressed proteins might
itself artificially influence localization.
Several observations suggest caution is warranted when interpreting results of
experiments based upon overexpressed RHEB. First, Saito and colleagues found that
overexpression of RHEB and RHEB2 (RHEBL1) induced the formation of multiple very
large endocytic (lysosome-like) vesicles. That such large vesicles seem absent or much
fewer in non-transfected cells questions the physiologic nature of these vesicles and
trafficking to them. Secondly, overexpressed wild-type RHEB proteins initially localized
to non-lysosomal membranes in this study prior to late lysosomal localization. This could
reflect normal vesicular trafficking. Alternatively, non-physiologic levels might saturate
normal compartments, overwhelm processing steps known to be required for proper
localization of RHEB (Hanker et al., 2010), or alter membrane compartment physiology
causing targeting for recycling through lysosome fusion. (Indeed, our ability to rescue
mTORC1 signaling from acid relies on and demonstrates an ability to drive atypical
localization of RHEB through overexpression). Consistent with existence of such
confounders, our own experience with LysoTracker dye, a means to label the acidic
lumens of lysosomes without exogenous protein overexpression, and an informal survey
of literature and web images depicting use of this reagent suggest the atypicality of such
large lysosomal structures, including for the same cell lines (Bobak et al., 2017). Similar
reservations might extend to the majority of reports on RHEB localization due to their
same reliance on overexpressed RHEB without corroborating visualization of
endogenous RHEB (Buerger et al., 2006). Nonetheless, if this GTP status-dependent
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compartmentalization of RHEB asserted by Saito and colleagues is validated, this would
interestingly suggest RHEB might alter its membrane localization in response to
activation, echoing similar signaling-induced relocation of mTOR (Sancak et al., 2008)
and TSC2 (Menon et al., 2014). However, as RHEB possesses a farnesylated tail that
anchors it in membranes (Hanker et al., 2010), how such rapid relocation would be
achieved is not immediately clear and would perhaps require release of this anchor or
endomembrane fusion events.
Future study is needed to integrate the above reports and clarify the localization
of RHEB and whether such localization varies across cell lines. High resolution
immunofluorescence microscopy using reliable antibodies to endogenous RHEB, such
as the one we have employed, could be complimented by immunoprecipitation,
organelle isolation, and electron microscopy or cryotomography techniques. Perhaps
differential localization of RHEB exists across cell types, reflecting differing
functionalities of cells and consequently differing quantities and character of
endomembranes. Differential RHEB localization might endow differential mTORC1
sensitivity to sensed environmental parameters or regulate where in the cell mTORC1
and its downstream substrates become activated. Indeed, if some cell types possess
RHEB constitutively anchored to lysosomes, as popularly believed, our model would
predict mTORC1 signaling in these cells to be insensitive to acid. Admittedly, it is difficult
to distinguish the location from which RHEB contacts and activates mTORC1 from
compartments the protein is trafficked through during protein and endomembrane
maturation. Reconstitution of RHEB knockout cells with mutant RHEB constructs
targeted to specific organelles could clarify these ambiguities.
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Tumor cell mTORC1 suppression by acidic microenvironment
Our in vitro data showing acid to be sufficient to inhibit mTORC1 signaling and our in
vivo data indicating rescue of mTORC1 signaling with bicarbonate treatment suggest
mTORC1 signaling is inhibited in acidic regions of tumors. Consistent with this
interpretation, sodium bicarbonate supplementation of mouse drinking water did not
significantly alter expression of a HIF target (carbonic anhydrase 9, CAIX) (Figure 12),
suggesting rescue of mTORC1 signaling with bicarbonate therapy occurs through
elevation of intratumoral pH rather than an effect on upstream HIF signaling or perfusion.
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Figure 12 – Bicarbonate therapy rescues mTORC1 signaling downstream of HIF.
A. Immunohistochemical carbonic anhydrase IX (CAIX) staining of HCT116 xenograft
tumors carried by host mice drinking normal tap water or 200 mM sodium bicarbonate
ad libitum throughout tumor hosting (up to 3 weeks). Representative high-power fields
with inset low-power images of entire tumor cross section. Positivity mask in lower
panels. Percent CAIX positive pixels quantified over entire viable area of tumor cross
section.

Mean±SD

n=4

mice

each

arm.

2-tailed

Student’s

t-test.

B/C.

Immunohistochemical CAIX staining of cross sections of MCF7 (B) and MDA-MB-231
(C) xenograft tumors carried by host mice drinking normal tap water or 400 mM
sodium bicarbonate ad libitum from 3 days post tumor cell inoculation through tumor
harvest (five weeks later). Representative images and quantification as in A.
Mean±SD, n=5 mice (B) or 4 mice (C) for each arm. 2-tailed Student’s t-tests, ns=not
significant. Same tumors stained for pS6 in Chapter 2 Figure 7 K and Supporting
Figure 7 L-M.
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We decided to use our xenograft model of B cell lymphoma (P493) to determine
if additional evidence indicative of tumor acidity suppressing mTORC1 signaling in vivo
could be obtained (Figure 13). We first determined whether mTORC1 signaling could be
inhibited by low pH in this cell line in vitro and confirmed that, like all the other cell lines
explored over the course of this study (U2OS, 293T, HCT116, MCF7, MDA-MB-231,
MEFs), mTORC1 signaling in these cells was sensitive to inhibition by acid (Figure 13A
in comparison to figures in Chapter 2 - Results). We then formed xenografts with the
P493 line and noted that the percentage of cells positive for phospho-S6 (pS6) by
immunofluorescence diminished with tumor size, with parallel assessment of a
rapamycin-treated mouse confirming the specificity of our quantitative assessment
(Figure 13B). As larger tumors would be anticipated to be larger because of higher rates
of proliferation, lower mTORC1 signaling in larger tumors is counterintuitive and
therefore perhaps is suggestive of mTORC1 suppression by increased hypoxia and
acidity

as

larger

tumors

outstrip

diffusion

and

perfusion.

Indeed,

further

immunohistochemical assessment suggested a gradient of pS6 such that the viable
tissue at the core of the tumor was nearly devoid of pS6 staining while the periphery
featured high pS6 staining (Figure 13C). Solid tumors have been shown to likewise
feature oxygen, lactate, and pH gradients, with the center and other regions remote from
blood supply being most severely hypoxic and acidic ((Gallagher et al., 2008; Gillies et
al., 2002; Manzoor et al., 2008; Sattler et al., 2007); in particular, Figure 4B in Gallagher
et al., Figure 6C in Sattler et al., and Figure 1 in Manzoor et al.) . Indeed, when we took
steps

to

attempt

to

quantify

the

three-dimensional

distribution

of

pS6

immunofluorescence in 13 tumors (with careful exclusion of necrotic areas), we saw a
clear reduction in pS6 intensity with radial distance from the tumor surface, again with
specificity confirmed by analysis of a rapamycin-treated mouse (Figure 13 D-E).
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To independently corroborate these observations, we turned to a second tumor
model, an orthotopic pancreatic tumor model (PANC02). In addition to pS6, we stained
for a HIF target (carbonic anhydrase IX, CAIX) as a marker of hypoxic regions and saw a
striking inverse spatial correlation between pS6 and this HIF target (Figure 13F),
consistent with suppression of mTORC1 in regions featuring hypoxia-stabilized HIF (and
therefore HIF-mediated anaerobic glycolysis), and consistent with observations of others
(He et al., 2016). Thus, both P493 and PANC02 tumors reveal data consistent with
mTORC1 suppression in vivo in the anticipated hypoxic and acidic regions of the tumor
microenvironment.
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Figure 13- mTORC1 signaling is low in anticipated hypoxic and acidic regions of
two tumors models in vivo.
A. Immunoblot for mTORC1 signaling and HIF1α using lysate collected from P493
cells treated with media of the indicated pH for 24 hours in vitro. B. Percent phosphoS6 (Ser235/236, pS6) immunofluorescence positive pixels in cross sections of P493
tumor xenografts from control (n=13) or rapamycin-treated (n=1) mice as function of
tumor volume (see methods). C. Representative immunohistochemical staining of
P493 xenograft tumors for pS6. Low power image (left) with high power fields at tumor
edge (middle) and tumor center (right). D. Schema for quantification in E. P493
xenograft tumors from control or rapamycin-treated mice were immunostained for pS6
by immunofluorescence protocol. Necrotic areas identified via comparison to
hematoxylin and eosin stained adjacent sections were excluded from analysis. Tumor
edge was demarcated and percent of pixels positive for pS6 was calculated in
concentric regions of 1 mm width as depicted. Positivity threshold was determined by
measurement of non-cytoplasmic (background) signal in representative region. E.
Percent pS6 positive pixels as a function of radial distance from tumor edge (as
described in D) for tumors from 13 mice. Data presented as raw quantification (left)
and after normalization to outermost shell (0-1 mm) (middle). Mean±SEM of
normalized data shown at right. Raw quantification of tumor from rapamycin-treated
mouse shown for comparison (black heavier line in left plot). F. Immunohistochemical
staining for carbonic anhydrase IX (CAIX) and pS6 using adjacent sections of four
PANCO2 orthotopic murine pancreatic tumors. Lower panel shows regions of interest
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(white boxes) enlarged at right.
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The above data suggest tumor acidity can dampen mTORC1 signaling in tumor
cells. Future work using fluorescent or bioluminescent circadian reporters in tumor
xenograft cells holds the promise of revealing whether such mTORC1 suppression
contributes to clock dampening in tumors. Interest in discerning whether such
dampening can be rescued with bicarbonate therapy and the effect such clock
reinstatement would have on tumors further motivates future study.
As mTOR directs biosynthetic activities in coordination with nutrient availability
and growth factors, we suspected this inhibition of mTORC1 signaling in acidic regions
of tumors might suppress tumor cell growth. However, immunohistochemical staining for
Ki67 in our P493 xenografts revealed high Ki67 even in regions featuring low pS6
(Figure 14), suggesting that even highly proliferative tumors such as this one can feature
regional suppression of mTORC1. This surprising result may be consistent with
published reports suggestive of a model by which mTOR suppression in hypovascular
areas promotes a switch to macropinocytosis which supports proliferation despite low
mTORC1 activity (Palm et al., 2015). This complex relationship between mTORC1
inhibition and proliferation requires further study in this and additional tumor models.
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Figure 14- Markers of proliferation remain uniformly high in P493 tumor
xenografts despite regional dampening of mTORC1 signaling.
A. Representative immunohistochemical staining of P493 tumor xenografts for Ki67.
Two tumors shown. B. Low power images of immunohistochemical staining for pS6
and Ki67 using adjacent tumor sections from four additional P493 xenograft tumors.
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Advantage of clock loss
The ability of a tumor microenvironmental parameter to suspend the circadian
clock motivates future inquiry into whether and how such clock suppression might
enhance the hypoxic response or contribute to cancer cell behavior. Because of the
many targets and processes under control of the clock, we speculate that shutting down
the clock through mTORC1 inhibition in hypoxia is an efficient means for the cell to
rapidly dampen many homeostatic energy-costly programs. This tempering of cell
activities might permit the cell to better endure the period of limited metabolic and energy
resources. It may also allow the stress response program to run without temporal
limitation to fulfill the acute need. When stress becomes chronic, as in the acidic tumor
microenvironment, oncogenes might be permitted to run a malignant program likewise
freed from clock-dictated constraints. Therefore, reinstallment of a clock may prove to
offer some tumor suppressive capacity. Regardless, the disruption of the temporal profile
of many clock-controlled targets in acidic tumor cells should allow identification of
optimal treatment times corresponding to when the therapeutic window over normal
tissue is maximal and therefore promising of greatest efficacy and least toxicity.
To test the idea that suppression of the clock in response to hypoxia and acid
has adaptive qualities, survival and growth rates of cancer cells with mTORC1goverened translation that is partially (4EBP1 knockout) or fully (RHEB overexpression)
resistant to suppression by acid could be assessed in vitro or in vivo (xenograft) relative
to wild-type cells. Combination with BMAL1 knockout could identify specifically if a
running clock hinders cancer cell adaptation to tumor microenvironmental stress.
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Immune cell mTOR inhibition by acidic tumor microenvironment
Our work also has potential implications for cancer immunotherapy, suggesting
the acidic tumor microenvironment might shut down mTOR signaling critical to T cell
function. Lymphocytes have long been recognized to alkalinize pHi upon stimulation
(Gerson et al., 1982). More recently, mTORC1 has been revealed to play a critical role in
the differentiation and activation of CD4+ and CD8+ T cells (Pollizzi et al., 2015; Pollizzi
et al., 2016; Powell et al., 2012). For instance, pharmacologic or genetic inhibition of
mTORC1 signaling prevents differentiation of CD8+ T cells into effector cells (Pollizzi et
al., 2015; Rao et al., 2010) and CD4+ T cells into Th1 and Th17 subtypes (Delgoffe et al.,
2011). Several reports have noted without mechanistic explanation that acidic media
reversibly suppresses T cell cytokine production and cytolytic abilities in vitro (Brand et
al., 2016; Calcinotto et al., 2012; Fischer et al., 2007; Pilon-Thomas et al., 2016), and
raising the pHe of in vivo tumor models with buffer therapy or a proton pump inhibitor
enhances responses to both checkpoint inhibition and adoptive immunotherapy
(Calcinotto et al., 2012; Pilon-Thomas et al., 2016). Correspondingly, the potent
suppression of mTORC1 signaling by acid observed by us in CD8+ and CD4+ cells might
be the mechanism behind acid’s suppressive effects on T cells. Consistent with this,
suppression

of

IFNγ

production

in

acid

was

noted

to

be

reversible

and

posttranscriptional in a manner suggestive of a translational block (Fischer et al., 2007;
Pilon-Thomas et al., 2016). Indeed, rapamycin has been used for decades for its
immunosuppressive function.
The peripheral redistribution of lysosomes in acid that we document suggests
microtubule-based vesicle trafficking events critical to T cell function might also be
disturbed in the acidic tumor microenvironment. After engaging an antigen presenting
cell, the MTOC of the naïve T cell moves beneath the immune synapse (point of T cell
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receptor (TCR) engagement) and additional TCR receptors are delivered in a dyneindependent manner. Additionally, when a cytolytic T cell encounters a target cell, lytic
granules (a lysosome-related organelle) are delivered to the MTOC through retrograde
movement for release of their contents (de la Roche et al., 2016). Moreover, asymmetric
partitioning (i.e. microtubule-directed trafficking) of fate-determining proteins amongst
daughter cells after antigen-stimulated cell divisions gives rise to memory and effector
lineages of CD8+ T cells (Pollizzi et al., 2015). Therefore, it is conceivable that acidmediated antegrade redistribution of vesicles and proteins could hinder activation,
differentiation, and effector abilities of T cells and thereby enhance tumor escape from
immune-mediated clearance. Consistent with this, in previous studies of T cell culture in
acid, perforin content was not only noted to be lower (Fischer et al., 2007) but
degranulation was also reversibly suppressed (Calcinotto et al., 2012). Given the acidic
nature of the solid tumor microenvironment, acid neutralizing tactics might thus be
helpful

adjuvants

to

traditional

cancer

therapeutics

and

newer

anti-cancer

immunotherapies through restoration of mTORC1 signaling and proper vesicle trafficking
in immune cells.

Thus, setting off to understand the interplay between hypoxic metabolism and the
circadian clock, we have surprisingly come to understand new or previously overlooked
fundamental and unanticipated features of a well-known key regulator of metabolism,
which curiously, we realize in retrospect, was known to time metabolism to match
environmental fluctuations in its own right. Given the centrality of the players—pH, the
clock, mTOR—the future directions are numerous.
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CHAPTER 4 – Materials and Methods
Experimental Model and Subject Details
Cell Lines
U2OS cells and clonal U2OS cells stably expressing Arntl::dLUC or Per2::dLUC (Zhang
et al., 2009) were kindly provided by Drs. Roger Greenberg and John Hogenesch,
respectively, and authenticated and confirmed free of mycoplasma by us. TSC2
knockout and wild-type p53 -/- MEFs (originally from the laboratory of Dr. David
Kwiatkowski (Zhang et al., 2003)) and 293T cells were provided by Dr. Celeste Simon.
Sestrin triple knockout 293T cells were provided by Dr. David Sabatini. MDA-MB-231
cells used in in vitro studies were provided by Dr. Donald Ayer and confirmed free of
mycoplasma by us. MCF7 and HCT116 cells used in vitro studies were originally
purchased from ATCC. U2OS, MDA-MB-231, and MCF7 cells are female. HCT116 is
male.
All U2OS, 293T, and MEF cell lines were maintained in standard DMEM (4 mM Lglutamine, 25 mM glucose; Corning MT10-013-CV) supplemented with 10% fetal bovine
serum (HyClone) and 1x penicillin/streptomycin (Corning) in standard humidified 5%
CO2, 37 °C tissue culture incubators. MDA-MB-231 cells used for in vitro study were
further supplemented with 1x MEM non-essential amino acids (Gibco). HCT116 cells
were

maintained

in

DMEM/F12

media

(Gibco)

supplemented

with

1x

penicillin/streptomycin and 10% newborn calf serum (HyClone). P493-6 were maintained
in

RPMI

1640

(Corning)

supplemented

with

10%

FBS

(Hyclone)

and

1x

penicillin/streptomycin (Corning) in standard humidified 5% CO2, 37 °C tissue culture
incubators.
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Generation of additional U2OS cell lines and experimental culture conditions described
below.
HCT116, MCF7, and MDA-MB-231 cells used in in vivo work were purchased from
ATCC, authenticated by short tandem repeat analysis, and confirmed to be free of
mycoplasma. P493-6 cells used in in vivo work were likewise confirmed free of
mycoplasma. Further details pertaining to these cell lines are detailed below in the
description of this in vivo work.
Animal Models
Primary T-cell cultures were sourced from C57BL/6 mice with loxP-flanked Tsc2 alleles
and Cd4-Cre (Tsc2fl/fl Cd4-Cre, resulting in TSC2 selectively deleted in T cells, “TSC2 -/”) or without Cre (Tsc2fl/fl, “TSC2 +/+”) or with OVA-specific CD8+ T cells (OT-I) (Pollizzi
et al., 2015). All relevant animal procedures were in accordance with the guidelines of
the Institutional Animal Care and Use Committee (IACUC) at Johns Hopkins University.
Male and female littermates were used for each experiment with sex matching
accordingly. Mice were provided with food ad libitum in standard 12-hour light/dark
housing.
Xenograft studies pertaining to bicarbonate treatment were performed in accordance
with the guidelines of the IACUC of the H. Lee Moffitt Cancer Center using eight- to tenweek-old randomized mixed male and female severe combined immunodeficient (SCID)
mice (Fox Chase SCID Beige mice, Charles River) or female nu/nu mice (Envigo) as
hosts as detailed below in the description of this in vivo work. Mice were provided with
food ad libitum in standard 12-hour light/dark housing.

122

For P493 xenograft studies, all animals were maintained in accordance with the
guidelines of the Institutional Animal Care and Use Committee (IACUC) at The Wistar
Institute. Xenografts were formed in 6- to 8-week old athymic female nude mice (Charles
River).
Primary cells
Cells from spleens and lymph nodes (“splenocytes”) were combined for all experiments.
In summary, single-cell suspensions were created by mashing organs through a 70 uM
filter. Red blood cells were removed through ACK lysing (Quality Biological).
Splenocytes from mice with TSC2 -/- and TSC2 +/+ T cells were resuspended directly
into experimental conditions as described below. Splenocytes from OT-I mice were
resuspended in RPMI-1640 media (Corning 10-040) with 10% FBS (Gemini
Bioproducts), 2 mM L-glutamine (Corning), 10 mM HEPES (Corning), 50 ug/mL
gentamycin (Quality Biological), 1x non-essential amino acids (Gibco), and 50 uM betamercaptoethanol (Sigma) and stimulated with 100 ng/mL OVA peptide (Anaspec) for 48
hrs then expanded in 10 ng/mL IL-2 (Preprotech) for 4 days to generate previously
activated T cells. Primary OTI cultures were maintained in standard humidified 5% CO2,
37° C tissue culture incubators media. Experimental culture conditions described below.
Method Details
Media formulations and culture conditions (cell lines)
DMEM media with four different buffering/pH characteristics were typically used for in
vitro experiments employing cell lines. These medias were referred to as “low buffer,”
“high buffer,” “pH 7.4” (i.e. neutral media), and “pH 6.3” (or pH 6.4, 6.5, 6.6, etc. as
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indicated in figures and legends, i.e. acidic media). These media formulations are
described below. Exceptions to use of these medias are also noted below.
Low buffer media
The real-time luminometers (LumiCycle instruments, described below) that continuously
measure

bioluminescence

from

cultured

cells

require

a

non-humidified

and

“atmospheric” CO2 (i.e. non-elevated CO2) environment for proper hardware function.
Therefore, the standard widely used media in these luminometers is DMEM with
buffering capacity appropriately adapted for atmospheric (0.04% CO2) culture (Yamazaki
and Takahashi, 2005). In detail, this is a phenol-red-free DMEM with 25 mM glucose, 4
mM L-glutamine (Lonza), 4.2 mM (350 mg/L) sodium bicarbonate (Gibco), 10 mM
HEPES

(Sigma),

5%

FBS,

and

0.25x

penicillin-streptomycin

(prepared

by

supplementation of USBiological D9812-05). This standard media is referred to as “low
buffer” media. Media pH was adjusted to pH 7.4 prior to filter sterilization. Except where
noted, this media was used in atmospheric CO2 conditions.
High buffer media
“High buffer” media is the above “low buffer” media with the HEPES eliminated and the
sodium bicarbonate increased to 44 mM (3.7 g/L). (Note, this is the bicarbonate
concentration in standard DMEM used in routine 5% CO2 culture.) This media was used
at atmospheric CO2 conditions or, if noted, in 5% CO2. When used at atmospheric CO2
conditions, the bicarbonate concentration is in excess of that indicated by the
Henderson-Hasselbalch equation to be required to achieve a physiologic pH (i.e. pH
7.4). This excess is deliberate and, in contrast to the above “low buffer” media, enables
absorption of the anticipated acid load generated by glycolytic (hypoxic) cells. High
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buffer and low buffer medias were prepared from the same concentrated common base
to ensure identical composition in all other regards. Media pH was adjusted to pH 7.4
prior to filter sterilization.
pH 7.4 and pH 6.3-6.6 medias
A media of acidity comparable to that observed in solid tumors (pH 6.2-6.6) (Gallagher et
al., 2008; Gillies et al., 2002) was desired. To enhance the pH-stability of such a media,
the bicarbonate-HEPES buffering system of low buffer media (above) was replaced with
25 mM PIPES (pKa of 6.66 at 37 °C, effective buffering range pH 6.1-7.5 at 25 °C;
Sigma). So as to allow this acidic media and its control physiologic pH media (pH 7.4) to
share the same chemical composition, 25 mM HEPES (pKa 7.31 at 37 °C, effective
buffering range pH 6.8-8.2 at 25 °C; Sigma H4034) was also added. Prior to filter
sterilization, a concentrated PIPES-HEPES DMEM media base was split, adjusted to pH
7.4 or pH 6.3-6.6 (as noted in figures), and brought to volume, ensuring identical media
composition of neutral and acidic media in all other regards. These medias were
exclusively used in atmospheric CO2. While medias of pH 7.4, 6.5, and 6.3 were
predominantly used, occasional figures and legends note the use of medias prepared to
other pH values, including pH 6.6, pH 6.8, pH 7.0, pH 7.5, and pH 8 (e.g. Figs. 1I, S1F,
4A, S4A-C, S5E, S7J, and S7K).
Additional experimental culture details
L-glutamine (Lonza) was typically left out of all DMEM media preparations and added
fresh immediately before use. Above medias were further supplemented with 1x nonessential amino acids when used for MDA-MB-231 in vitro experiments. After seeding,
cells remained in standard humidified tissue culture incubators (5% CO2, 37 °C) in
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normal DMEM for typically two days until experiment initiation and treatment with one of
the above medias. To protect against desiccation during the course of experiments, all
cells were cultured in humidified tissue culture incubators or sealed with autoclaved
vacuum grease (Dow-Corning).
Media formulations and culture conditions (T cells)
For experimental manipulation of pH of splenocytes or purified T cell cultures, cultures
were resuspended in RPMI-1640 (Sigma R1383 with 11.1 mM glucose restored)
supplemented with 10% FBS (Gemini Bioproducts), 2 mM L-glutamine (Corning), 50
ug/mL gentamycin (Quality Biological), and 50 uM beta-mercaptoethanol (Sigma) in
which the bicarbonate-CO2 buffering was replaced with 25 mM PIPES and 25 mM
HEPES. These cultures were maintained at 37 °C in atmospheric CO2 in a humidified
incubator. When prepared, a slightly concentrated media was split into multiple volumes
before adjusting pH to target values, bringing to volume, and sterilizing by filtering,
ensuring identical media composition in all regards other than pH. pH of stored media
was frequently monitored to guard against drift and ensure correct record of
experimental conditions.
Hypoxic culture
Hypoxic conditions (1% O2) were achieved by culturing cells in a humidified incubation
box within a Coy Labs oxygen control glove box (“hypoxia chamber”) capable of
regulating both oxygen and CO2 levels by mixing N2 and CO2 with ambient air. Normoxia
refers to ambient 21% oxygen levels. Both normoxic and hypoxic arms of Fig. 1A utilized
low buffer media in atmospheric CO2. Figure S1A used 5% CO2 in all conditions, with
high buffer media in normoxia and low buffer media in hypoxia. All other hypoxic cultures
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and respective normoxic controls were in 5% CO2 with media buffering as noted in
figures.
Cell synchronization
Cells were synchronized in circadian time where indicated in figure legends by aspiration
of media and replacement with fresh media containing 0.1 uM dexamethasone (Sigma)
at time 0 (Altman et al., 2015). “Unsynchronized” if indicated emphasizes no
dexamethasone exposure. All T cell experiments reflect “unsynchronized” cells. MCF7,
HCT116, and P493 were unsynchronized in in vitro experiments.
In Figure 8 where desynchronized cells were explicitly studied “no dex” refers to the
omission of dexamethasone from the pH 7.4 media. For the “No dex, no media change”
arm, cells grew undisturbed for 5 days in pH 7.4 media without dexamethasone prior to
timecourse start to avoid the synchronizing influence of media change. See further
description below under timecourse design.
Luciferase reporter cell lines and monitoring
Generation of real-time luciferase reporters
Clonal U2OS Arntl::dLUC and U2OS Per2::dLUC cell lines (sourced as noted above)
stably express firefly luciferase under the control of mouse Arntl or Per2 promoters. The
luciferase has been destabilized (“dLUC”) through addition of degradation sequences
enabling it to serve as a real-time reporter of the activity of the clock network (Zhang et
al., 2009). A portion of the Arntl::dLUC data shown and not shown was generated in a
clonal cell line also stably expressing Renilla luciferase driven by an independent
promoter. This line was generated by transfection (Lipofectamine LTX with Plus reagent,
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Promega) followed by 150 ug/mL hygromycin selection (Corning) for a vector in which
the SV40 promoter from pGL4.73 (Promega) was inserted in front of destabilized Renilla
(hRlucCP) in pGL4.78 (Promega). Derivation of a representative clone by serial dilution
allowed cessation of antibiotic selection. This control reporter enabled early
characterization and validation of the clock reporter. However, the luciferase activity data
shown in this paper exclusively represent the luciferase activity of the firefly luciferase
clock reporter, as only the substrate for this enzyme (beetle luciferin (Promega), which is
not a Renilla luciferase substrate) was supplied regardless of Renilla status.
Experiments (shown and not shown) employing Arntl::dLUC cells both with and without
renilla expression demonstrated that the background presence of this control enzyme
had no effect on the presented data. Therefore, both cell lines are referred to here as
U2OS Arntl::dLUC for simplicity.
PGK1-HRE::dLUC and VEGF-HRE::dLUC real-time luciferase-based reporters of
hypoxia response element (HRE) activity were generated by inserting three copies of an
HRE motif derived from the human PGK1 promoter (lifted from HRE-pGL2-TK (Li et al.,
2014)) or five copies of an HRE motif from the human VEGF promoter (derived from
5HRE/GFP (a gift from Martin Brown and Thomas Foster, Addgene plasmid #46926))
into the promoter region of destabilized firefly luciferase (Luc2CP, “dLUC”) in the
puromycin-selectable vector pGL4.22 (Promega) and confirmed by sequencing. Stable
cell lines expressing an HRE::dLUC luciferase reporter and the control Renilla reporter
described above were generated in U2OS cells through co-transfection of cells plated in
6-well dishes with 1.25 ug of each plasmid using Lipofectamine LTX with Plus reagent
followed by 1.5 ug/mL puromycin (Gibco) and 150 ug/mL hygromycin selection
simultaneously (PGK1::dLUC) or sequentially (VEGF::dLUC). Single-cell clones of the
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HRE::dLUC, SV40::hRlucCP reporters representative of the population were derived by
serial dilution and antibiotic selection ceased. As above, the data presented in this paper
reflect luciferase activity exclusively of the firefly luciferase reporter as only substrate for
this enzyme was supplied. Thus, these lines are referred to as PGK1-HRE::dLUC and
VEGF-HRE::dLUC for simplicity.
Real-time monitoring of luciferase reporters
Reporter cells were plated in 35 mm dishes or 24-well plates to be confluent at the start
of analyses. For example, typically 375,000 U2OS cells per 35 mm dish or 62,500 cells
per well of a 24-well plate were seeded two days prior. At time zero, culture plates were
aspirated, administered fresh media supplemented 0.1 uM dexamethasone and 0.1 mM
beetle potassium luciferin (Promega), sealed against desiccation with vacuum grease
(35 mm dishes) or adhesive optical PCR plate film (24-well plates, Applied Biosystems),
and immediately placed in a Lumicycle-32 or Lumicycle-96 luminometer (Actimetrics).
Luminescence (counts/sec; “relative light units (RLU) per second”) was recorded every
10 minutes for multiple days and exported to Excel (Microsoft) with LumiCycle Analysis
software (Actimetrics). If monitored cells were treated with chemical inhibitors, these
were added to the media at time zero; if siRNA treated, except where noted, siRNA was
delivered the day prior as described below and in legends. Depicted “washouts” were
achieved by temporary removal of a plate from the Lumicycle and media replacement.
All Lumicycle data are generated in atmospheric CO2 conditions for reasons noted
above. All data are presented as raw data with no detrending. Reported amplitudes for
Torin treatments (below) represent the mean peak-to-peak amplitude over four days
manually calculated from the mean luminescence of biological triplicates (as in Figures
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4I, S4N) as the difference between a peak and the following trough beginning 1 day after
synchronization.
Lysate luciferase assay
The photon-producing luciferase reaction requires oxygen as a reactant and is therefore
susceptible to suppression of enzymatic rate in hypoxia. Therefore, we did not monitor
luminescence in real-time in hypoxia. Instead, lysate was collected from hypoxic (1% O2)
and normoxic control plates at time points and then subsequently assayed for luciferase
activity in normoxia. In brief, reporter cells were plated in 35 mm dishes as above. Were
indicated in legends, the following day, media was placed in the hypoxia chamber
overnight in flasks to permit pre-equilibration. Media was similarly allowed to equilibrate
in normoxia for control arms. The following day, cells were brought to the hypoxia
chamber (or normoxic incubators) and media was exchanged for (pre-equilibrated)
media supplemented with 0.1 uM dexamethasone. At time points, cells were rinsed once
with PBS and then lysed by scraping in 500 uL passive lysis buffer (Promega E1501).
Cleared supernatant was then frozen at -80 °C until assay by luminescence with the
Luciferase Assay System (Promega) in 96-well format on a GloMax 96 microplate
luminometer (Promega) or Biotek Synergy HT microplate reader.
Luciferase assay of cell lysates was also used to verify live-cell real-time luminescence
data (Fig. S1C-D). 13,000 U2OS Arntl::dLUC cells per well were plated in opaque 96well culture plates. Beginning two days later, a reverse timecourse was initiated by
synchronizing wells in triplicate in staggered fashion. Media contained luciferin allowing
luminescence from live cells to be measured with the same microplate luminometer
immediately prior to lysis of cells and luciferase assay directly in the plate with the
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Luciferase Assay System. In Fig. S1C-D, low buffer is in atmospheric CO2 and high
buffer media is in 5% CO2.
Single-cell luminescence imaging
Cell culture
Frozen Arntl::dLUC U2OS cells were received by the Welsh lab on dry ice from the Dang
lab and thawed. Cells were grown in 35 mm cell culture dishes in DMEM cell culture
medium with 10% heat inactivated fetal bovine serum (GIBCO), 1x MEM non-essential
amino acids, and 1x penicillin-streptomycin in a humidified atmosphere of 5% CO2 at 37
°C. Cells were imaged at 30% confluence to allow for clear visual discrimination of single
cells.
Imaging
Immediately before imaging, medium was replaced with PIPES/HEPES-buffered media
adjusted to pH 6.3, 6.8, or 7.4 and containing 1 mM luciferin and 0.1 uM dexamethasone
prepared as described above but with the serum replaced by 1X B-27 (Gibco). Imaging
was conducted in two darkrooms, each with a slightly different camera and temperature
control setup. In both darkrooms, plates were sealed and placed on an inverted
microscope stage (Olympus IX71) within a heated lucite chamber (Darkroom 1: Solent
Scientific, UK; Darkroom 2: Precision Control Systems, Eden Prairie, MN) at a constant
temperature of 36 °C. Light from the samples was collected using an Olympus 4x
XLFLUOR objective (NA 0.28) and transmitted to a CCD camera (Darkroom 1: Spectral
Instruments SI800, Tucson, AZ, USA; Darkroom 2: Andor Technologies DU934, Belfast,
UK) cooled to -90 °C. Noise was reduced by 4x4 pixel binning. Exposure was set to 12
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min, and images were collected at 30 min intervals for 4 days. Further details in
published methods (Welsh et al., 2005; Welsh et al., 2004).
Image processing
Cosmic ray artifacts were removed in MetaMorph (Molecular Devices, Sunnyvale, CA)
by taking the minimum value of pixelwise comparison of consecutive images.
Luminescence intensity was measured in a manually defined region of interest (ROI) for
each cell. ROI positions were adjusted to accommodate cell movement. Seven to ten
cells were analyzed per plate (10 cells per plate at pH 7.4, fewer (7-9 cells per plate) for
pH 6.3 due to cell death). Criteria for cell selection were that cells had to survive the
course of the experiment and cells could not touch other cells to the point that they could
not be tracked. Luminescence intensity values and ROI areas were logged in Microsoft
Excel, and intensity was converted to analog-to-digital units (ADU) according to the
following equation:
ADU= (luminescence intensity-background intensity) × ROI area
Background intensity was set as the minimum luminescence intensity recorded across
all cells for each experiment.
Determination of rhythmicity
To exclude high initial luminescence transients, the first twelve hours of data were
excluded. Luminescence values between 0.5 and 3.5 days, for a total of 72 hours of
data, were analyzed for each experiment. To determine average brightness of each cell,
mean ADU was computed across 0.5 to 3.5 days. Luminescence time series were
imported into LumiCycle Analysis. To determine period, phase and amplitude, data were
132

fitted to a best fit sine curve corrected for dampening. Circadian rhythmicity was
determined by the fast Fourier transform (FFT) peak, or percent of total variance within
the circadian range corresponding to 20-36 hour periods. The scatter plot was obtained
by plotting FFT peak against period. FFT peak value of 0.07 was chosen to exclude
period values that were clearly outside the typical circadian range. Cells with FFT peak ≥
0.07 were considered to be rhythmic. Percent rhythmic cells was computed for each pH
value. Only rhythmic cells were analyzed for the below attributes.
Analysis of circadian attributes
After excluding data from cells with FFT peak < 0.07, the impact of equipment between
the two darkrooms on average brightness, normalized FFT peak, period, phase and
amplitude were investigated using a t-test for each pH. As expected with two different
camera setups, only average brightness and amplitude were influenced. Consequently,
average brightness and amplitude values were normalized by scaling to the maximum
and minimum values found for each darkroom. We verified that our normalization
method did not influence results by analyzing raw data from each darkroom individually
before pooling normalized data from both darkrooms. As values for FFT peak, period
and phase were unaffected by darkroom, raw data were pooled without normalizing for
analysis of these metrics. An outlier was excluded when α ≤ 0.05 (Grubb’s test).
Significance was found by running ANOVA and post-hoc Dunnett’s multiple comparison
tests comparing pH 6.8 and pH 6.3 to the control (pH 7.4).
CRISPR-editing
EIF4EBP1 (4EBP1) and TSC2 were silenced in U2OS Arntl::dLUC cells through
CRISPR editing using pSpCas9(BB)-2A-GFP (PX458) (a gift from Feng Zhang, Addgene
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plasmid #48138) with sgRNA sequences from the GeCKO library (Shalem et al., 2014):
TGAAGAGTCACAGTTTGAGA for EIF4EBP1 and TCTGCTGAAGGCCATCGTGC for
TSC2. Oligos were phosphorylated, annealed, and ligated into the PX458 backbone,
which was then transformed into bacteria, isolated, and verified by sequencing. The
empty PX458 vector was used as control. 1.15 million cells were seeded in 10 cm plates
and the following day transiently transfected with 5 ug of plasmid using Lipofectamine
3000 (Invitrogen) according to the manufacturer’s directions. 24 hours later, GFP
positive cells were sorted by FACS as single cells into 96-well plates. Resulting clonal
lines were then screened by immunoblot for silencing of target. Because clones derived
from the parental U2OS Arntl::dLUC line exhibit heterogeneity in intensity of luciferase
expression (regardless of transfection), edited cell lines were matched to an empty
vector clonal line determined to have similar luciferase expression in control (pH 7.4)
conditions (#EV1_16) for the convenience of more ready visualization of changes in
amplitude of oscillation in response to experimental manipulations during real-time
bioluminescence monitoring.
Stable overexpression
U2OS Arntl::dLUC lines stably expressing constitutively active RAGB or a control GTPbinding protein, RAP2A, were created by moving the flag-tagged inserts in Flag-pLJM1RagB99L and Flag-pLJM1-Rap2A (gifts from David Sabatini, Addgene plasmids #19315
and #19311) (Sancak et al., 2008) into pcDNA3.1+ (Invitrogen) using NheI and EcoRI
restriction sites and confirming by sequencing. 200,000 cells were seeded into 6-well
plates and the following day transfected with 0.5 ng of linearized (BglII) plasmid using
Lipofectamine 3000 and then selected with 600 ug/mL G418 (Corning) beginning two
days later. Cells were maintained in selection until the initialization of experiments.
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U2OS Arntl::dLUC lines stably expressing constitutively active RHEB (Urano et al.,
2005) where similarly created by seeding 200,000 cells in a 6-well dish and the following
day transfecting with 0.5 ng of sequence-confirmed pcDNA3-FLAG-Rheb-N153T (gift
from Fuyuhiko Tamanoi, Addgene plasmids #19997) using Lipofectamine 3000.
Beginning two days later, cells were selected with 800 ug/mL G418 followed by 400
ug/mL maintenance. Clones were derived by serial dilution and screened for expression
of the transgene. As for CRISPR lines discussed above, a clone (#EV2_6) also derived
from U2OS Arntl::dLUC and transiently transfected with an empty vector (PX458) was
designated a control for its similar baseline luciferase expression in pH 7.4 conditions.
G418 selection was ceased after derivation of clones.
293T cells stably expressing WDR24 (a subunit of GATOR2) or a control protein
(RAP2A) were created through lentiviral infection. 293T cells were seeded in 10 cm
plates so as to be 75% confluent the following day when transfected with 3 ug of
sequence-confirmed Flag-pLJM1-WDR24 or Flag-pLJM1-Rap2A (gifts from David
Sabatini, Addgene plasmids #46337 and #19311) and 2.25 ug second-generation
packaging plasmid psPAX2 and 0.75 ug pMD2.G envelope plasmid (gifts of Didier
Trono, Addgene #12260 and #12259) using Lipofectamine 3000. Virus-containing
supernatant was collected after 72 and 96 hours, filtered, concentrated with an Amicon
Ultra-15 10K centrifugal filter device (Millipore), and used to transduce in the presence of
8 ug/mL polybrene (Millipore) subconfluent 293T cells seeded the day prior in 35 mm
dishes. The following day, cells were trypsinized and expanded and 1 ug/mL puromycin
selection was begun. Cells were maintained in selection until initialization of
experiments.
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U2OS Arntl::dLUC cells stably expressing a genetically-encoded cytoplasmic ratiometric
pH probe, mCherry-SuperEcliptic (SE) pHluorin (a gift from Sergio Grinstein, Addgene
plasmid #32001) (Koivusalo et al., 2010), were generated by seeding 250,000 U2OS
Arntl::dLUC cells into one well of a 6-well plate and the following day transfecting with
1.25 ug of sequence verified mCherry-SEpHluorin using Lipofectamine LTX with Plus
reagent. Beginning three days later, cells were selected with 400 ug/mL G418. After
emergence of a stable line, fluorescence-activated cell sorting was used to derive a
polyclonal population with mid-range brightness of the reporter to avoid reporter
mislocalization from excessive expression. This line was maintained in selection until
initialization of experiments.
pH measurements
Extracellular pH
Extracellular pH was determined by measuring the pH of a sample of culture media
using the Mettler Toledo SevenGo pH meter SG2 with either the InLab micro probe or
the InLab 413 SG/2m probe with automatic temperature compensation. These meters
were also used to adjust the pH of media and other reagents as needed. The pH meter
was recalibrated with 3 standards (Mettler Toledo 51302080) at the start of every
experiment.
Intracellular pH
Intracellular pH was assessed by a method adapted from previous descriptions
(Koivusalo et al., 2010) and the manufacturer-provided protocol for the intracellular pH
buffer calibration kit (Invitrogen P35379). U2OS Arntl::dLUC cells stably expressing a
genetically-encoded cytoplasmic ratiometric pH probe, mCherry-SuperEcliptic (SE)
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pHluorin, in which the fluorescence intensities of the fused modified GFP (SE pHluorin)
and mCherry are pH sensitive (pKa = 7.2) and insensitive, respectively, were generated
as described above. 200,000 cells were plated in 6-well dishes and allowed to grow for
two days in standard humidified tissue culture incubators (5% CO2, 37 °C) in normal
DMEM before treating with the inhibitors or medias for the duration indicated in figure
legends. To generate a standard curve, each well of an untreated plate grown in parallel
was washed twice with PBS and then incubated with a media pH standard (25 mM
HEPES, 25 mM PIPES DMEM, pre-adjusted to pH 8.0, 7.5, 7.0, 6.5, or 6.0, as above)
containing 10 uM valinomycin and 10 uM nigercin (Invitrogen) for 5 minutes in
atmospheric CO2 at 37 °C before imaging. Alternatively, the same well was serially
treated with each standard and imaged with similar results. Three or more 10x fields
were captured from each standard using an Olympus IX81 inverted fluorescence
microscope quipped with a 10X objective (UPLFLN10X2PH) and a cooled 12 bit CCD
camera (Sensicam QE, PCO) controlled by SlideBook 6 software (e.g. S4B).
Experimental plates (DMOG-treated, etc.) were subsequently likewise imaged with
identical microscope hardware and acquisition settings (e.g. S4C). Images were then
background-corrected in Fiji (Image J2, rolling ball background subtraction) before
measuring the integrated intensity across the whole field (Schindelin et al., 2012). The
ratio of the SE pHluorin (GFP) and mCherry intensities for each field was calculated. A
standard curve (e.g. S4A) was generated relating the mean ratios of the standards to the
pH of the standard (calibration) medias. The linear fit equation was used to calculate the
intracellular pH of the experimentally treated plates (e.g. 4A). This described approach
yielded similar results in validation experiments (not shown) as ratiometric assessment
of regions of interest drawn within the cytoplasm of cells imaged under higher power
(40x). Displayed images are uniformly contrasted.
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Chemical inhibitor treatments
Prior to treatment with inhibitors, 375,000 cells plated in 35 mm dishes were allowed to
expand in normal DMEM in standard 5% CO2 37 °C incubators. Dose and duration of
treatments are as indicated in legends. DMOG (Sigma) and vehicle (DMSO) treatment
(regardless of buffer conditions) were in atmospheric CO2, except S1D and S4L where
high buffer media was used in 5% CO2 (and low buffer media was used in atmospheric
CO2). All other chemical inhibitors (desferrioxamine (Calbiochem), GNE-140 (NCATS
Chemical Genomics Center) (Boudreau et al., 2016), amiloride hydrochloride hydrate
(Sigma) (Pouyssegur et al., 1982), α-cyano-4-hydroxycinnamic acid (Sigma) (McBrian et
al., 2013), Torin1 (Cayman), Torin2 (Cayman), rapamycin (Sigma), n-butanol and tertbutanol (Sigma) (Toschi et al., 2009), ciliobrevin D (Calbiochem) (Li et al., 2016),
nocodazole (Cayman), A-484954 (Sigma) (Xie et al., 2015)), and cycloheximide (Sigma
C4859) were used in standard low buffer media in atmospheric CO2.
Primary alcohols like n-butanol deplete phosphatidic acid required for mTORC1
signaling by substituting for water in phosphatidic acid synthesis pathways, effectively
resulting in generation of phosphatidylalcohol at the expense of phosphatidic acid.
Bulkier tertiary alcohols, like tert-butanol, do not efficiently participate in these
transphosphatidyl reactions and therefore are used as a negative control (Toschi et al.,
2009).
Timecourse design
Each 48- or 52-hour timecourse with 4-hour intervals of RNA or protein lysate harvest
was collected as a pair of staggered 24- or 28-hour parallel timecourses. Three days
prior to the timecourse start, 375,000 U2OS Arntl::dLUC cells were seeded in 35 mm
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dishes and allowed to grow in normal DMEM in 5% CO2. Twenty-four hours later,
another set of plates was seeded in identical fashion. Twenty-four hours later, cells of
the first set were then synchronized and treated with media of the indicated oxygen
tension, pH, buffering capacity, or DMOG concentration. Twenty-four hours later, the
second set of plates was synchronized and conditioned in identical fashion. For such
timecourses in hypoxia, media was equilibrated overnight in the hypoxia chamber (and
in parallel in normoxia) prior to relocation of cells to the hypoxia chamber and media
exchange. Harvest of RNA or protein began at the indicated intervals with the 4-hour
and 28-hour samples of each arm being collected together, followed by the 8-hour and
32-hour samples and so forth.
In Figure 8, where desynchronized cells were explicitly studied, pH 7.4 and 6.3 arms
were set up as described above. The “no dex” arm refers to the omission of
dexamethasone from the pH 7.4 media. For the “No dex, no media change” arm, six and
five days prior to timecourse start (i.e. staggered timecourse beginning 3 days in
advance of typical), cells were resuspended in pH 7.4 media containing no
dexamethasone (but typical 5% serum) and seeded at 1/12 the typical density (to
attempt to account for extra 3 days cells would be allowed to grow). Cells were permitted
to grow in atmospheric conditions. No media change was made prior to lysate harvests
beginning 5-6 days later. Lumicycle analysis was performed in parallel by adding
luciferin to replicate plates.
Protein Immunoblotting
Following media aspiration, cells in 35 mm dishes were washed once with cold PBS and
then harvested by scraping over ice in lysis buffer (Mammalian Protein Extraction
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Reagent (Thermo Fisher Scientific) supplemented with protease inhibitor cocktail
(Promega G6521), two phosphatase inhibitors (Sigma P5726, P0044), and, typically,
prolyl hydroxylase inhibitor (200 uM desferrioxamine)). (For Figure S1I, protein was
instead harvested by trypsinizing cells, washing once in PBS, and resuspending in lysis
buffer.) After collection of scraped cells and lysate (or after suspending cells in lysis
buffer), lysis was allowed to continue on ice for at least 20 minutes. Protein lysates were
cleared by centrifugation at 13,000 rpm at 4 °C and stored at -80 °C until further use.
After thawing lysates on ice and quantifying protein yield with the DC Protein Assay (BioRad), equal ug of total protein were resolved by SDS-PAGE using Criterion pre-cast
Tris-Glycine 7.5% or 4-20% gradient gels (Bio-Rad). Protein was transferred by dry
transfer (iBlot) to nitrocellulose membranes, which were then blocked in 5% BSA
(Sigma) in TBST for 1 hour. Primary antibodies included anti-HIF1α (Cayman; 1:500),
anti-α-tubulin (Calbiochem; 1:10,000), anti-PER2 (Proteintech; 1:1000), anti-CRY2
(Epitomics, 1:500); anti-REDD1 (Proteintech; 1:1000), anti-EX2/3 (Clippinger et al.,
2011) (1:6000), anti-kinesin-1 (Santa Cruz; 1:1000), anti-phospho-Thr202/Tyr204 of
ERK1/2 (Cell Signaling; 1:2000), anti-RHEB (Abnova, 1:1000), anti-phospho Thr982 of
PERK (lab of Constantinos Koumenis; 1:1000), and TXNIP (Abnova 1:2000). Primary
antibodies against BMAL1, CLOCK, phospho-Ser2448 of mTOR, mTOR, phosphoThr389 of S6K, S6K, phospho-Ser235/236 of S6, S6, phospho-Thr37/46 of 4EBP1,
4EBP1, 4EBP2, phospho-Ser209 of eIF4E, eIF4E, phospho-Thr56 of eEF2, eEF2,
Sestrin-2, FLAG-tag, TSC2, phospho-Thr172 of AMPKα, AMPKα, phospho-Ser338 of cRaf, c-Raf, ERK 1/2, phospho-Ser9 of GSK3β, RHEB, PERK, ATF4, CHOP, phosphoSer51 of eIF2α, and eIF2α were all from Cell Signaling and used at 1:1000. Secondary
antibodies included Alexa Fluor 790 goat anti-mouse IgG (H+L) (Invitrogen; 1:10,000)
and Alexa Fluor 680 goat anti-rabbit IgG (H+L) (Invitrogen; 1:8000). All antibodies were
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diluted in blocking buffer. Immunoblots were imaged with Odyssey CLx infrared imaging
system (LI-COR) and uniformly contrasted.

See Appendix for product numbers of

reagents.
Where quantification is reported, background-corrected band intensities were calculated
with Image Studio software with background defined as the median intensity immediately
above and below the quantified band. Immunoblots from the same gel are enclosed
within a box with black outline. Yellow lines are for readability only. When reprobing for
additional targets of closely separated molecular weights, membranes were stripped with
stripping buffer (Thermo) to dim signal of first target to facilitate imaging. Except when
reblotting for total protein (e.g. S6K) after phosphoblot (e.g. pS6K), reprobing for
additional targets of similar molecular weight was avoided. Blots of tubulin loading
controls appear in multiple figures when data from a single membrane were divided
between these multiple figures for clarity of presentation.
Protein Immunoprecipitation
Starvations and subsequent immunoprecipitation proceeded as adapted from previous
descriptions (Wolfson et al., 2016) and the manufacturer-provided protocol for AntiFLAG M2 affinity gel (Sigma). 2 million 293T cells stably expressing FLAG-tagged
WDR24 or RAP2A (described above) were seeded in 10 cm plates and allowed to
expand in normal DMEM in 5% CO2. Two days later, media was aspirated and cells
were incubated for 50 minutes in 10 mL “starvation” conditions consisting of either amino
acid free media (-AA) or leucine free media (-L) of pH 7.4 or pH 6.3 after washing twice
with these respective medias. For “rescues,” one mL of 11x concentrated solution of
amino acids (+AA) or leucine (+L) (in water) was spiked into plates so as to restore
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amino acids to normal DMEM levels. (See starvation media descriptions below.) An
equal volume of water was added to control (continued starvation) plates.
After 10 minutes, cells were washed once with cold PBS and then lysed with Triton lysis
buffer (1% Triton X-100 (Sigma), 10 mM β-glycerol phosphate (Sigma), 10 mM
pyrophosphate (Sigma), 40 mM HEPES pH 7.4, 2.5 mM MgCl2 (Sigma), and EDTA-free
protease inhibitor (Roche, two mini tablets per 14 mL)) by scraping plates over ice. After
20 minutes incubation on ice, lysate was cleared. Anti-FLAG M2 affinity gel was washed
three times in lysis buffer by resuspension. These resuspensions, and those during all
subsequent washes, were performed by pipetting up and down with tips enlarged by
cutting. 30 uL of a 50:50 slurry of lysis buffer and gel were then added to each lysate (or
to a volume of lysate diluted in lysis buffer to normalize input volume and total protein
across samples). As a negative control, slurry was similarly added to lysis buffer. Lysate
and resin then incubated rotating for 2 hours at 4°C. Resin was then washed once in
lysis buffer and three times in lysis buffer containing 500 mL NaCl. Resin was then
resuspended in 30 uL 2x SDS loading dye with DTT (125 mM Tris-HCl pH 6.8, 4% SDS,
20% glycerol, 200 mM DTT, and 0.004% bromophenol blue), heated to 95 °C for 5
minutes, and resolved by SDS-PAGE as above. Note the Ig anti-FLAG heavy chain
(visible in all lanes, including the no lysate control) appears to run just below sestrin-2 on
immunoblots. Equal volume aliquots of cleared lysate (or diluted lysate) set aside prior to
addition of resin were boiled in SDS loading dye in parallel and resolved on the same gel
to reflect inputs.
Serum and amino acid starvations
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Medias used for 293T or U2OS starvations were DMEM medias buffered in one of the
manners described above but without the indicated amino acid(s) or serum. In detail,
medias used for starvations in immunoprecipitations (S5C, S5D) or for Figure 5C were
pH 7.4 and pH 6.3 media (buffered as described above) but without amino acids
(USBiologic 9800-13 with 25 mM glucose and 1 mM pyruvate (Gibco) restored) or
without leucine (USBiologic D9806-05, with 25 mM glucose and 4 mM glutamine
restored). These medias were made with 5% undialyzed (full) FBS (HyClone), so are
more accurately “near-starvation” conditions. For all other amino acid starvation
experiments, medias were formulated from USBiologic 9800-13 with appropriate
restorations and 5% (or 10% in Figure 5B) dialyzed serum (Gibco; making them
complete amino acid starvations), with Figure 5B and 6J using buffering/pH as in pH 7.4
and pH 6.3 media and all others using buffering as in low buffer media (described
above). Prior to incubation in starvation media, cells were washed at least twice in
starvation media. Where applicable, “no starvation” controls were similarly washed with
replete media. All amino acid rescues used 11x concentrates of amino acid(s) (made
from powders (Sigma)) such that addition of a volume equal to 10% of culture volume
restored amino acid content to that of normal DMEM. An equal volume of solvent (water)
was spiked into control plates. Serum starvation, as in Figure 5A, was pH 7.4 or 6.3
media without serum and was rescued by addition of undialyzed (full) FBS to restore
10% serum levels. Rescues were confirmed to not appreciably alter media pH. Duration
of starvations and rescues as indicated in legends. All starvation medias were used in
atmospheric CO2.
Viable previously activated OTI CD8+ T cells were obtained through Ficoll (GE
healthcare) gradient of splenocytes (derived as described above). Cells were washed
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two times in PBS before starvation of amino acids and growth factors by incubation in
PBS (pH 7.4) for 1 hour. Cells then either continued in starvation for 30 minutes or were
rescued from starvation into RPMI media of the indicated pH (formulated as described
above) for 60 minutes.
RNA collection
Media was aspirated from cells growing in 35 mm dishes. 1 mL of TRIzol Reagent
(Invitrogen) was added to plates. A cell scraper was then used to collect cells and lysate
which was frozen at -80 °C until RNA isolation following the manufacturer’s instructions
with substitution of 1-Bromo-3-chloropropane for chloroform. RNA used for qPCR in
Figures S1K or S7F was instead extracted with the RNeasy Plus Mini Kit (Qiagen)
following cell trypsinization (S1K) or direct application of the kit’s lysis buffer to aspirated
12-well culture plates and scraping (S7F).
Quantitative Real-Time PCR
Isolated RNA was reverse transcribed to complementary DNA (cDNA) using TaqMan
Reverse Transcription Reagents (Invitrogen) using the Oligo d(T) method. cDNA was
then used as template for quantitative real-time PCR with specific human primers using
Power SYBR Green or TaqMan Universal PCR master mixes (Thermo Fisher) using a
ViiA 7 real-time PCR system or StepOnePlus Real-Time PCR System (Applied
Biosystems). Target expression was normalized to B2M and relative expression was
calculated using the delta-delta CT method. For 52-hour qPCR timecourses (Figures 2BD, S2A, S2C, S2F, S3A (right)), data are normalized to the respective 4-hour control
(vehicle, normoxia, or pH 7.4) time point.
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siRNA knockdown
Effective dicer-substrate short interfering RNAs (DsiRNAs, referred to as “siRNA”) in
Trifecta kits (IDT) were identified through qPCR-based assessment of knockdown of
target transcript in U2OS cells prior to use. 185-375,000 or 50,000 cells were seeded in
35 mm dishes or 24-well dishes, respectively, and allowed to expand in standard DMEM
in 5% CO2 incubators. The following day, cells were transfected with DsiRNA at the
concentrations indicated in legends using Lipofectamine RNAiMAX (Invitrogen) 26-31
hours prior to cell synchronization and further treatment, except Figure 7B where time
points are as detailed in figure and legend. DsiRNA included those against HIF1A,
EPAS1, EIF4EBP1 (DsiRNA oligo #1 used in Lumicycle experiment, #2 used in
western), EIF4EBP2, SESN1, SESN2, SESN3, KIF5B, TSC2, and TXNIP. Equimolar
non-targeting DsiRNA was used as a control. Concentrations of DsiRNA in Fig. 1E are
20 nM each condition (10 nM when two siRNA). Concentrations elsewhere as indicated
in figure legends. DsiRNA sequences in Appendix.
For validation of the anti-RHEB antibody used for immunofluorescence (see below),
200K U2OS Arntl::dLUC cells were seeded in each well of a 6-well plate. The following
day, cells were transfected with 20 nM total siRNA per condition using RNAiMAX. More
precisely, the “siCtl” condition was 20 nM non-targeting DsiRNA, “siRHEB” was 10 nM
DsiRNA targeting RHEB and 10 nM non-targeting DsiRNA, “siRHEBL1” was 3.33 nM
each of three different DsiRNA against RHEBL1 and 10 nM non-targeting DsiRNA, and
“siRHEB + siRHEBL1” was 10 nM DsiRNA targeting RHEB and 3.33 nM of the three
siRNA against RHEBL1. After 26 hours, cells were trypsinized and reseeded in 12-well
dishes with or without glass coverslips for immunofluorescence (described below) or
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RNA and protein harvests, respectively. Cells were fixed or harvested 56 hours after
siRNA treatment. DsiRNA sequences in Appendix.
RNA-sequencing and data processing
RNA integrity was verified by bioanalyzer (Agilent Technologies) (RIN 8.7-10.0, median
= 9.7). Libraries were prepared from total RNA using the Illumina TruSeq Stranded
mRNA Library Preparation kit (Illumina). Pooled libraries were sequenced as single 100
base pair reads on the HiSeq 2500 in rapid mode using V4 chemistry at the University of
Pennsylvania Next Generation Sequencing Core. The RNA-seq raw reads (FASTQ files)
were

aligned

to

the

reference

genome

hg38

(https://genome.ucsc.edu/cgi-

bin/hgGateway?db=hg38) using Spliced Transcripts Alignment to a Reference (STAR)
aligner (https://github.com/alexdobin/STAR) (Dobin et al., 2013). The GENCODE v22
(https://www.gencodegenes.org/releases/22.html) annotation was used as the guiding
transcriptome annotation during STAR alignment. The aligned RNA-Seq reads (BAM
files) were further processed through Cufflinks (http://cole-trapnell-lab.github.io/cufflinks/)
(Trapnell et al., 2013) to assemble and quantify transcripts, using GENCODE v22 as the
reference transcriptome annotation. The fragments per kilobase of transcript per million
mapped reads (FPKM) calculation was used to normalize read count by dividing it by the
gene length and the total number of reads mapped to genes. Analysis was limited to
protein-coding genes (as defined by GENCODE v22 annotation) with mean FPKM
expression over all time points and pH conditions greater than 2 (10,794 genes).
Global gene expression analyses
Circadian rhythmicity of the 10,794 protein-coding transcripts detected by RNAsequencing was assessed by ARSER algorithm (Yang and Su, 2010). ARSER detrends
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data and then detects rhythmic signals with a period between 20 and 28 hours through a
combination of autoregressive spectral analysis (alternative to the classical fast Fourier
transformation) and harmonic regression (sinusoidal fits) and then reports relevant
parameters such as period, phase, and amplitude along with significance statistics.
ARSER was run through the MetaCycle package implemented in R (Wu et al., 2016).
ARSER has been shown to frequently perform better than other popular circadian gene
identification algorithms when analyzing data collected over two days with 4-hour
resolution (Wu et al., 2016; Yang and Su, 2010). Cutoffs of p<0.05 and Benjamini and
Hochberg false-discovery rate (FDR) <0.20 were used to identify circadian transcripts.
The Ensembl IDs of these genes with statistically significant circadian expression in pH
7.4 and pH 6.3 were then submitted to ToppFun (Chen et al., 2009) with default settings
to determine significantly enriched Pathway ontologies (p<0.05, Benjamini and Yekutieli
(B&Y) FDR (q) < 0.05). All significant Pathway ontologies and associated p-values are
presented in corresponding figures.
Transcripts highly induced or suppressed in acid were defined as those for which the
log2 of the ratio of the mean expression over all 13 time points (4h-52h) in pH 6.3 to pH
7.4 (

was greater than 1 or less than -1, respectively. The Ensembl

IDs for these genes were then submitted to ToppFun (Chen et al., 2009) to determine
significantly enriched GO:Biological Process ontologies (p<0.05, Benjamini and
Hochberg (B&H) FDR (q) < 0.05). All significant Biologic Process ontologies and
associated p-values are presented in figures for acid-suppressed genes. For induced
genes, the top 10 are presented.
All heatmaps and to-scale Venn Diagrams were generated with ggplot2 and
VennDiagram packages implemented in R Studio. For heatmaps in 3A and S3B,
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expression in each pH condition was normalized separately for each gene, with each
gene’s maximum and minimum expression values across all 13 time points (52-hours) in
that pH condition set to 1 (navy) and 0 (white), respectively, with linear scaling over the
intervening expression range (i.e. 0.5 is midway between minimum and maximum
expression). For heatmaps in 3F and 3G, the maximum and minimum expression values
for each gene across all time points and pH conditions (i.e. regardless of pH) were set to
1 (navy) and 0 (white), respectively, with linear scaling over the intervening expression
range (i.e. 0.5 is midway between minimum and maximum expression). Heatmaps in 3A
and S3B are ranked by phase of transcript oscillation in pH 7.4 or 6.3, respectively.
Heatmaps in 3F and 3G are ranked from top by most highly induced or suppressed
gene, respectively.
Polysome profiling
2 million or 1 million U2OS Arntl::dLUC cells were seeded in normal DMEM and cultured
in standard 5% CO2 37 °C humidified tissue culture incubators. The following day, media
of the higher density plates was aspirated and replaced with media pH 6.3 (formulated
as above). The plates seeded at 1 million cells per plate were changed to pH 7.4 media
in parallel. Plates were moved to humidified 37 °C incubators with atmospheric CO2 and
allowed to grow for 37 hours prior to harvesting for polysome profiling as described
(Brady et al., 2017; Johannes and Sarnow, 1998) using RNAse-free conditions wherever
possible.
One day prior to harvest, 10-50% sucrose gradients were poured. Briefly, a 75% sucrose
(Fisher Scientific) solution was diluted in RNAse free water to prepare 10%, 20%, 30%,
40%, and 50% sucrose solutions each with final concentrations of 0.3 M NaCl
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(Invitrogen), 15 mM Tris-Cl pH 7.5 (Invitrogen), 15 mM MgCl2 (Invitrogen), 1 mg/mL
heparin (Sigma), and 0.1 mg/mL cycloheximide (prepared fresh from powder (Sigma
C1988)). 2.1 mL of the 10% sucrose solution was added to the bottom of round bottom
tubes. A glass pipette was used to layer the same volume of the 20% sucrose solution
underneath the 10% layer with minimal disturbance of the layer interface, followed
similarly by the 30% solution under the 20%, and so forth to form a layered gradient
increasing in density with depth. Gradients were sealed with parafilm and stored at 4 °C
overnight.
After 37 hours pH exposure, four plates each pH condition were harvested pairwise.
(Counting of plates seeded in parallel indicated an expected thus total yield of 23 million
cells for pH 7.4 and 25 million for pH 6.3.) Briefly, freshly prepared 10 mg/mL
cycloheximide was spiked 1:100 (0.1 mg/mL final) into one pH 7.4 and one pH 6.3 plate.
Plates were gently swirled and returned to 37°C for 3 min. Media was then aspirated and
replaced with ice-cold PBS containing 0.1 mg/mL cycloheximide. Plates were placed on
ice and washed once more with cold cycloheximide-containing PBS. Cells were lysed on
plates by scraping in 300-400 uL cold polysome extraction buffer (PEB: 0.3 M NaCl, 15
mM MgCl2, 15 mM Tris-HCl pH 7.5, 1% Triton X-100 (Sigma), 0.1 mg/mL cycloheximide
(added fresh), and 1 mg/mL heparin) and transferring lysate to tubes on ice. The next
pair of plates was cycloheximide treated and washed in analogous fashion prior to
scraping in the corresponding lysate of the first set of plates. Harvest continued for the
remaining two pairs of plates similarly transferring lysate from plate to plate and thus
pooling lysate from all 4 plates. Lysates were then brought up to 1000 uL with PEB.
Lysates were left on ice for > 10 minutes following harvest of final plates and then spun
down at 10K RPM at 4 °C.
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Each cleared lysate was layered onto one gradient. Gradients were pre-balanced for
weight as necessary with PEB and centrifuged for 3 hours and 10 min at 35K RPM in a
SW41Ti rotor at 4 °C. 1 mL fractions were collected in Eppendorf tubes by pumping
push solution (67.5% sucrose with bromophenol blue) into the bottom of the gradient
and collecting from the top with a fraction collection system with concurrent monitoring of
the absorbance of the passing gradient at 254 nm (OD 254). Fractions were transferred
to round bottom tubes using 1 mL of nuclease free water as rinse. After addition of 3 mL
of 8 M guanidine HCl (Thermo Scientific), samples were vortexed for 1-2 minutes. One
volume (5 mL) of 100% ethanol was added and samples were vortexed again before
incubating at -20 °C until further processing several days later.
Samples were centrifuged for 45 minutes at 4 °C in the outer tier of a SM24 rotor in the
Thermo RC6+ centrifuge at 10K RPM (12.4 RCF). Supernatants were carefully removed.
After addition of 4 mL of ice cold 75% ethanol, samples were vortexed and spun again
for 30 minutes. Supernatants were carefully removed and pellets were allowed to dry for
10 minutes before resuspension in 400 uL of Tris-EDTA (TE) buffer, pH 7.4 (Sigma).
RNA was precipitated by addition of 3 M sodium acetate, pH 5.2 (Thermo Scientific) to a
final concentration of 0.3 M followed by addition of 2.5 volumes of 100% ethanol and
incubation overnight at -20 °C.
Samples were then centrifuged for 20 min at room temperature at 13K RCF and
supernatants were carefully removed. Pellets were washed with 400 uL of ice cold 75%
ethanol, vortexed, and centrifuged again for 20 min at room temperature. After removing
supernatant, pellets were dried for 10 minutes and resuspended in 50 uL of 0.1x TE
buffer. RNA yield was then assessed by nanodrop. Additionally, RNA was subjected to
Tape Station analysis to corroborate fraction identity inferred from OD 254 profiles.
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Volumes of sample per each tape station run were variable, chosen based on nanodrop
results to load Tape Station chips within their target quantitative range. The intensity of
each “gel-like image” from each sample’s Tape Station run was scaled relative to loading
volume to create in-silico an approximated multilane gel-like image analogous to a
tradition RNA gel. The OD254 reading, 28S/18S ratio, and appearance of 28S and 18S
bands were used to identify likely fraction compositions with consultation of published
methods (Brady et al., 2017; Fromm-Dornieden et al., 2012; Johannes and Sarnow,
1998).
30 pg of b-galactosidase mRNA (CleanCap™ β-gal mRNA, TriLink) was spiked into 27
uL of each extracted RNA fraction. Lithium chloride (LiCl) (Invitrogen) was added to a
final concentration of 2.5 M. Samples were vortexed and placed in -20 °C for 30 min.
Samples were then spun for 30 minutes at 4 °C at 13K RCF. Supernatant was aspirated
and discarded. Pellet was washed in 75% ethanol and spun again for 15 minutes at 13K
RCF at room temperature. Supernatant was again carefully removed and discarded. LiCl
precipitation was then performed once more again at -20 °C for 30 min with
centrifugation at 16K RCF. After resuspension of pellets in 75% ethanol, samples were
stored at -20 °C overnight. After carefully removing supernatants, pellets were dried, and
resuspended in 100 uL water with the aid of heating to 55-60 °C for 10-15 minutes. RNA
was then purified over a RNeasy column (Qiagen) using the manufacturer’s RNA
cleanup protocol with elution in equal 50 uL volumes of water. Concentrations were then
measured by nanodrop. Displayed nanodrop yields encompass (i.e. are corrected for)
known sample usage (e.g. Tape Station analysis, nanodrop) and banking en route to
final elution to straightforwardly reflect starting cell numbers.
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Isolated RNA was reverse transcribed to complementary DNA (cDNA) using the iScript
Reverse Transcription Supermix, a blend of oligo-dT and random hexamer primers (BioRad). cDNA was then used as template for quantitative real-time PCR with specific
validated primers as indicated (sequences in Appendix). Target expression was
normalized to β-galactosidase spike-in using the following primers:

β‐galactosidase #4

Fwd:
CCACCAGCGAGATGGACTTC

Rev:
CTTGTCGCCGATCCACATCT

Relative expression was calculated using the delta-delta CT method. Data are presented
with normalization to respective pH 7.4 fraction #5 value. Presented qPCR results are
limited to fractions 4-12 where efficient recovery and amplification of spike-in was
achieved.
Immunofluorescence
10,000-20,000 U2OS Arntl::dLUC cells were plated on 18mm glass coverslips in 12-well
dishes and allowed to adhere and grow in normal DMEM in 5% CO2 for 1-2 days. Media
was then changed to experimental conditions (pH 7.4, pH 6.3, starvations medias, etc.)
as described above and as indicated in figure legends. Where indicated, starvation was
followed by “rescue” of pH/starvation by change of media (for pH conditions) or spike in
of amino acids (as described above). Cells were then rinsed with PBS once and fixed for
15 min with fresh 4% paraformaldehyde in PBS at room temperature. Cells were then
rinsed twice with PBS (1x quick, 1 x 5 min) before permeabilizing for 5 min in 0.05%
Triton X-100 in PBS. Coverslips were then washed two times for 5 min each in PBS and
then blocked for 30 min in filtered 5% goat serum (Sigma) in PBS. Coverslips were then
incubated in primary antibody in blocking buffer for 2 hours at room temperature (rabbit
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anti-mTOR, Cell Signaling, 1:40-1:320; mouse anti-LAMP2, Abcam 25631, 1:100) or
overnight at 4 °C in a humidified chamber (rabbit anti-mTOR,1:200; rabbit anti-LAMP1,
Cell Signaling, 1:200; mouse anti-RHEB, Abnova, 1:1000), washed three times in PBS,
and then incubated for 1 hour in secondary antibodies (goat anti-rabbit Alexa Fluor 488
and goat anti-mouse Alexa Fluor 594 (1:400-1:1000) or 555 (1:500-1:1000)) in blocking
buffer at room temperature. Alexa Fluor 488-conjugated rabbit anti-α-tubulin (Cell
Signaling, 1:100-1:200) was co-incubated with goat anti-mouse Alexa Fluor 594 when
used. When combined with goat anti-mouse Alexa Fluor 555, tubulin staining was
performed separately after this secondary antibody. Filamentous actin was stained with
330 nM Alexa Fluor 488 phalloidin (Cell Signaling) for 15 min in blocking buffer following
other secondaries. When performed, a 140 - 860 nM solution of DAPI in PBS was
applied to coverslips for 1-10 min after aspirating secondaries.
For four-color staining, coverslips seeded two days prior with 10,000 U2OS Arntl::dLUC
cells or U2OS Arntl::dLUC RHEBN153T cells were treated and processed as above with
overnight incubation with rabbit anti-mTOR and mouse anti-RHEB. After washing,
coverslips were incubated with goat anti-rabbit Alexa Fluor 647 (Invitrogen, A32733,
1:1000) and goat anti-mouse Alexa Fluor 555 secondaries as above. Coverslips were
then blocked for 30 minutes in filtered 5% rabbit serum (Sigma) in PBS, incubated
overnight with sheep Alexa Fluor 488-conjugated anti-LAMP1 (1:200, R&D Systems) in
blocking buffer (5% rabbit serum in PBS) at 4°C, and stained for DAPI.
After washing three times for 5 min each in PBS, coverslips were rinsed once in distilled
water and mounted onto glass slides with Fluoromount-G (SouthernBiotech) and later
sealed with covergrip coverslip sealant (Biotium). All immunofluorescence reflects
unsynchronized cells (no dexamethasone). No primary, no secondary, and single-color
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controls were performed to validate specificity of antibodies and confirm negligible bleed
through across antibody-channel combinations.
For validation of the anti-RHEB antibody used for immunofluorescence, U2OS
Arntl::dLUC cells were treated with siRNA as described above and 26 hours later
reseeded onto glass coverslips in 12-well dishes at a density of 100K cells per well. The
following day (56 hours after siRNA treatment), cells were fixed and processed as
described above with overnight incubation with anti-RHEB (1:1000) and anti-LAMP1
(1:200) antibodies followed by goat anti-mouse Alexa Fluor 488 and goat anti-rabbit
Alexa Fluor 594 (Invitrogen, 1:1000 each).
Following starvation and rescue as described above and in figure legends, previously
activated OTI CD8+ T were processed for immunofluorescence. Cells were fixed by
resuspension in methanol free 4% PFA (Invitrogen) for 10 minutes at 37 °C, and then
washed 3 times with PBS and stored in PBS at 4 °C. A hydrophobic barrier (PAP pen,
71310 Electron Microscopy Sciences) was used to demarcate a region on glass
coverslips that was then coated with 1 mg/mL poly-D-lysine (Sigma) for 1 hour at room
temperature before washing three times with water and once with PBS. Fixed cells
resuspended in PBS were then allowed to settle onto the poly-D-lysine coating overnight
humidified at 4° C. Coverslips were then washed twice with PBS before permeabilizing
with 0.1% Triton X-100 in PBS for 15 minutes at room temperature. After washing four
times with PBS, cells were blocked with 5% goat serum in PBS with 0.05% Tween-20
(PBST) for 30 minutes. Coverslips were then incubated with primary antibody (antimTOR 1:200; anti-LAMP2, Abcam 13524, 1:200) overnight humidified at 4 °C.
Coverslips were then washed five times with PBST and incubated with Alexa Fluor goat
secondary antibodies (anti-rabbit 488 and anti-rat 555, 1:500) for 90 minutes at room
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temperature. Following five washes with PBST, cells were stained with DAPI as above.
Coverslips were then washed three times with PBS and mounted in Fluoromount-G and
sealed as above. See Appendix for product numbers of reagents.
Live-cell imaging
Transient transfection of LAMP1 fusion proteins
200,000-215,000 U2OS Arntl::dLUC cells were plated in plastic or glass-bottom 35mm
culture dishes in normal DMEM in 5% CO2. The following day, cells were transfected
with 0.5-1.0 ug of LAMP1-FLAG(x2)-mRFP (gift from David Sabatini, Addgene plasmid
#34611) or LAMP1-mGFP (gift from Esteban Dell'Angelica, Addgene plasmid #34831.
mGFP is a non-dimerizing GFP variant that reduces aberrant aggregation of
overexpressed protein). 48-96 hours later, media was exchanged for media of pH 7.4 or
6.3 and plates were moved to atmospheric CO2. After 2.5-4 hours incubation (as
indicated in legends), cells were imaged as described below. For the timecourses of
ciliobrevin D and nocodazole treatments (Figures 6N, S6I, S6L, S6M), the day following
transfection cells were instead trypsinized and reseeded at lower density (75,000
cells/plate). Two days later, cells were treated with 60 uM ciliobrevin D or 2 uM
nocodazole and imaged at intervals as indicated in figures.
LysoTracker and TubulinTracker
30 minutes prior to imaging, media was exchanged for fresh media with 50 nM
LysoTracker Deep Red (Invitrogen) and 500 nM TubulinTracker Green (Oregon Green
488 Taxol bis-acetate, Invitrogen). Cells were then washed three times with media and
then imaged in media. For cells treated with vehicle or inhibitor (nocodazole, ciliobrevin
D), media both during the 30 min staining and during imaging contained vehicle or drug.
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When only LysoTracker was used, media was changed after staining but washes were
omitted.
Microscopy and image processing
Images of immunofluorescence staining of U2OS cells were acquired using Dapi, GFP,
and DsRed filter sets as needed on an upright Nikon Eclipse Ni microscope equipped
with 20x/0.5 PlanFluor, 40x/0.75 PlanFluor, and 60x/0.95 Plan Apo λ objectives and 12bit QImaging QIClick CCD and DS-Fi2 Nikon cameras controlled by Nikon NIS-Elements
Basic Research software or using Dapi, GFP, dsRed, mCherry/TxRed, and Cy5 filter
sets as needed on a Nikon Eclipse 80i microscope using a 60x objective with a 0.63x cmount and a QImaging camera controlled by Image-Pro Plus v 7.0 software. Live cell
images were acquired with GFP, TxRed, Cy5 and phase contrast filter sets as needed
on an Olympus IX81 inverted fluorescence microscope quipped with 10x, 20x, and 40x
objectives (UPLFLN10X2PH, LUCPLFLN20XPH, LUCPLFLN40XPH) and a 12-bit CCD
camera (Sensicam QE, PCO) controlled by SlideBook 6 software. All exposure times
and other hardware settings were identical for all images captured in the same channel
within an experiment. This includes Figure 7F where acquisition settings were identical
for imaging of RHEB in both wild-type (U2OS Arntl::dLUC) and RHEBN153T-expressing
cells. Scale bars are shown. Where not otherwise indicated, a scale bar shown in one
image of a multi-image panel is applicable to all images.
Confocal microscopy images of immunofluorescence staining of CD8+ T cells were
acquired as 2048 x 2048 pixel images on a Zeiss LSM 880 using excitation wavelengths
of 405, 488, and 561 nm and a Plan-apochromat 63x 1.40 0.1 DIC M27 objective with
zoom factor 1.0 controlled by ZEN v2.3 software. Scale bars are shown.
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Fiji software (Schindelin et al., 2012) was used for background subtraction (rolling ball
method or subtraction of a constant as described below) and brightness (contrast)
adjustment if needed. For immunofluorescence and LysoTracker and TubulinTracker
live-cell imaging (i.e. methods labeling endogenous proteins and compartments), all
processing (background subtraction, brightness adjustment) was uniform across all
acquired images within that channel in that experiment. The only exception was DAPI
staining which was occasionally independently contrasted for display purposes only (but
quantified using raw or uniformly processed (background subtracted) images). For livecell imaging of LAMP1-GFP and LAMP1-mRFP, images in the GFP and RFP channels,
respectively, were contrasted individually owing to variability in transfection efficiency
across the population of cells. For all microscopy, representative images of random
fields acquired from at least three biological replicates are shown.
Microscopy for in vivo studies discussed below in description of that work.
Image quantification
mTOR enrichment on lysosomes as a function of amino acids and pH was quantified
from 40x widefield images of U2OS cells coimmunostained for mTOR and LAMP2 using
a quantification method modified from that previously described (Wolfson et al., 2017).
mTOR and LAMP2 channels were background corrected in Fiji (Schindelin et al., 2012)
by subtracting a constant equal to the mean of three regions of interest (ROIs) drawn
within the image background of each channel. The borders of each cell or cell cluster
were drawn by applying the Analyze Particle function to the thresholded mTOR channel
image (settings: particles > 200 pixels2, exclude holes) and supplementing this with
manual additions and subtractions as needed to define the “cell” ROI of each field. The
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LAMP2 channel images were then thresholded (same threshold across all images) to
define the “lysosome” ROI within each field. The “lysosome” ROI was subtracted from
the “cell” ROI of a field to define the “cytoplasm” ROI of each field. LAMP2 and mTOR
mean fluorescence intensity (MFI) were then measured in each compartment. To
calculate the relative enrichment of mTOR in the lysosomal compartment over the
cytoplasm in each field, the MFI of mTOR in the cytoplasm ROI was subtracted from the
MFI of mTOR in the lysosome ROI. The lysosomal LAMP2 MFI was similarly corrected
for the background cytoplasmic MFI of that channel. The mTOR difference was then
divided by the LAMP2 difference to account for varying amounts and densities of
lysosomes across fields. Hence, the reported mTOR lysosomal enrichment score for
each field (image) was (L – C)mTOR/(L – C)LAMP2 where L and C are the MFI of the
respective channels in the lysosomal and cytoplasmic ROIs, respectively, as previously
described (Wolfson et al., 2017). Prior to quantification, pixels containing rare obvious
small processing artifacts were excluded across all channels when observed although
post hoc analysis revealed near identical results had this step been skipped. Replicates
and statistics as described in legends.
mTOR lysosomal enrichment in CD8+ T cells was similarly quantified from 63x
magnification confocal images. Background correction was omitted as background was
confirmed negligible. Cells were outlined to define the “cell” ROI by using the analyze
particle function on uniformly thresholded mTOR channel images (settings: particles >5
um2, include holes). Because the nucleus takes up a significant portion of the volume in
T cells, the “nucleus” ROI was defined by applying the analyze particle function to
thresholded DAPI channel images. The union of “nucleus” ROI and “lysosome” ROI
(determined as above) was then subtracted from the “cell” ROI to determine the
158

“cytoplasm” ROI for each field. The mTOR lysosomal enrichment score for each field
was then calculated as (L – C)mTOR/(L – C)LAMP2 as above, with replicates and statistics
as described in legends.
Radial distributions of LAMP2, tubulin, and DAPI intensity were quantified in Fiji
(Schindelin et al., 2012) from 3-channel background corrected (rolling ball method or
subtraction of a constant as above) 40x images of immunostained U2OS cells. Radial
distributions of mTOR, LAMP1, RHEB, and DAPI were similarly quantified from 4channel 60x (+0.63x c-mount) images. For each cell analyzed, the outline of the cell was
manually delineated and all pixels outside this area were cleared in all channels to
define the “cell” ROI. The nucleus was then defined with the aid of the Analyze Particle
function (default settings) applied to the thresholded DAPI channel. This “nucleus” ROI
was then subtracted from the “cell” ROI to define the “cytoplasm” ROI. The tubulin and
LAMP2 intensities as a function of radial distance from the nucleus center were
calculated within the “cytoplasm” ROI with the Radial Profile plugin for a circle centered
on the nucleus with a 500-pixel (80.5 µm (40x) or 85 µm (60x + 0.63x c-mount)) radius
(i.e. a circle encompassing the entire cell area). This plugin returned the intensities as a
function of the radius (r) in 1.33-pixel (0.215 or 0.226 µm) steps (r = 1.33, 2.66, 3.99,
…500 pixels). Here, intensity is the integrated fluorescence around a circumference
(defined by the radius) divided by that circumference. As these output intensities are not
corrected for cell shape, the output intensities were multiplied by π2r (the circumference,
giving integrated fluorescence) and divided by the arc length through the “cytoplasm
ROI” at that radius (calculated by running the plugin on a new image created with every
background pixel 0 and every pixel within the “cytoplasm” ROI set to 1). DAPI radial
distribution was similarly calculated over the “cell” ROI. For LAMP2, tubulin, and DAPI 3159

channel images, 15 cells were analyzed for each pH condition and the mean profile was
calculated. For display purposes, calculated mean intensities were normalized to the
maximum mean value within that channel (irrespective of pH). Unadjusted t-tests (i.e. no
multiple testing correction) were performed at each r comparing the intensity of a given
channel at each pH. For each r for which p<0.05, an asterisk appears above the graph.
For mTOR, LAMP1, RHEB, and DAPI 4-channel images, 10 cells were analyzed for
each pH condition for U2OS Arntl::dLUC cells and 13 cells for each pH condition for
U2OS Arntl::dLUC RHEBN153T cells. Mean profiles were calculated and normalized to the
maximum mean value within that channel in U2OS Arntl::dLUC pH 7.4 cells.
Intensity profiles of RHEB, mTOR, LAMP1, and DAPI along a manually drawn reference
line were obtained using the Plot Profile command in Fiji.
Flow cytometry
T cell mTOR activity
Primary splenocytes were derived as above and resuspended in RPMI media of the
corresponding pH as indicated in figure legends and formulated as described above.
Splenocytes from mice with TSC2 -/- and TSC2 +/+ T cells were stimulated with 3 ug/mL
cross-linked anti-CD3 and 2 ug/mL anti-CD28 (in-house hybridomas). After 1 hour,
splenocytes were fixed with 2% PFA for 10 minutes at 37 °C then washed two times with
PBS. Cells were then permeabilized with ice cold 90% methanol for 20 minutes at -20
°C, washed three times with 1% FBS/PBS (staining solution), and stained with brilliant
violet 786-conjugated rat anti-CD4 (BD Bioscience, 1:500), brilliant violet 650-conjugated
rat anti-CD8 (BD Bioscience, 1:500), and anti-phospho serine 240/244 S6 (1:1000) in
staining solution for 45 minutes at room temperature. Cells were then washed two times
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with staining solution before staining with goat anti-rabbit IgG Alexa Fluor 647 (Invitrogen
A21244, 1:500) for 30 minutes at room temperature. Cells were then washed two times
before analysis with a BD Celesta and FlowJo software. Gates were set appropriately
with the aid of unstimulated and secondary-alone controls. See Appendix for product
numbers of reagents.
Cytomegalovirus infection
Human cytomegalovirus (HCMV) preparation and infection proceeded as previously
described (Clippinger et al., 2011). The virus used was a derivative of the Towne strain
of HCMV in which some nonessential genes have been replaced with GFP expressed by
the SV40 promoter (Clippinger et al., 2011). 150,000 U2OS Arntl::dLUC cells were
seeded in 35 mm dishes. Three days later, one plate was trypsinized to determine the
number of cells. An aliquot of previously titered human cytomegalovirus was thawed,
sonicated on low power, and added to standard culture media (DMEM, 5% CO2) that
was then applied to cells at a multiplicity of infection of 3. Media without virus was
similarly used to refresh plates of “mock infected” cells. After two hours, media was
aspirated and replaced with fresh DMEM. This was considered time zero of infection. At
19 hours post infection (hpi), media of two virus- and two mock-infected plates was
exchanged for low buffer media containing vehicle or 500 uM DMOG and moved to
atmospheric CO2. At 26 hpi, media of an additional two virus- and two mock-infected
plates was exchanged for media of pH 7.4 or pH 6.3 and moved to atmospheric
conditions. Protein was then harvested from all 8 plates one hour later (at 27 hpi). These
media exchanges were repeated once more for an additional time point, with
vehicle/DMOG treatment beginning at 47 hpi, pH 7.4/6.3 at 58 hpi, and protein harvest at
59 hours. Consequently, the first immunoblot time point (27 hpi) reflects 8 hours of
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vehicle/DMOG or 1 hour of neutral/acidic pH treatment, while the second time point (59
hpi) reflects 12 hours of vehicle/DMOG or 1 hour of neutral/acidic pH treatment. To
confirm infection, two immediate-early viral proteins, immediate-early protein 72 (IE72)
and immediate-early protein 86 (IE87), were probed with an antibody recognizing major
immediate-early viral proteins containing viral exon 2 and 3 regions (Clippinger et al.,
2011).
Bicarbonate treatment of tumors
Tumor tissue specimens were obtained from two previously conducted studies(Estrella
et al., 2013; Ibrahim-Hashim et al., 2017) in which the drinking water of mice bearing
xenograft tumors was either supplemented with bicarbonate to raise intratumoral pH or
not supplemented (“tap” water). These tissues were then queried for the current study
for the impact of bicarbonate therapy on tumor mTORC1 signaling. In detail:
Cell Culture
The human breast cancer cell lines MCF7 and MDA-MB-231 and the human colon
cancer cell line HCT116 were acquired from the American Type Culture Collection
(ATCC, Manassas, VA). MCF7 and MDA-MB-231 cell lines were maintained in RPMI
medium

1640

(Gibco)

penicillin/streptomycin.

supplemented

HCT116

cells

with

were

10%

FBS

maintained

in

(Hyclone)
DMEM/F12

and

1x

(Gibco)

supplemented with 10% newborn calf serum and 1x penicillin/streptomycin. Medias were
further supplemented with 0.75 mg/mL of G418 to maintain stable polyclonal expression
of previously transfected pIRES2-EGFP (MCF7), pDsRed2-N1 (MDA-MB-231), and
pcDNA3-GFP (HCT116) for in vivo tumor border demarcation. During in vitro HCT116
experiments, G418 selection was not maintained. All cells were maintained in standard
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humidified tissue culture incubators at 37 °C with 5% CO2 and manipulated under sterile
conditions in a tissue culture hood. All three cell lines were authenticated by short
tandem repeat analysis and confirmed to be free of mycoplasma.
Tumor development and bicarbonate treatment
All animals were maintained in accordance with the guidelines of the Institutional Animal
Care and Use Committee (IACUC) at H. Lee Moffitt Cancer Center. Eight- to ten-weekold male and female (randomized) severe combined immunodeficient (SCID) mice
(Charles River) were used to host HCT116 tumors. Eight- to ten-week-old female nu/nu
mice (Envigo) were used to host MDA-MB-231 and MCF7 tumors.
HCT116 cells were implanted into a dorsal window chamber using the tumor droplet
method as described previously (Estrella et al., 2013). Briefly, a dorsal window chamber
was implanted into a host mouse. The following day, HCT116 cells were suspended in
0.8 mg/ml of type I collagen (BD Bioscience) and 1x DMEM at a final concentration of
2.5x106 cells/mL.15 uL of the tumor suspension was then polymerized in the center of a
well of a 48-well non-tissue culture-treated multiwall plate. After polymerizing for 20-30
min at 37 °C, the droplet was surrounded by a layer of 1.25 mg/mL type I collagen,
which encouraged the tumor to maintain a circular shape with well-defined borders. After
polymerizing for 20-30 min at 37°C, the construct was incubated with 200 uL of DMEM
with 10% FBS at 37°C. After 2 days of culture, the constructs were aseptically inoculated
into the window chamber. Six days prior to the inoculation of tumor constructs into the
dorsal window chamber, mice were randomly assigned to receive 200 mM sodium
bicarbonate (n=4) (Fisher Scientific) or tap water (n=4) provided ad libitum for the
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duration of the experiment. Treatment continued for up to three weeks with tumors
harvested when they reached the capacity of the window chamber.
For MDA-MB-231 and MCF7 tumor formation, 10 million cells were injected into cleared
mammary fat pads as described previously (Ibrahim-Hashim et al., 2017). One week
prior to cell injection, an estrogen pellet (0.72 mg slow release, Innovative Research of
America) was implanted to allow growth of ER-positive MCF7 tumors. Three days after
tumor injection the mice were randomly assigned to drinking water supplemented with
400 mM sodium bicarbonate or tap water (n=5 each arm for MCF7; n=4 each arm for
MDA-MB-231) provided ad libitum for the duration of the experiment. Five weeks later,
tumors were harvested.
Immunohistochemistry (IHC)
At endpoints of the study, tumors were harvested, fixed in 10% neutral buffered formalin
(Thermo Fisher Scientific), processed, embedded in paraffin, and sliced to 4-5 m
sections. Slides were stained with hematoxylin and eosin (H&E) stain.
Immunohistochemistry for phospho-S6 was performed using the Leica BOND RX stainer
as per the manufacturer's protocol with ancillary reagents. Briefly, slides were
deparaffinized with Dewax solution and antigens heat-retrieved in the ER2 buffer. Rabbit
primary antibody that reacts to pS6 (Ser240/Ser244, ThermoFisher Scientific) was used
at a 1:200 concentration for 15 min. The Bond Polymer Refine Red Detection system
with alkaline phosphatase-linked polymers and red chromagen (Fast Red) was used to
detect primary antibody with subsequent hematoxylin counterstain. Slides were then
dehydrated and coverslipped as per normal laboratory protocol. Histology slides were
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scanned using the Aperio™ ScanScope XT (Leica) with a 20x/0.8NA objective lens
(200x) at a rate of 2 minutes per slide via Basler tri-linear-array.
Carbonic anhydrase IX immunohistochemistry was performed using the a Ventana
Discovery XT automated system (Ventana) as per the manufacturer's protocol with
proprietary reagents. Briefly, slides were deparaffinized on the automated system with
EZ Prep solution (Ventana). Heat-induced antigen retrieval method was carried out in
RiboCC (Ventana). Rabbit primary antibody that reacts to CAIX (Abcam) was used at a
1:250 concentration in Dako antibody diluent (Agilent) and incubated for 32 min. The
Discovery OmniMap Anti-Rabbit HRP Secondary Antibody (Ventana) was used for 20
min. The detection system used was the Ventana Discovery ChromoMap DAB kit
(Ventana). Slides were then counterstained, coverslipped, and scanned as above.
Image analysis
An Aperio Positive Pixel Count® v9.0 algorithm with the following thresholds: [Hue Value
= 0.1; Hue Width = 0.5; Color Saturation Threshold = 0.04; IWP(High) = 220; Iwp(Low) =
Ip(High) = 175; Ip(low) = Isp(High) = 100; Isp(Low) = 0] was used to categorize inverted
image pixels across the entire tumor cross section as negative (>220), weakly positive
(175-220), positive (100-175), and strongly positive (0-100) which were then
pseudocolored as displayed in figures (“positivity mask”). The percentage of positive
pixels (number of weakly positive, positive, or strongly positive pixels divided by total
pixels) in the applicable viable tumor area (designated by excluding necrotic volumes
identified on H&E images) was then calculated. Scale bars are shown.
In vitro corollary
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HCT116 GFP cells discussed above and MCF7 cells separately purchased from ATCC
(not transfected with fluorescent reporter and maintained in DMEM with 10% FBS and
1x penicillin/streptomycin) were used for in vitro experiments paralleling the above in
vivo queries. 450,000 HCT116 cells were seeded in 35 mm dishes and allowed to
expand for 3 days in normal culture conditions (DMEM/F12 supplemented with 10%
newborn calf serum in standard 5% CO2 incubators). Media was then changed to DMEM
medias as used for U2OS experiments (defined in detail above): low buffer with DMSO
(vehicle), low buffer with 1 mM DMOG, high buffer with DMSO, high buffer with 1 mM
DMOG, or PIPES/HEPES buffered DMEM pre-adjusted to six different pH values (pH
7.4, 7.0, 6.8, 6.6, 6.5, and 6.3). Plates with highly buffered media continued in 5% CO2
incubators. All other plates were moved to humidified incubators with atmospheric CO2.
Protein was harvested for western blots and media pH was assessed at the indicated
time points. MCF7 cells were split into 35 mm dishes, allowed to expand for several days
until confluent, and then treated with the same media and DMOG conditions as with
HCT116 cells with time points as indicated.
P493 xenografts
Tumor formation
P493 cells were cultured in standard RPMI 1640 media with 10% FBS and antibiotics in
standard 37 °C humidified incubators in 5% CO2 as described above. All animals were
maintained in accordance with the guidelines of the Institutional Animal Care and Use
Committee (IACUC) at The Wistar Institute. Xenografts were formed in 6- to 8-week old
athymic female nude mice (Charles River) through subcutaneous flank injection of 20
million P493 cells collected from culture.
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The rapamycin-treated mouse received one dose of rapamycin (8 mg/kg) administered
intraperitoneally in a vehicle of 5% PEG-400 (Sigma) and 5% Tween 80 (Sigma) (Bitto et
al., 2016; Huang et al., 2012) one hour before sacrifice and xenograft harvest.
At study endpoints, mice were sacrificed by cervical dislocation. Tumor volumes were
approximated by caliper measurement as length*width*width*0.52 (where width <
length).
Immunofluorescence and immunohistochemical staining
Immunofluorescence staining was performed on 5 µm formalin-fixed, paraffin-embedded
sections. The sections were deparaffinized in Xylene Substitute (Surgipath) and then
iteratively rehydrated with 100%, 95%, and 70% ethanol followed by Millipore water.
Antigen retrieval was performed in a digital decloaking chamber (Biocare Medical) using
citric acid-based antigen unmasking solution (Vector Laboratories). Sections were
blocked with avidin/biotin blocking kit (Vector Laboratories) followed by 4% BSA (Sigma)
at room temperature for 30 minutes. Sections were then incubated overnight at 4 °C with
rabbit anti-phospho S6 (Ser235/236) (Cell Signaling, Cat#4858) diluted 1:100 in blocking
buffer. Sections were then washed three times with 0.1% PBST prior to incubation with
Alexa Fluor 488 conjugate anti-rabbit secondary antibody (Invitrogen, A11034) for 45
minutes at room temperature. After three washes, incubation with DAPI (ThermoFisher,
D3571) for 5 minutes, and another three washes, sections were mounted with
VECTASHIELD (Vector Laboratories).
For immunohistochemistry staining of pS6 and Ki67, sections were prepared as above
with the addition of an additional incubation in 1% H2O2 at room temperature for 15
minutes to block endogenous peroxidase activity prior to proceeding with the above
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blocking. Primary antibodies included anti-phospho-S6 as above and anti-Ki67 (Thermo
Scientific) diluted 1:100. For dual-target staining, staining was performed on adjacent
sections. After overnight incubation and washes as above, sections were incubated for
40 minutes at room temperature with biotinylated goat anti-rabbit secondary antibody
(Vector Laboratories) diluted 1:250. Sections were then washed three times, treated for
40 minutes with ABC-HRP (Vector Laboratories), and then washed another three times
for 5 minutes each. Colorimetric detection then proceeded with DAB (Vector
Laboratories) with diluted Harris Hematoxylin (Fisher Chemical) to counterstain nuclei.
Product numbers of reagents in Appendix.
Image acquisition and processing
Confocal images of pS6 immunofluorescence staining across the entire tumor crosssectional area were obtained using a Leica TCS SP8 confocal scanning microscope
through a semi-automated stitching protocol. Data were analyzed using Nikon
microscope image software NIS. Necrotic areas identified via comparison to hematoxylin
and eosin stained adjacent slices were excluded from analysis. Tumor edge was
demarcated and the percent of pixels positive for pS6 was calculated for the entire viable
tumor cross sectional area as well as for concentric regions of interest (shells) of 1 mm
width. Positivity threshold was determined by measurement of non-cytoplasmic
(background) signal in a representative region.
Images of immunohistochemical staining of pS6 and Ki67 were obtained on a Nikon
Eclipse 80i microscope equipped with 2x and 10x objectives using Nikon NIS-Elements
Basic Research software or on an Epson Perfection V39 scanner at 2400-4800 dpi
resolution. Scale bars as shown.
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In vitro corollary
2.1 million cells were resuspended in 7 mL of PIPES/HEPES buffered DMEM media (as
above) preadjusted to pH 7.4, 7.0, 6.8, 6.6, 6.5, and 6.3 and flasks were moved to a
humidified incubator with atmospheric CO2. After 24 hours culture, cells were spun down
at 300 RCF for 5 min, washed once with cold PBS, spun down again for 5 min at 4°C,
and then lysed in lysis buffer and subjected to western blot analysis as above.
PANC02 tumors
Formalin-fixed, paraffin-embedded tissue blocks of the murine orthotopic pancreatic
tumor

model

PANC02

were

generously

provided

by

Dr.

Robert

Gillies.

Immunohistochemistry staining for carbonic anhydrase IX (Novus Biologicals, 1:500) and
phospho-S6

was

performed

on

adjacent

5

μm

sections

as

for

P493

immunohistochemistry described above. Product numbers of reagents in Appendix.
Images were then acquired using an Epson Perfection V39 scanner at 4800 dpi
resolution. Scale bars are shown.
Quantification and Statistical Analysis
Statistical details of experiments, including the number of biological replicates, are as
described in legends and above. Pooled data are presented as the mean plus and minus
the standard error of the mean (SEM) or standard deviation (SD) of biological replicates
as indicated in legends and calculated by Microsoft Excel or GraphPad Prism. In rare
instances of error bars representing variation among technical replicates (Figures S1E,
S1K, S7F), this is indicated in legend. For continuous luminometer readings of cells
expressing luciferase-based reporters presented as the mean of biological replicates
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(e.g. Figure 1J), most error bars have been removed to enhance readability of figures;
however, to give a sense of the typical variation among replicates with this technique,
SEM error bars have been retained for randomly selected figures (Figures S1G, S1J,
S2B, 4I, and S4N). For analysis of the RNA-sequencing timecourses, statistical criteria
for designation as circadian and enriched ontology calls are described above. Other
tests for statistical significance, including t-tests, ANOVA, and post-hoc tests are
described in figure legends. When tests that correct for multiple comparisons are
employed, adjusted p-values are presented. Referenced biological replicates in some
instances encompass experiments with minor alterations of procedure (e.g. modified
drug concentrations, modified timings of exposures and sampling, immunoblot
assessment of alternate proteins within the pathway or network, etc.) intended to verify
robustness of result and independence from technical artifacts.
Data and Software Availability
Raw and processed RNA-seq data from this study have been submitted to NCBI Gene
Expression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/) under accession number
GSE101988.
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APPENDIX
Table 1 - Regents and Resources
REAGENT or RESOURCE
Antibodies

SOURCE

IDENTIFIER

Rabbit polyclonal anti-HIF1α

Cayman
Chemical

Cat#:10006421;
RRID:AB_10099184

Mouse monoclonal anti-α-tubulin (clone DM1A)

Calbiochem

Cat#:CP06;
RRID:AB_212802

Rabbit polyclonal anti-PER2

Proteintech

Cat#:20359-1-AP;
RRID:AB_10733224

Rabbit monoclonal anti-BMAL1 (clone D2L7G)

Cell Signaling

Cat#:14020;
RRID:AB_2728705

Rabbit monoclonal anti-CLOCK (clone
D45B10)

Cell Signaling

Cat#:5157;
RRID:AB_10695411

Rabbit polyclonal anti-CRY2

Epitomics

Cat#:T1225;
RRID:AB_10706277

Rabbit monoclonal anti-phospho-mTOR
(Ser2448) (clone D9C2)

Cell Signaling

Cat#:5536;
RRID:AB_10691552

Rabbit monoclonal anti-mTOR (clone 7C10)

Cell Signaling

Cat#:2983;
RRID:AB_2105622

Rabbit monoclonal anti-phospho-p70 S6
Kinase (Thr389) (clone108D2)

Cell Signaling

Cat#:9234;
RRID:AB_2269803

Rabbit polyclonal anti-p70 S6 kinase

Cell Signaling

Cat#:9202;
RRID:AB_331676

Rabbit monoclonal anti-phospho-S6 ribosomal
protein (Ser235/236) (clone D57.2.2E)

Cell Signaling

Cat#:4858;
RRID:AB_916156

Rabbit monoclonal anti-phospho-S6 ribosomal
protein (Ser235/236) (clone2F9)

Cell Signaling

Cat#:4856;
RRID:AB_2181037

Mouse monoclonal anti-S6 ribosomal protein
(clone 54D2)

Cell Signaling

Cat#:2317;
RRID:AB_2238583

Rabbit monoclonal anti-phospho-4E-BP1
(Thr37/46) (clone 236B4)

Cell Signaling

Cat#:2855;
RRID:AB_560835

Rabbit monoclonal anti-4E-BP1 (clone 53H11)

Cell Signaling

Cat#:9644;
RRID:AB_2097841
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Rabbit polyclonal anti-4EBP2

Cell Signaling

Cat#:2845;
RRID:AB_10699019

Rabbit polyclonal anti-phospho-eIF4E (Ser209)

Cell Signaling

Cat#:9741;
RRID:AB_331677

Rabbit monoclonal anti-eIF4E (clone C46H6)

Cell Signaling

Cat#:2067;
RRID:AB_10828612

Rabbit polyclonal anti-phospho-eEF2 (Thr56)

Cell Signaling

Cat#:2331;
RRID:AB_10015204

Rabbit polyclonal anti-eEF2

Cell Signaling

Cat#:2332;
RRID:AB_10015206

Rabbit polyclonal anti-Sestrin-2 (clone D1B6)

Cell Signaling

Cat#:8487;
RRID:AB_11178663

Rabbit monoclonal anti-DYKDDDDK (FLAG)
tag (clone D6W5B)

Cell Signaling

Cat#:14793;
RRID:AB_2572291

Rabbit monoclonal anti-Tuberin/TSC2 (clone
D93F12)

Cell Signaling

Cat#:4308;
RRID:AB_10547134

Rabbit monoclonal anti-phospho-AMPKα
(Thr172) (clone 40H9)

Cell Signaling

Cat#:2535;
RID:AB_331250

Rabbit monoclonal anti-AMPKα (clone 23A3)

Cell Signaling

Cat#:2603;
RRID:AB_490795

Rabbit monoclonal anti-AMPKα (clone D5A2)

Cell Signaling

Cat#:5831;
RRID:AB_10622186

Rabbit monoclonal anti-phospho-c-Raf
(Ser338) (clone 56A6)

Cell Signaling

Cat#:9427;
RRID:AB_2067317

Mouse monoclonal anti-c-Raf (clone D5X6R)

Cell Signaling

Cat#:12552;
RRID:AB_2728706

Rabbit monoclonal anti-phospho-p44/42 MAPK
(Erk1/2) (Thr202/Tyr204) (clone D13.14.4E)

Cell Signaling

Cat#:4370;
RRID:AB_2315112

Rabbit monoclonal anti-p44/42 MAPK (Erk1/2)
(clone 137F5)

Cell Signaling

Cat#:4695;
RRID:AB_390779

Rabbit monoclonal anti-phospho-GSK-3β
(Ser9) (clone D85E12)

Cell Signaling

Cat#:5558;
RRID:AB_10013750

Rabbit polyclonal anti-REDD1

Proteintech

Cat#:10638-1-AP;
RRID:AB_2245711

Mouse monoclonal anti-LAMP2 (clone H4B4)

Abcam

Cat#:ab25631;
RRID:AB_470709
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Rat monoclonal anti-LAMP2 (clone GL2A7)

Abcam

Cat#:ab13524;
RRID:AB_2134736

Rabbit monoclonal anti-α-tubulin (clone 11H10)
Alexa Fluor 488 conjugate

Cell signaling

Cat#:5063;
RRID:AB_10694858

Alexa Fluor 488 phalloidin

Cell signaling

Cat#:8878

Rabbit monoclonal anti-EX2/3

Clippinger et al.,
2011.

Rabbit polyclonal anti-kinesin-1 heavy chain

Santa Cruz

Cat#:28538;
RRID:AB_2280915

Rabbit monoclonal anti-RHEB (clone E1G1R)

Cell Signaling

Cat#:13879;
RRID:AB_2721022

Rabbit anti phospho-PERK (Thr 982)

Laboratory of
Constantinos
Koumenis

Rabbit monoclonal anti-PERK (clone C33E10)

Cell Signaling

Cat#:3192;
RRID:AB_2095847

Rabbit monoclonal anti-ATF4 (clone D4B8)

Cell Signaling

Cat#:11815;
RRID:AB_2616025

Mouse monoclonal anti-CHOP (clone L63F7)

Cell Signaling

Cat#: 2895;
RRID:AB_2089254

Rabbit monoclonal anti-phospho-eIF2α (Ser51)
(clone D9G8)

Cell Signaling

Cat#:3398;
RRID:AB_2096481

Rabbit monoclonal anti-eIF2α (clone D7D3)

Cell Signaling

Cat#:5324;
RRID:AB_10692650

Rabbit monoclonal anti-phospho-S6 ribosomal
protein (Ser240/244) (clone D68F8)

Cell signaling

Cat#: 5364;
RRID:AB_10694233

Brilliant violet 650 rat monoclonal anti-mouse
CD8a (clone 53-6.7)

Biolegend

Cat#: 100742;
RRID:AB_2563056

Brilliant violet 786 rat monoclonal anti-mouse
CD4 (clone RM4-5)

BD Bioscience

Cat#: 563727;
RRID:AB_2728707

Mouse monoclonal anti-RHEB (clone 2C11)

Abnova

Cat#: H00006009-M01;
RRID:AB_1112097

Sheep polyclonal anti-LAMP1 Alexa Fluor 488
conjugate

R&D Systems

Cat#: IC7985G

Rabbit monoclonal anti-LAMP1 (cloneD2D11)

Cell Signaling

Cat#:9091;
RRID:AB_2687579
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Rabbit polyclonal anti-phospho-S6
(Ser240/244)

Thermo Fisher
Scientific

Cat#: PA1-39503;
RRID:AB_10977292

Rabbit polyclonal anti-carbonic anhydrase IX
(CAIX)

Abcam

Cat#:ab15086

Rabbit monoclonal anti-TXNIP
(cloneEPR14774)

Abcam

Cat#:ab188865

Mouse polyclonal anti-PER2

Sigma

Cat#: HPA060510

Rabbit monoclonal anti-Ki-67 (clone SP6)

Thermo Fisher

Cat#: RM-9106

Rabbit polyclonal anti-carbonic anhydrase IX

Novus Biologicals

Cat#: NB100-417

Alexa Fluor 647 goat anti-rabbit IgG (H+L)
cross-adsorbed

Invitrogen

Cat#: A21244;
RRID:AB_141663

Alexa Fluor plus 647 goat anti-rabbit IgG (H+L)
highly cross-adsorbed

Invitrogen

Cat#:A32733;
RRID:AB_2633282

Alexa Fluor 790 goat anti-mouse IgG (H+L)
highly cross-adsorbed

Invitrogen

Cat#: A11357;
RRID:AB_2534140

Alexa Fluor 680 goat anti-rabbit IgG (H+L)
highly cross-adsorbed

Invitrogen

Cat#: A-21109;
RRID:AB_2535758

Alexa Fluor 488, goat anti-rabbit IgG (H+L)
highly cross-adsorbed

Invitrogen

Cat#: A-11034;
RRID:AB_2576217

Alexa Fluor 594 goat anti-mouse IgG (H+L)
highly cross-adsorbed

Invitrogen

Cat#: A-11032;
RRID:AB_141672

Alexa Fluor Plus 555 goat anti-mouse IgG
(H+L) highly cross-adsorbed

Invitrogen

Cat#: A-32727;
RRID:AB_2633276

Alexa Fluor 555 goat anti-rat IgG (H+L) crossadsorbed

Invitrogen

Cat#: A-21434;
RRID:AB_141733

Alexa Fluor 488, goat anti-mouse IgG (H+L)
cross-adsorbed

Invitrogen

Cat#: A-11001;
RRID:AB_2534069

Alexa Fluor 594 goat anti-rabbit IgG (H+L)
highly cross-adsorbed

Invitrogen

Cat#: A-11037;
RRID:AB_2534095

Biotinylated Goat Anti-Rabbit IgG Antibody

Vector
Laboratories

Cat#: BA-1000

Hamster monoclonal anti-CD3 (clone 1452c11)

In-house
hybridoma
(Laboratory of
Jonathan Powell)
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Hamster monoclonal anti-CD28 (clone 37.51)

In-house
hybridoma
(Laboratory of
Jonathan Powell)

Mouse monoclonal anti-Hamster IgG1 (clone
HIG-632)

BD Biosciences

Cat#: 550637;
RRID:AB_393797

Bacterial and Virus Strains
Human cytomegalovirus (Towne strain variant)

Clippinger et al.,
2011.

Biological Samples
Formalin-fixed, paraffin-embedded tissue
blocks of the murine orthotopic pancreatic
tumor model PANC02

Robert Gillies
Lab

Chemicals, Peptides, and Recombinant Proteins
Beetle luciferin, potassium salt

Promega

E1602;

Dexamethasone

Sigma

D4902; CAS 50-02-2

Dulbecco's MEM (DMEM) high glucose

Corning

MT10-013-CV

DMEM high glucose w/o L-glutamine, phenol
red, and sodium bicarbonate (powder)

USBiological

D9812-05

DMEM low glucose w/o L-glutamine, leucine,
phenol red, and sodium bicarbonate (powder)

USBiological

D9806-05

DMEM low glucose, w/o amino acids, pyruvic
acid, and sodium bicarbonate (powder)

USBiological

D9800-13

DMEM/F12 (Ham)

Gibco

11320-033

RPMI-1640

Corning

10-040

RPMI-1640 without glucose and sodium
bicarbonate (powder)

Sigma

R1383

RPMI-1640

Gibco

11875-093

Sodium bicarbonate 7.5% solution

Gibco

25080094

Sodium bicarbonate

Fisher Scientific

S233-3; CAS 144-55-8
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HEPES solution

Sigma, Corning

H0887, 25-060-CI; CAS
7365-45-9

HEPES

Sigma

H4034;CAS 7365-45-9

PIPES

Sigma

P1851; CAS 5625-37-6

L-arginine monohydrochloride

Sigma

A6969; CAS 1119-34-2

L-cystine dihydrochloride

Sigma

C6727; CAS 30925-07-6

L-glutamine

Sigma

G3126; CAS 56-85-9

Glycine

Sigma

G8790; CAS 56-40-6

L-histidine

Sigma

H6034; CAS 71-00-1

L-isoleucine

Sigma

I7403; CAS 73-32-5

L-leucine

Sigma

L8912; CAS 61-90-5

L-Lysine monohydrochloride

Sigma

L8662; CAS 657-27-2

L-methionine

Sigma

M5308; CAS 63-68-3

L-phenylalanine

Sigma

P5482; CAS 63-91-2

L-serine

Sigma

S4311; CAS 56-45-1

L-threonine

Sigma

T8441; CAS 72-19-5

L-tryptophan

Sigma

T8941; CAS 73-22-3

L-tyrosine

Sigma

T8566; CAS 60-18-4

L-valine

Sigma

V0513; CAS 72-18-4

Glutamine (solution)

Lonza, Corning

17-605E; 25-005

Pyruvate

Gibco

11360070

D-(+)-glucose powder

Sigma

G7021; CAS 50-99-7

Fetal bovine serum

HyClone, Gemini
Bioproducts

SH30910.03

Fetal Bovine Serum, dialyzed

Gibco

26400044

Newborn Calf Serum

HyClone GE
Healthcare

SH30118.02

Penicillin-Streptomycin Solution (100x)

Corning

MT30002CI

Penicillin-Streptomycin Solution (100x)

Gibco

15140122
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MEM non-essential amino acids solution
(100x)

Gibco

11140050

B-27 Supplement (50x), serum free

Gibco

17504044

High-vacuum silicone grease

Dow
Corning/Sigma

Z273554

Bovine Serum Albumin

Sigma

A7906

Restore Western blot stripping buffer

Thermo Scientific

21059

2-Mercaptoethanol

Sigma

M3148; CAS 60-24-2

Gentamycin

Quality Biological

120-098-661

G418 sulfate

Corning

MT30-234-CR

Hygromycin B solution

Corning

30-240-CR

Puromycin dihydrochloride

Gibco

A1113803

DMOG (dimethyloxalylglycine)

Sigma

D3695; CAS 89464-63-1

Desferrioxamine mesylate

Calbiochem

252750; CAS 138-14-7

GNE-140

Matt Hall,
National Center
for Advanced
Translational
Sciences
(NCATS)
Chemical
Genomics
Center, NIH

CAS:1802977-61-2

TRIzol reagent

Invitrogen

15596018

TaqMan Reverse transcription kit

Invitrogen

N8080234

iScript reverse transcription supermix

Bio-Rad

1708841

Valinomycin

Invitrogen

P35379; CAS 2001-95-8

Nigercin, free acid

Invitrogen

P35379; CAS 28380-247

Amiloride hydrochloride hydrate

Sigma

A7410; CAS 2016-88-8

α-cyano-4-hydroxycinnamic acid

Sigma

C2020; CAS 28166-41-8

Mammalian protein extraction reagent (M-PER)

Thermo Scientific

PI78501

A-484954

Sigma

SML0861; CAS 14255761-7
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Torin1

Cayman
chemical

10997; CAS 222998-368

Torin2

Cayman
chemical

14185; CAS 122300151-1

Rapamycin

Sigma

R0395; CAS 53123-88-9

n-butanol

Sigma

537993; CAS 71-36-3

tert-butanol (t-butanol)

Sigma

B85927; CAS 75-65-0

Anti-FLAG M2 affinity gel

Sigma

A2220

β-glycerophosphate disodium salt hydrate

Sigma

G9422; CAS 154804-510

Sodium pyrophosphate dibasic

Sigma

71501; CAS 7758-16-9

cOmplete, Mini, EDTA-free Protease Inhibitor
Cocktail

Roche

4693159001

Magnesium chloride

Sigma

M8266; CAS 7786-30-3

Ciliobrevin D

Calbiochem

250401; CAS

Nocodazole

Cayman
chemical

13857; CAS 31430-18-9

Polybrene

Millipore

TR-1003-G

Paraformaldehyde

Electron
Microscopy
Sciences

19208; CAS 30525-89-4

Methanol free 4% paraformaldehyde

Invitrogen

FB002

10% neutral buffered formalin

Thermo Fisher
Scientific

5705

Poly-D-lysine hydrobromide (mol wt 70,000150,000)

Sigma

P0899; CAS 27964-99-4

Type I collagen, rat tail

Corning

354249

Goat serum

Sigma

G9023

Rabbit serum

Sigma

R9133

DAPI

Invitrogen

D21490; CAS 28718-903

Fluoromount-G

SouthernBiotech/
Fisher

OB10001
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Covergrip coverslip sealant

Biotium

23005

Lipofectamine LTX reagent with PLUS reagent

Invitrogen

15338100

Lipofectamine 3000 transfection reagent

Invitrogen

L3000008

Lipofectamine RNAiMAX transfection reagent

Invitrogen

13778150

ACK lysing buffer

Quality Biological

118-156-101

Recombinant Murine IL-2

Peprotech

212-12

Recombinant SIINFEKL (ovalbumin) peptide

Anaspec

AS-60193

Cycloheximide solution

Sigma

C4859; CAS 66-81-9

Cycloheximide

Sigma

C1988; CAS 66-81-9

Sucrose

Fisher scientific

S25590B; CAS 57-50-1

NaCl, 5M solution

Invitrogen

AM9759; CAS 7647-145

Tris-HCl, 1M solution, pH 7.5

Invitrogen

15567-027

MgCl2, 1M solution

Invitrogen

AM9530G; CAS 778630-3

Heparin sodium salt

Sigma

H3149; CAS 9041-08-1

Triton X-100

Sigma

T8787; CAS 9002-93-1

Guanidine-HCl, 8M solution

Thermo Scientific

24115

Tris-EDTA

Sigma

93302

Sodium acetate, 3M, pH 5.2

Thermo Scientific

R1181

LiCl Solution, pH 7.5

Invitrogen

AM9480

Tween 80

Sigma

P4780

Poly(ethylene glycol), 400

Sigma

91893; CAS 25322-68-3

17β-ESTRADIOL pellet, 0.72 mg, 60-day
release

Innovative
Research of
America

SE-121

Bond dewax solution

Leica

AR9222

Bond TM Epitope Retrieval 2 (ER2) solution

Leica

AR9640

Bond Polymer Refine Red Detection

Leica

DS9390

EZ Prep solution (10x)

Ventana

950-102
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RiboCC

Ventana

760-107

Dako antibody diluent

Agilent

S080983-2

DISCOVERY OmniMap anti-Rb HRP (RUO)

Ventana

760-4311

DISCOVERY ChromoMap DAB Kit (RUO)

Ventana

760-159

SUB-X CLEARING AGENT (Xylene substitute)

Leica/Surgipath

3803672

Antigen Unmasking Solution, Citric Acid Based

Vector
Laboratories

H-3300

Avidin/Biotin Blocking Kit

Vector
Laboratories

SP-2001

DAPI

Thermo Fisher

D3571

VECTASHIELD Antifade Mounting Medium

Vector
Laboratories

H-1000

VECTASTAIN Elite ABC HRP Kit (Peroxidase,
Standard)

Vector
Laboratories

PK-6100

DAB Peroxidase (HRP) Substrate Kit (with
Nickel), 3,3’-diaminobenzidine

Vector
Laboratories

SK-4100

Harris Modified Method Hematoxylin Stain with
Acetic Acid

Fisher Chemical

SH26-500D

RNeasy plus mini kit

Qiagen

74134

DC protein assay kit II

Bio-Rad

5000112

Luciferase assay system

Promega

E1501

TaqMan universal PCR master mix

Thermo Fisher

4304437

Power SYBR™ Green PCR Master Mix

Thermo Fisher

4368708

Illumina TruSeq Stranded mRNA Library
Preparation kit

Illumina

RS-122-2101

LysoTracker Deep Red

Invitrogen

L12492

TubulinTracker Green (Oregon Green™ 488
Taxol, Bis-Acetate)

Invitrogen

T34075

Critical Commercial Assays

Deposited Data
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Raw and processed RNA-sequencing

This study

GEO: GSE101988

Human: U2OS

Laboratory of
Roger Greenberg

ATCC HTB-96

Human: U2OS Arntl::dLUC

Laboratory of
John Hogenesch

Human: U2OS Per2::dLUC

Laboratory of
John Hogenesch

Human: U2OS PGK1-HRE::dLUC

This study

Human: U2OS VEGF-HRE::dLUC

This study

Human: U2OS mCherry-SEpHluorin

This study

Human: U2OS EIF4EBP1 -/- (4EBP1 -/-)

This study

Human: U2OS TSC2 -/-

This study

Human: U2OS PX458 empty vector (“no
gRNA”) clone #EV1_16

This study

Human: U2OS PX458 empty vector (“no
gRNA”) clone #EV2_6

This study

Human: U2OS RAP2A

This study

Human: U2OS RaGB99L

This study

Human: U2OS RHEBN153T

This study

Human: 293T

Laboratory of

Experimental Models: Cell Lines

Celeste Simon
Human: 293T Flag-WRD24

This study

Human: 293T Flag-RAP2A

This study

Human: 293T SESTRIN TKO

Laboratory of
David Sabatini

Mouse: Tp53 -/- MEFs

Laboratory of
David
Kwiatkowski via
laboratory of
Celeste Simon
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ATCC CRL-3216

Mouse: Tp53 -/- TSC2-/- MEFs

Laboratory of
David
Kwiatkowski via
laboratory of
Celeste Simon

Human: MDA-MB-231

Laboratory of
Donald E. Ayer
(in vitro work)

ATCC HTB-26

Human: MDA-MB-231 DsRed

Ibrahim-Hashim
et al., 2017

ATCC HTB-26

Human: MCF7 eGFP

Ibrahim-Hashim
et al., 2017

ATCC HTB-22

Human: MCF7

ATCC

ATCC HTB-22

Human: HCT-116 GFP

Estrella et al.,
2013

ATCC CCL-247

Mouse: Tsc2fl/fl Cd4-Cre (TSC2 -/-) T cells

Laboratory of
Jonathan Powell

Mouse: Tsc2fl/fl (TSC2 +/+) T cells

Laboratory of
Jonathan Powell

Mouse: OT-1 (OVA-specific CD8+ T cells)

Laboratory of
Jonathan Powell

Experimental Models: Organisms/Strains
Mouse: TSC2 -/-: C57BL/6 Tsc2fl/fl Cd4-Cre

Pollizzi et al.,
2015

CD4 Cre: JAX: 017336;

Mouse: TSC2 +/+: C57BL/6 Tsc2fl/fl

Pollizzi et al.,
2015

Tsc2fl/fl: Laboratory of
Michael Gambello

Mouse: OT-1 (OVA-specific CD8+ T cells):
C57BL/6-Tg(TcraTcrb)1100Mjb/J

Pollizzi et al.,
2015

JAX: 003831

Mouse: SCID (Fox Chase SCID Beige):
SCB17.Cg-PrkdcscidLystbg-J/Crl

Charles River

Charles River: strain
code 250

Mouse: nu/nu: Foxn1nu/nu

Envigo

Envigo: 069

Oligonucleotides
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Tsc2fl/fl : Laboratory of
Michael Gambello

For qPCR primers, see Appendix Table 2
For DsiRNA oligos, See Appendix Table 2
sgRNA targeting EIF4EBP1:
TGAAGAGTCACAGTTTGAGA

GeCKO library;
Shalem et al.,
2014

CCDS ID: CCDS6100.1

sgRNA targeting TSC2:
TCTGCTGAAGGCCATCGTGC

GeCKO library;
Shalem et al.,
2014

CCDS ID:
CCDS10458.1

CleanCap™ β-gal mRNA (capped and poly-A
tailed codon optimized beta galactosidase
mRNA)

Trilink

L-7608

pGL4.22

Promega

E6771

HRE-pGL2-TK

Li et al., 2014

N/A

HRE/GFP

Laboratory of
Martin Brown and
Thomas Foster

Addgene plasmid
#46926

pGL4.22-PGK1-HRE::dLUC

This study

N/A

pGL4.22-VEGF-HRE::dLUC

This study

N/A

mCherry-SEpHluorin

Koivusalo et al.,
2010

Addgene plasmid
#32001

pSpCas9(BB)-2A-GFP (PX458)

Laboratory of
Feng Zhang

Addgene plasmid
#48138

PX458-sgEIF4EBP1 (sgRNA against
EIF4EBP1)

This study

N/A

PX458-sgTSC2 (sgRNA against TSC2)

This study

N/A

Flag-pLJM1-RAP2A

Sancak et al.,
2008

Addgene plasmid
#19311

Flag-pLJM1-RAGB99L

Sancak et al.,
2008

Addgene plasmid
#19315

pcDNA3.1+

Invitrogen

V79020

pcDNA3.1+ Flag-RAP2A

This study

N/A

pcDNA3.1+ Flag-RAGB99L

This study

N/A

Recombinant DNA
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Flag-pLJM1-WDR24

Laboratory of
David Sabatini

Addgene plasmid
#46337

LAMP1-mGFP

Laboratory of
Esteban DellAngelica

Addgene plasmid #
34831

LAMP1-mRFP-FLAG

Laboratory of
David Sabatini

Addgene plasmid
#34611

pcDNA3-FLAG-RHEB-N153T

Laboratory of
Fuyuhiko
Tamanoi

Addgene plasmid
#19997

psPAX2

Laboratory of
Didier Trono

Addgene plasmid
#12260

pMD2.G

Laboratory of
Didier Trono

Addgene plasmid
#12259

LumiCycle Analysis software, v. 2.56

ActiMetrics

http://actimetrics.com/pr
oducts/lumicycle/

R Studio, v. 0.99.491

RStudio

https://www.rstudio.com/

Spliced Transcripts Alignment to a Reference
(STAR) aligner

Dobin et al.,
2013.

https://github.com/alexd
obin/STAR

Cufflinks

Trapnell et al.,
2013

http://cole-trapnelllab.github.io/cufflinks/

MetaCycle (includes ARSER), v. 1.1.0

Wu et al., 2016.

https://cran.rproject.org/web/package
s/MetaCycle/index.html

ToppFun, version accessed 01/17/18

Chen et al., 2009.

https://toppgene.cchmc.
org/enrichment.jsp

VennDiagram package, v. 1.6.17

Hanbo Chen

https://CRAN.Rproject.org/package=Ve
nnDiagram

ggplot2

Hadley Wickham,

http://ggplot2.org/

Software and Algorithms

Winston Chang
Image Studio software, version 2.0

LI-COR
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https://www.licor.com/bio
/products/software/imag
e_studio_lite/

SlideBook 6

3i Intelligent
Imaging
Innovations

NIS-Elements Basic Research software, v.
4.13

Nikon

Zeiss ZEN, v2.3

Zeiss

Fiji (image J2 version)

Schindelin et al.,
2012.

https://fiji.sc/

Radial Profile plugin for Fiji

Paul Baggethun

https://imagej.nih.gov/ij/p
lugins/radial-profile.html

FlowJo

FlowJo

Prism, v. 7.03

GraphPad

Excel, 2010

Microsoft

MetaMorph

Molecular
Devices

Aperio Positive Pixel Count Algorithm, v. 9.0

Leica

Image-Pro Plus, v. 7.0

Media
Cybernetics

Other
Polymer oxygen control glove box (hypoxia
chamber)

Coy Labs

Custom size

LumiCycle 32

ActiMetrics

N/A

LumiCycle 96

ActiMetrics

N/A

SevenGo pH meter SG2 with InLab 413
SG/2m pH probe

Mettler Toledo

51302522

InLab micro pH probe

Mettler Toledo

51343160
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Table 2 – qPCR primers and DsiRNA oligos
qPCR primers and DsiRNA oligos
qPCR primers targeting B2M;
GGCCGAGATGTCTCGCTCCG,
TGGAGTACGCTGGATAGCCTCC

Primer-BLAST

qPCR primer targeting HIF1A;
AAGTTCTTCTGGCTCATATCCC,
ACCCATTCCTCACCCATCA

IDT

Hs.PT.58.20233486

qPCR primer targeting EPAS1;
CTTTGCGAGCATCCGGTA,
AGCCTATGAATTCTACCATGCG

IDT

Hs.PT.58.2273374

qPCR primer targeting PGK1;
AGAACCTCCGCTTTCATGTG, CATTGA
CATAGACATCCCCTAGC

IDT

Hs.PT.39a.1406561

qPCR primer targeting VEGF;
GTTCCCGAAACCCTGAGG,
GACGTGTAAATGTTCCTGCAAA

IDT

Hs.PT.56a.19704989

qPCR primer targeting PDK1;
CAAGAAGCTCCTGAAGACTCTG,
CAAGAGTTGCCTGTCAGACTG

IDT

Hs.PT.58.19794808

qPCR primer targeting SLC2A1 (GLUT1);
GTGCCATACTCATGACCATCG,
GGCCACAAAGCCAAAGAT

IDT

Hs.PT.56a.25872862

qPCR primer targeting ARNTL;

Taqman Gene

Hs00154147_m1

Expression
Assay
qPCR primer targeting PER2;
GGATGCCCGCCAGAGTCCAGAT,
TGTCCACTTTCGAAGACTGGTCGC

Primer-BLAST

qPCR primer targeting CRY1;

Taqman Gene

Hs01565974_m1

Expression
Assay
qPCR primer targeting NR1D1;
TGGACTCCAACAACAACACAG,
GATGGTGGGAAGTAGGTGGG

PrimerBank
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ID#300116298c1

qPCR primer targeting NR1D2;
AGTGTCTGTCTGTTGGAATGTC,
TCATGGTCTTCATTGCACTTTG

IDT

Hs.PT.51.14785042

qPCR primer targeting RORA;

Taqman Gene

Hs00536545_m1

Expression
Assay
qPCR primer targeting BHLHE40 (DEC1);
CTGTTTCGACATTTCTCCCTGA,
CTTGAACTTACCTTGAAGCATGT

IDT

Hs.PT.58.40041848

qPCR primer targeting EIF4EBP1 (4EBP1);
GCAATAGCCCAGAAGATAAGCG,
CCTTGGTAGTGCTCCACAC

IDT

Hs.PT.58.21283123

qPCR primer targeting EIF4EBP2 (4EBP2);
CCCAATATCCCAGGAGTCACT,
CTTGCAGGAGAGTCAGATGTC

IDT

Hs.PT.58.20248205

qPCR primer targeting TSC2

Taqman Gene

Hs01020387_m1

Expression
Assay
qPCR primer targeting SESN;
ATGACGAGATACAGCTCTTGC,
GGAATGTCGAGATGAAGAAGAGG

IDT

Hs.PT.58.15586412

qPCR primer targeting SESN2;
CAGGAGCTGGTTCACCTC,
CCTCACCTACAATACCATCGC

IDT

Hs.PT.58.19441147

qPCR primer targeting SESN3;
AAGTTCAGCTTGCATTCGTG,
AGTGACCTGCTATCCTGAGA

IDT

Hs.PT.58.26332673

qPCR primer targeting KIF5B;
GCTCTTGAGATGTGCTTGACT;
TCAACGAGTCTGAAGTGAACC

IDT

Hs.PT.58.25460225

qPCR primer targeting RHEB;
CCACCATATCCAACAATTTGCC,
TCTATCTTTCCTCAGACATACTCCA

IDT

Hs.PT.58.26919255

qPCR primer targeting RHEBL1;

IDT

Hs.PT.58.1282208

TTCCTTCAACTGCCTGTACC;
CTGCATAGCTTCCAAGTCATTG
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qPCR primer targeting TXNIP

Taqman Gene

Hs01006900_g1

Expression
Assay
Primer-BLAST

qPCR primer targeting β‐galactosidase;

CCACCAGCGAGATGGACTTC;
CTTGTCGCCGATCCACATCT
DsiRNA targeting HIF1A;
rArCrArArUrArCrCrCrUrArUrGrUrArGrUrUrGrUrGr
GrAAG;
rCrUrUrCrCrArCrArArCrUrArCrArUrArGrGrGrUrAr
UrUrGrUrUrU

IDT

HSC.RNAI.N001530.
12.2

DsiRNA targeting EPAS1 (HIF2α)
rGrCrArGrUrArCrCrCrArGrArCrGrGrArUrUrUrCrAr
ArUGA;
rUrCrArUrUrGrArArArUrCrCrGrUrCrUrGrGrGrUrA
rCrUrGrCrArU

IDT

HSC.RNAI.N001430.
12.2

DsiRNA targeting EIF4EBP1 #1;
rCrCrUrUrCrCrGrArArUrGrArUrCrArGrCrArGrUrUr
CrCAG;
rCrUrGrGrArArCrUrGrCrUrGrArUrCrArUrUrCrGrG
rArArGrGrArA

IDT

HSC.RNAI.N004095.
12.1

DsiRNA targeting EIF4EBP1 #2;
rGrGrCrCrUrUrArUrGrArArArGrUrGrArUrCrArUrAr
CrUGG;
rCrCrArGrUrArUrGrArUrCrArCrUrUrUrCrArUrArAr
GrGrCrCrUrG (used in western)

IDT

HSC.RNAI.N004095.
12.2

DsiRNA targeting EIF4EBP2;
rGrGrUrCrCrArUrArCrCrArArGrUrArArUrArGrArGr
GrCAC;
rGrUrGrCrCrUrCrUrArUrUrArCrUrUrGrGrUrArUrG
rGrArCrCrUrG

IDT

HSC.RNAI.N004096.
12.1

DsiRNA targeting KIF5B #1;
rGrUrArUrCrArArGrCrArGrUrCrArUrUrCrArArUrGr
ArCTA;
rUrArGrUrCrArUrUrGrArArUrGrArCrUrGrCrUrUrG
rArUrArCrCrA

IDT

hs.Ri.KIF5B.13.1

DsiRNA targeting KIF5B #2;
rCrCrArArGrArArUrArGrUrGrCrArArGrArUrArUrUr
UrUTA;
rUrArArArArArUrArUrCrUrUrGrCrArCrUrArUrUrCr
UrUrGrGrArA

IDT

hs.Ri.KIF5B.13.2
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DsiRNA targeting KIF5B #3;
rArArGrUrCrArUrUrGrArCrUrGrArArUrArCrCrUrUr
CrAAA;
rUrUrUrGrArArGrGrUrArUrUrCrArGrUrCrArArUrGr
ArCrUrUrGrA
DsiRNA targeting SESN1;
rGrGrArArUrGrUrCrGrArGrArUrGrArArGrArArGrAr
GrGCA;
rUrGrCrCrUrCrUrUrCrUrUrCrArUrCrUrCrGrArCrAr
UrUrCrCrUrG1

IDT

hs.Ri.KIF5B.13.3

IDT

HSC.RNAI.N014454.
12.1

DsiRNA targeting SESN2;
rCrCrArCrCrCrGrArArGrArArUrGrUrArCrArArCrCr
UrCTT;
rArArGrArGrGrUrUrGrUrArCrArUrUrCrUrUrCrGrG
rGrUrGrGrUrC

IDT

HSC.RNAI.N031459.
12.3

DsiRNA targeting SESN3;
rGrCrUrArArUrArUrCrArGrUrCrArArCrArArUrUrUr
CrUGC;
rGrCrArGrArArArUrUrGrUrUrGrArCrUrGrArUrArUr
UrArGrCrCrU

IDT

HSC.RNAI.N144665.
12.2

DsiRNA targeting TSC2;
rCrCrArArGrUrUrUrArArUrCrArGrUrArCrArUrCrGr
UrGTG;

IDT

HSC.RNAI.N0011143
82.12.2

IDT

hs.Ri.RHEB.13.1

IDT

hs.Ri.RHEBL1.13.1

IDT

hs.Ri.RHEBL1.13.2

rCrArCrArCrGrArUrGrUrArCrUrGrArUrUrArArArCr
UrUrGrGrArG
DsiRNA targeting RHEB;
rArCrArArArGrUrUrGrArUrCrArCrArGrUrArArArUr
GrGAC;
rGrUrCrCrArUrUrUrArCrUrGrUrGrArUrCrArArCrUr
UrUrGrUrArA
DsiRNA targeting RHEBL1 #1;
rCrUrUrArCrArGrCrArArGrArUrArGrUrGrArCrUrCr
UrUGG;
rCrCrArArGrArGrUrCrArCrUrArUrCrUrUrGrCrUrGr
UrArArGrUrA
DsiRNA targeting RHEBL1 #2;

rCrCrArArGrUrCrArUrUrGrArGrArGrUrCrUrGr
UrArCrCAA;
rUrUrGrGrUrArCrArGrArCrUrCrUrCrArArUrGr
ArCrUrUrGrGrArA
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DsiRNA targeting RHEBL1 #3;

IDT

hs.Ri.RHEBL1.13.3

IDT

hs.Ri.TXNIP.13.2

IDT

NC1 control duplex

rUrGrArUrGrArArUrUrCrUrGrUrUrArUrArArCr
CrUrArUGG;
rCrCrArUrArGrGrUrUrArUrArArCrArGrArArUr
UrCrArUrCrArArA
DsiRNA targeting TXNIP #2;
rGrCrArArCrArUrCrCrUrUrCrGrArGrUrUrGrArArUr
ArUTC;
rGrArArUrArUrUrCrArArCrUrCrGrArArGrGrArUrGr
UrUrGrCrArG
Control non-targeting DsiRNA:
rCrGrUrUrArArUrCrGrCrGrUrArUrArArUrArCrGrCr
GrUrArT;
rArUrArCrGrCrGrUrArUrUrArUrArCrGrCrGrArUrUr
ArArCrGrArC
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